近畿大学医学部放射線医学教室放射線腫瘍学部門

近畿大学医学部放射線医学講座、研究業績目録

I. 博士学位

放射線医教室・放射線腫瘍学部門 (Radiation Oncology)　2005-2021年
1. 2021年
  氏名：植原拓也　 (Uehara Takuya)
  Dose-volume histogram analysis and clinical evaluation of knowledge-based plans with manual objective constraints for pharyngeal cancer
2. 2021年
  氏名：和田祐太郎 (Wada Yutaro)
  Difference in VMAT dose distribution for prostate cancer with/without rectal gas removal and/or adaptive replanning
3. 2018年
  氏名：建部仁志 (Tatebe Hitoshi)
  Two-step intensity-modulated radiation therapy for oropharyngeal cancer:
  initial clinical experience and validation of clinical staging.
4. 2017年
  氏名：稲田正浩（Masahiro Inada）
  Dosimetry advantages of intraoperatively built custom-linked seeds compared with loose seeds in permanent prostate brachytherapy.
5. 2016年
  氏名：松浦知弘（Tomohiro Matsuura）
  Clinical outcomes of IMRT planned with or without PET/CT simulation for patients with pharyngeal cancers.
6. 2015年
  氏名：石川一樹（Kazuki　Ishikawa）
  Doctoral Dissertation：Clinical results of definitive-dose(50Gy/25 fraction) preoperative chemotherapy for unresectable esophageal cancer.
7. 2014年
  氏名：立花和泉（Izumi Tachibana）
  Doctoral Dissertation：A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.
8. 2009年
  氏名：小池竜太（Ryuta Koike）
  Doctoral Dissertation：Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.
9. 2009年
  氏名：大久保充　(Mitsuru Okubo)
  Doctoral Dissertation：Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system.
10. 2006年
  氏名：西田千嘉子（Chikako Nishida）
  Doctoral Dissertation：The relationship between coronary artery calcification detect by non-gate multi detector CT in patients with suspected ischemic heart disease and myocardial ischemia detected by Thallium exercise stress testing.
11. 2005年
  氏名：中松清志　（Kiyoshi Nakamatsu）
  Doctoral Dissertation：Erythropoietin / Erythropoietin-receptor system as an angiogenic factor in chemically-induced murine hepatic tumors.

大学院医学研究科・医学物理学 (Medical Physics)　2013-2021年

II. 英文原著論文

2021年
1. Inagaki T, Doi H , Ishida N, Ri A, Tatsuno S, Wada Y, Uehara T, Inada M, Nakamatsu K, Hosono M, Nishimura Y. Escalated maximum dose in the planning target volume improves local control in stereotactic body radiation therapy for T1-2 lung cancer. Cancers. 2022; 14(4):933. DOI: 10.3390/cancers14040933
2. Tatsuno S, Doi H, Okada W, Inoue E, Nakamatsu K, Tanooka M, Tanaka M, Nishimura Y. Risk factors for radiation pneumonitis after rotating gantry intensity-modulated radiation therapy for lung cancer. Scientific Reports. 2022 ,12, 590, DOI: 10.1038/s41598-021-04601-0
3. Kiyota N, Tahara M, Mizusawa J, Kodaira T, Fujii H, Yamazaki T, Mitani H, Iwae S, Fujimoto Y, Onozawa Y, Hanai N, Ogawa T, Hara H, Monden N, Shimura E, Minami S, Fujii T, Tanaka K, Homma A, Yoshimoto S, Oridate N, Omori K, Ueda T, Okami K, Ota I, Shiga K, Sugasawa M, Asakage T, Saito Y, Murono S, Nishimura Y, Nakamura K, Hayashi R, Head and Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG). Weekly cisplatin plus radiation for postoperative head and neck cancer (JCOG1008): a multicenter, noninferiority, phase II/III randomized controlled trial. J Clin Oncol. 2022;JCO2101293. Online ahead of print.
  DOI: 10.1200/JCO.21.01293
4. Akiyama H, Yoshida K, Takenaka T, Kotsuma T, Masui K, Monzen H, Sumida I, Tsujimoto Y, Miyao M, Okumura H, Shimbo T, Takegawa H, Murakami N, Inaba K, Kashihara T, Takácsi-Nagy Z, Tselis N, Yamazaki H, Tanaka E, Nihei K, Ariji Y. Effect of a lead block on alveolar bone protection in image-guided high-dose-rate interstitial brachytherapy for tongue cancer: using model-based dose calculation algorithms to correct for inhomogeneity. J Contemp Brachytherapy. 2022;14(1):87-95. DOI: 10.5114/jcb.2022.113232
5. Uehara T, Monzen H, Tamura M, Inada M, Otsuka M, Doi H, Matsumoto K, Nishimura Y. Feasibility study of volumetric modulated arc therapy with Halcyon™ linac for total body irradiation. Radiation Oncology. 2021;16(1):236. DOI: 10.1186/s13014-021-01959-3 DOI: 10.1186/s13014-021-01959-3
6. Hosono M, Takenaka M, Monzen H, Tamura M, Kudo M, Nishimura Y. Cumulative radiation doses from recurrent PET-CT examinations. Br J Radiol. 2021;94(1126):20210388. DOI: 10.1259/bjr.20210388 DOI: 10.1259/bjr.20210388
7. Wada Y, Monzen H, Otsuka M, Doi H, Nakamatsu K, Nishimura Y. Difference in VMAT dose distribution for prostate cancer with/without rectal gas removal and/or adaptive replanning. Med Dosim. 2022;47(1):87-91. DOI: 10.1016/j.meddos.2021.09.002
8. Doi H, Yokoyama H, Beppu N, Fujiwara M, Harui S, Kakuno A, Yanagi H, Hishikawa Y, Yamanaka N, Kamikonya N. Neoadjuvant Modified Short-Course Radiotherapy Followed by Delayed Surgery for Locally Advanced Rectal Cancer. Cancers. 2021;13(16):4112. DOI: 10.3390/cancers13164112
9. Uehara T, Doi H, Ishikawa K, Inada M, Tatsuno S, Wada Y, Oguma Y, Kawakami H, Nakamatsu K, Hosono M, Nishimura Y. Serum lactate dehydrogenase is a predictive biomarker in oropharyngeal cancer patients undergoing radiotherapy; a retrospective study on predictive factors.　Head & Neck 2021;43(10):3132-3141. DOI: 10.1002/hed.26814
10. Doi H, Tamari K, Oh RJ, Nieder C. New clinical data on human spinal cord re-irradiation tolerance.　Strahlentherapie und Onkologie. 2021;197(6):463-473. DOI: 10.1007/s00066-021-01772-7
11. Inada M, Nishimura Y, Ishikawa K, Uehara T, Wada Y, Oguma Y, Doi H, Nakamatsu K. Outcome of chemoradiotherapy using intensity-modulated radiation therapy for cervical esophageal cancer: a single institute experience. Esophagus. 2021;18(3):638-644. DOI: 10.1007/s10388-020-00812-y
12. Hattori S, Monzen H, Tamura M, Kosaka H, Nakamura Y, Nishimura Y. Estimating radiation exposure of the brain of a physician with a protective flap in interventional radiology: A phantom study. J Appl Clin Med Phys. 2022:e13532. Online ahead of print. DOI: 10.1002/acm2.13532
13. Okuhata K, Tamura M, Monzen H, Nishimura Y. Dosimetric characteristics of a thin bolus made of variable shape tungsten rubber for photon radiotherapy. Phys Eng Sci Med. 2021;44(4):1249-1255. DOI: 10.1007/s13246-021-01059-2
14. Wakabayashi K, Monzen H, Tamura M, Takei Y, Okuhata K, Anami S, Doi H, Nishimura Y. A novel real-time shapeable soft rubber bolus for clinical use in electron radiotherapy. Phys Med Biol. 2021;66(18). DOI: 10.1088/1361-6560/ac215b
15. Nakamura K, Okuhata K, Tamura M, Otsuka M, Kubo K, Ueda Y, Nakamura Y, Nakamatsu K, Tanooka M, Monzen H, Nishimura Y. An updating approach for knowledge-based planning models to improve plan quality and variability in volumetric-modulated arc therapy for prostate cancer. J Appl Clin Med Phys. 2021;22(9):113-122. DOI: 10.1002/acm2.13353
16. Tamura M, Monzen H, Matsumoto K, Otsuka M, Nishimura Y. Feasibility study of a photochromic diarylethene film as a clinical dosimeter for kV X-rays. Radiat Meas. 2021;145:106608. DOI: 10.1016/j.radmeas.2021.106608
17. Wada Y, Monzen H, Tamura M, Otsuka M, Inada M, Ishikawa K, Doi H, Nakamatsu K, Nishimura Y. Dosimetric Evaluation of Simplified Knowledge-Based Plan with an Extensive Stepping Validation Approach in Volumetric-Modulated Arc Therapy-Stereotactic Body Radiotherapy for Lung Cancer. J Med Phys. 2021;46(1):7-15. DOI: 10.4103/jmp.JMP_67_20
18. Okuhata K, Monzen H, Tamura M, Matsumoto K, Otsuka M, Kubo K, Ueda Y, Uehara T, Doi H, Ishikawa K, Nishimura Y. Plan Complexity and Delivery Accuracy of Knowledge-based Volumetric Modulated Arc Therapy Plans with Single Optimization for Oropharyngeal Cancer. Anticancer Res. 2021;41(6):2925-2931. DOI: 10.21873/anticanres.15074
19. Wakabayashi K, Monzen H, Tamura M, Matsumoto K, Takei Y, Nishimura Y. Dosimetric evaluation of skin collimation with tungsten rubber for electron radiotherapy: A Monte Carlo study. J Appl Clin Med Phys. 2021;22(4):63-70. DOI: 10.1002/acm2.13210
20. Inoue E, Okajima K, Doi H, Fukuda K, Oguma Y, Ri A, Nishikawa D, Yane K, Matsuura T, Nishimura Y. Factors Predictive of the Development of Hypothyroidism after Intensity-Modulated Radiation Therapy for Pharyngeal Cancer. Acta Oto-Laryngologica. 2021;141(11):1022-1026. DOI: 10.1080/00016489.2021.1998615
21. Hamada A, Soh J, Hata A, Nakamatsu K, Shimokawa M, Yatabe Y, Oizumi H, Tsuboi M, Horinouchi H, Yoshino I, Tanahashi M, Toyooka S, Okada M, Yokomise H, Yamashita M, Nishimura Y, Yamamoto N, Nakagawa K, Mitsudomi T. Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-small-cell Lung Cancer: SQUAT trial (WJOG 12119L). Clin Lung Cancer. 2021;22(6):596-600. DOI: 10.1016/j.cllc.2021.04.006
22. Miyawaki T, Kenmotsu H, Harada H, Ohde Y, Chiba Y, Haratani K, Okimoto T, Sakamoto T, Wakuda K, Ito K, Uemura T, Sakata S, Kogure Y, Nishimura Y, Nakagawa K, Yamamoto N. Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L). BMC Cancer. 2021;21(1):1121. DOI: 10.1186/s12885-021-08851-z
23. Arakawa Y, Sasaki K, Mineharu Y, Uto M, Mizowaki T, Mizusawa J, Sekino Y, Ono T, Aoyama H, Satomi K, Ichimura K, Kinoshita M, Ohno M, Ito Y, Nishikawa R, Fukuda H, Nishimura Y, Narita Y; Brain Tumor Study Group and Radiation Therapy Study Group of the Japan Clinical Oncology Group. A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII). BMC Cancer. 2021;21(1):1105. DOI: 10.1186/s12885-021-08834-0
24. Akamatsu H, Murakami H, Harada H, Shimizu J, Hayashi H, Daga H, Hasegawa Y, Kim YH, Kato T, Tokunaga S, Nishimura Y, Yamamoto N, Nakagawa K. Gefitinib With Concurrent Thoracic Radiotherapy in Unresectable Locally Advanced NSCLC With EGFR Mutation; West Japan Oncology Group 6911L. J Thorac Oncol. 2021;16(10):1745-1752. DOI: 10.1016/j.jtho.2021.05.019
25. Sakisuka T, Kashiwagi N, Doi H, Takahashi H, Arisawa A, Matsuo C, Masuda Y, Inohara H, Sato K, Outani H, Outani H, Ishii K, Tomiyama N. Prognostic factors for bone metastases from head and neck squamous cell carcinoma: A case series of 97 patients. Molecular and Clinical Oncology. 2021;15(5):246. DOI: 10.3892/mco.2021.2408
26. Murakami N, Mori T, Machida R, Kodaira T, Ito Y, Shikama N, Konishi K, Matsumoto Y, Murakami Y, Nakamura N, Yamashita H, Yorozu A, Yoshimura M, Inoue K, Nozaki M, Ishikura S, Itami J, Nishimura Y, Kagami Y. Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer. Laryngoscope. 2021;131(7):1522-1527. DOI: 10.1002/lary.29348
27. Nozaki M, Kagami Y, Machida R, Nakamura K, Ito Y, Nishimura Y, Teshima T, Saito Y, Nagata Y, Matsumoto Y, Akimoto T, Hiraoka M; Japan Clinical Oncology Group, Radiation Therapy Study Group. Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906. Jpn J Clin Oncol. 2021;51(6):865-872. DOI: 10.1093/jjco/hyab024
28. Yamamoto N, Harada H, Okamoto I, Masuda N, Hayakawa K, Satouchi M, Soejima T, Nishio M, Kozuka T, Takeda K, Tanaka M, Seto T, Sasaki T, Tsubouchi H, Kakurai Y, Nishimura Y, Nakagawa K.Clin Lung Cancer. Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer. 2021;22(2):134-141. DOI: 10.1016/j.cllc.2020.12.012
29. Kobayashi N, Takano S, Ito K, Sugiura M, Ogawa M, Takeda Y, Okubo N, Suzuki A, Tokuhisa M, Kaneta T, Utsunomiya D, Hata M, Inoue T, Hosono M, Kinuya S, Ichikawa Y. Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors. Ann Nucl Med. 2021 Dec;35(12):1332-1341. DOI: 10.1007/s12149-021-01674-9
30. Uemura H, Masumori N, Takahashi S, Hosono M, Kinuya S, Sunaya T, Horio T, Okayama Y, Kakehi Y. Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketing surveillance, according to prior chemotherapy status and in patients without concomitant use of second-generation androgen-receptor axis-targeted agents. Int J Clin Oncol. 2021 Apr;26(4):753-763. DOI: 10.1007/s10147-020-01850-3
31. Kamima T, Ueda Y, Fukunaga JI, Tamura M, Shimizu Y, Muraki Y, Yoshioka Y, Kitamura N, Nitta Y, Otsuka M, Monzen H. Knowledge-based planning using pseudo-structures for volumetric modulated arc therapy (VMAT) of postoperative uterine cervical cancer: a multi-institutional study. Rep Pract Oncol Radiother. 2021;26(6):849-860. DOI: 10.5603/RPOR.a2021.0089
32. Kawai Y, Tamura M, Amano M, Kosugi T, Monzen H. First Clinical Experience of Tungsten Rubber Electron Adaptive Therapy With Real-time Variable-shape Tungsten Rubber. Anticancer Res. 2021;41(2):919-925. DOI: 10.21873/anticanres.14845

2020年
1. Nishimura Y, Ishikura S, Ishikawa K, et. al., A phase II study of adaptive two-step inteinsity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015). International Journal of Clinical Oncology (2020) 25: 1250-1259
2. Nishimura Y. A message from the new editor-in-chief. Int J Clin Oncol. 2020; 25(5), 785-786
3. Monzen H, Tamura M, Ueda Y, Fukunaga J, Kamima T, Muraki Y, Kubo K, Nakamatsu K. Dosimetric evaluation with knowledge-based planning created at different periods in volumetric-modulated arc therapy for prostate cancer: a multi-institution study. Radiol Phys Technol. 2020; 13:327-335.
4. Doi H, Tamari K, Oh RJ, et. al., Intensity-modulated radiation therapy administered to a previously irradiated spine is effective and well-tolerated. Clinical and Translational Oncology 2020
5. Doi H, Tamura M, Nakamatsu K, MonzenH and Nishimura Y. Experimental animal model of re-irradiation to evaluate radiation-induced damage in the normal intestine. Anticancer Research 40: 1981-1988 (2020)
6. Doi H, Kuribayashi K, Kitajima K, Yamakado K, Kijima T. Development of a Novel prognostic risk classification system for malignant pleural mesothelioma. Clin Lung Cancer 2020;21:66-74.
7. Uehara T, Monzen H, Tamura M, Ishikawa K, Doi H and Nishimura Y. Dose-volume histogram analysis and clinical evaluation of knowledge-based plans with manual objective constraints for pharyngeal cancer. Journal of Radiation Research, Vol. 61 No. 3, 2020, pp. 499-505
8. Inoue E, Doi H, Monzen H, Tamura M, Inada M, Ishikawa K, Nakamatsu K and Nishimura Y. Dose-volume histogram analysis of knowledge-based volumetric-modulated arc therapy planning in postoperative breast cancer irradiation. In Vivo 34: 1095-1101 (2020)
9. Tamura M, Monzen H, Matsumoto K, Kubo K, Ueda Y, Kamima T, Inada M, Doi H, Nakamatsu K, Nishimura Y. Influence of cleaned-up commercial knowledge-based treatment planning on volumetric-modulated arc therapy of prostate cancer. J Med Phys. 2020; 45:71-77.
10. Tamura M, Monzen H, Matsumoto K, Otsuka M, Nishimura Y, Okumura M. Design of commissioning process for Halcyon™ linac with a new rigid board: A clinical experience. Phys Med. 2020; 77:121-126.
11. Tamura M, Matsumoto K, Otsuka M, Monzen H. Plan complexity quantification of dual-layer multi-leaf collimator for volumetric modulated arc therapy with Halcyon linac. Phys Eng Sci Med. 2020; 43:947-957.
12. Kosaka H, Monzen H, Amano M, Tamura M, Hattori S, Kono Y, Nishimura Y. Radiation dose reduction to the eye lens in head CT using tungsten functional paper and organ-based tube current modulation. Eur J Radiol. 2020;124:108814.
13. Takei Y, Kamomae T, Monzen H, Nakaya T, Sugita K, Suzuki K, Oguchi H, Tamura M, Nishimura Y. Feasibility of using tungsten functional paper as a thin bolus for electron beam radiotherapy. Phys Eng Sci Med. 2020; 43:1101-1111.
14. Takei Y, Monzen H, Tamura M, Doi H, Nishimura Y. Dose reduction potential of using gold fiducial markers for kilovoltage image-guided radiotherapy. J Appl Clin Med Phys. 2020; 21:151-157.
15. Tatebe H, Masunaga S, Nishimura Y.　Effect　of　rapamycin　on　the　radio-sensitivity of cultured tumor cells following boron neutron capture reaction. World J Oncol. 2020; 11(4): 158-164
16. Kijima K, Krisanachinda A, Pasawang P, Hanaoka K, Monzen H, Nishimura Y. Shielding efficiency of novel tungsten rubber against radionuclides of 99mTc, 131I, 18F and 68Ga. Radiat. Phys. Chem. 2020; 172:108755.
17. Choi MG, Law M, Yoon DK, Tamura M, Matsumoto K, Otsuka M, Kim MS, Djeng SK, Monzen H, Suh TS. Simplified sigmoidal curve fitting for a 6 MV FFF photon beam of the Halcyon to determine the field size for beam commissioning and quality assurance. Radiat Oncol. 2020;15:273.
18. Onishi H, Nishimura Y, Yamada S, et. al., Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity. Journal of Radiation Research, Vol.61, No.3, 2020, pp. 426-430
19. Kimura K, Doi H, Tomita N, et. al., Impact of preoperative chemoradiotherapy using concurrent S-1 and CPT-11 on long-term clinical outcome in locally advanced rectal cancer. World J Gastrointest Oncol 2020 March 15; 12(3): 311-322
20. Ueda Y, Miyazaki M, Sumida I, Ohira S, Tamura M, Monzen H, Tsuru H, Inui S, Isono M, Ogawa K, Teshima T. Knowledge-based planning for esophageal cancers using a model trained with plans from a different treatment planning system. Acta Oncol. 2020;59:274-283.
21. Ueda Y, Monzen H, Fukunaga J, Ohira S, Tamura M, Suzuki O, Inui S, Isono M, Miyazaki M, Sumida I, Ogawa K, Teshima T. Characterization of knowledge-based volumetric modulated arc therapy plans created by three different institutions' models for prostate cancer. Rep Pract Oncol Radiother. 2020; 25:1023-1028.
22. Nishio T, Nakamura M, Nishimura Y, et. al., An overview of the medical-physics-related verification system for raidotherapy multicenter clinical trials by the Medical Physics Working Group in the Japan Clinical Oncology Group-Radiation Therapy Study Group. Journal of Radiation Research. Vol.61, N9. 6, 2020, pp. 999-1008
23. Murakami Y, Ishikawa K, Nishimura Y, et. al., Risk factors for severe gastrointestinal toxicity in patients receiving palliative radiotherapy for metastatic bone tumors: association with the use of molecular-targeted agents. 3.　　
24. Yamamoto N, Harada H, Okamoto I, Masuda N, Hayakawa K, Satouchi M, Soejima T, Nishio M, Kozuka T, Takeda K, Tanaka M, Seto T, Sasaki T, Tsubouchi H, Kakurai Y, Nishimura Y, Nakagawa K. Phase 2 study of nimotuzumab in combination with concurrent chemoradiotherapy in patients with locally advanced non–small-cell lung cancer. Clinical Lung Cancer (in press)
25. Nishio T, Nakamura M, Okamoto H, Kito S, Minemura T, Ozawa S, Kumazaki Y, Ishikawa M, Tohyama N, Kurooka M, Nakashima T, Shimizu H, Suzuki R, Ishikura S, Nishimura Y. An overview of the medical-physics-related verification system for radiotherapy multicenter clinical trials by the Medical Physics Working Group in the Japan Clinical Oncology Group–Radiation Therapy Study Group. J Radiat Res 2020, 61(6), 999-1008
26. Takei Y, Monzen H, Tamura M, Doi H, Nishimura Y. Dose reduction potential of using gold fiducial markers for kilovoltage image-guided radiotherapy. J Appl Clin Med Phys 2020; 1–7
27. Onishi H, Shioyama Y, Matsumoto Y, Shibamoto Y, Miyakawa A, Suzuki G, Nishimura Y, Sasaki R, Miyawaki D, Kuriyama K, Komiyama T, Marino K, Aoki S, Saito R, Araya M, Maehat Ya, Nonaka H, Tominaga L, Saito M, Sano N, Yamada S. Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity.
  Journal of Radiation Research 2020: 61: 426-430

2019年
1. Inada M, Nishimura Y, Ishikawa K, Nakamatsu K, Wada Y, Uehara T, Fukuda K, Anami S, Doi H, Kanamori S.
  Comparing the 7th and 8th editions of the American Joint Committee on Cancer/ Union for International Cancer Control TNM staging system for esophageal squamous cell carcinoma treated by definitive radiotherapy. Esophagus. 2019;16:371-376.
2. Hiroshi Doi, Kiyoshi Nakamatsu and Yasumasa Nishimura.
  Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a review. Int J Clin Oncol. 2019;24:899-909.
3. Doi H, Nakamatsu K, Anami S, Fukuda K, Inada M, Tatebe H, Ishikawa K, Kanamori S, Monzen H, Nishimura Y.
  Neutrophil-to-lymphocyte ratio predicts survival after whole brain radiotherapy in non-small cell lung cancer. In Vivo. 33(1):195-201, 2019.
4. Kijima K, Krisanachinda A, Tamura M, Monzen H, Nishimura Y.
  Reduction of Occupational exposure using a novel tungsten-containing rubber shield in interventional radiology. Health Phys. Dec18,2019
5. Kubo K, Monzen H, Ishii K, Tamura M, Nakasaka Y, Kusawake M, Kishimoto S, Nakahara R, Matsuda S, Nakajima T, Kawamorita R.
  Inter-planner variation in treatment-plan quality of plans created with a knowledge-based treatment planning system. Phys Med. 2019;67:132-140.
6. Kubo K, Monzen H, Shimomura K, Matsumoto K, Sato T, Tamura M, Nakamatsu K, Ishii K, Kawamorita R.
  Comparison of patient-specific intensity modulated radiation therapy quality assurance for the prostate across multiple institutions. Rep Pract Oncol Radiother. 2019;24:600-605.
7. Monzen H, Tamura M, Kijima K, Otsuka M, Matsumoto K, Wakabayashi K, Choi MG, Yoon DK, Doi H, Akiyama H, Nishimura Y.
  Estimation of radiation shielding ability in electron therapy and brachytherapy with real time variable shape tungsten rubber. Phys Med. 2019;66:29-35.
8. Otsuka M, Monzen H, Ishikawa K, Doi H, Matsumoto K, Tamura M, Nishimura Y.
  Variations of the dose distribution between CT- and CBCT-based plans for oropharyngeal cancer. In Vivo. 2019;33:1271-1277.
9. Kijima K, Krisanachinda A, Tamura M, Nishimura Y, Monzen H.
  Feasibility of a tungsten rubber grid collimator for electron grid therapy. Anticancer Res. 2019;39:2799-2804.
10. Hirata M, Hanaoka K, Matsumoto K, Tamura M, Okumura M, Monzen H.
  The impact of the offset distance between the planning target volume and isocenter on irradiation time in TomoTherapy: A phantom study. Phys Med. 2019;63:19-24.
11. Kosaka H, Monzen H, Matsumoto K, Tamura M, Nishimura Y.
  Reduction of operator hand exposure in interventional radiology with a novel finger sack using tungsten-containing rubber. Health Phys. 2019;116:625-630.
12. Takei Y, Monzen H, Matsumoto K, Hanaoka K, Tamura M, Nishimura Y.
  Registration accuracy with the low dose kilovoltage cone-beam CT : A phantom study. British Journal of Radiology Open. 2019;1:1–7.
13. Anami S, Doi H, Nakamatsu K, Uehara T, Wada Y, Fukuda K, Inada M, Ishikawa K, Kanamori S, Nishimura Y.
  Serum lactate dehydrogenase predicts survival in small-cell lung cancer patients with brain metastases that were treated with whole-brain radiotherapy. J Radiat Res. 2019;60(2):257-263.
14. Suzuki A, Kashiwagi N, Doi H, Ishii K, Doi K, Kitano M, Kozuka T, Hyodo T,Tsurusaki M, Yagyu Y, Nakanishi K.
  Patterns of bone metastases from head and neck squamous cell carcinoma. Auris Nasus Larynx 2019 Aug 21 Epub.
15. Okada W, Tanooka M, Sano K, Shibata M, Doi H, Miyazaki M, Nakahara R, Sueoka M, Suzuki H, Fujiwara M, Inomata T, Yamakado K.
  Couch modeling optimization for tomotherapy planning and delivery. J Appl Clin Med Phys. 2019;20:114-121.
16. Okamoto H, Murakami N, Isohashi F, Kasamatsu T, Hasumi Y, Iijima K, Nishioka S, Nakamura S, Nakamura M, Nishio T, Igaki H, Nakayama Y, Itami J, Ishikura S, Nishimura Y, Toita T.
  Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402). Radiat Oncol. 2019;14:133.
17. Nishio T, Tachibana H, Kase Y, Hotta K, Nakamura M, Tamura M, Terunuma T, Toshito T, Yamashita H, Ishikura S, Fuji H, Akimoto T, Nishimura Y.
  Liver phantom design and dosimetric verification in participating institutions for a proton beam therapy in patients with resectable hepatocellular carcinoma: Japan Clinical Oncology Group trial (JCOG1315C). Radiother Oncol. 2019;140:98-104.
18. Murakami N, Isohashi F, Hasumi Y, Kasamatsu T, Okamoto H, Nakamura K, Shibata T, Ito Y, Ishikura S, Nishimura Y, Yaegashi N, Toita T.
  Single-arm confirmatory trial of postoperative concurrent chemoradiotherapy using intensity modulated radiation therapy for patients with high-risk uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402). Japanese Journal of Clinical Oncology, 2019-49(9):881-885
19. Tanaka Y, Monzen H, Matsumoto K, Inomata S, Fuse T.
  Dose distribution comparison in volumetric-modulated arc therapy plans for head and neck cancers with and without an external body contour extended technique. Rep Pract Oncol Radiother. 2019;24(6):576-584.
20. Kamima T, Ueda Y, Fukunaga JI, Shimizu Y, Tamura M, Ishikawa K, Monzen H.
  Multi-institutional evaluation of knowledge-based planning performance of volumetric modulated arc therapy (VMAT) for head and neck cancer. Phys Med. 2019;64:174-181.
21. Hayama Y, Doi H, Hasegawa T, Minami Y, Ichimura N, Koike M, Shiomi H, Oh RJ, Oishi F.
  Lower urinary tract symptoms in patients with prostate cancer under and after intensity-modulated radiation therapy. Lower Urinary Tract Symptoms. 2019 Apr;11(2):O127-O134.
22. Tarutani K, Tanooka M, Doi H, Fujiwara M, Miyashita M, Kagawa K, Kamikonya N, Yamakado K.
  Improved error detection using a divided treatment plan in volume modulated arc therapy. Reports of Practical Oncology and Radiotherapy. 2019 Mar-Apr;24(2):133-141.
23. Kawai Y, Tamura M, Amano M, Kamomae T, Monzen H.
  Dosimetric Characterization of a novel surface collimator with tungsten functional paper for electron therapy. Anticancer Res. 2019;39:2839-2843.

2018年
1. Inada M, Monzen H, Matsumoto K, Tamura M, Minami T, Nakamatsu K, Nishimura Y.
  A novel radiation-shielding undergarment using tungsten functional paper for patients with permanent prostate brachytherapy. J Radiat Res, 59 (3) 333-337, 2018
2. Doi H, Fujiwara M, Kitajima K, Tanooka M, Terada T, Noguchi K, Ishikura R, Kamikonya N, Yamakado K.
  Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma. Nagoya Journal of Medical Science. 2018 Nov;80(4):541-550.
3. Doi H, Uemoto K, Masai N, Tatsumi D, Shiomi H, Oh RJ.
  Definitive re-irradiation using intensity modulated radiation therapy in cancers of the head and neck, focusing on rare tumors. Acta Oto-Laryngologica. 2018 Aug;138(8):750-758.
4. Tatebe H, Doi H, Ishikawa K, Kawakami H, Yokokawa M, Nakamatsu K, Kanamori S, Shibata T, Kitano M, Nishimura Y.
  Two-step intensity-modulated radiation therapy for oropharyngeal cancer: initial clinical experience and validation of clinical staging. Anticancer Res 38: 979-986, 2018
5. Tamura M, Monzen H, Matsumoto K, Okumura M, Doi H, Nishimura Y.
  Reduction of potential risk for skin toxicity in megavoltage radiotherapy using a novel rigid couch. In Vivo. 2018;32:531-536.
6. Tamura M, Monzen H, Matsumoto K, Kubo K, Otsuka M, Inada M, Doi H, Ishikawa K, Nakamatsu K, Sumida I, Mizuno H, Yoon DK, Nishimura Y.
  Mechanical performance of a commercial knowledge-based VMAT planning for prostate cancer. Radiat. Oncol. 2018;13:163.
7. Tachibana I, Nishimura Y, Hanaoka K, Inada M, Fukuda K, Tatebe H, Ishikawa K, Nakamatsu K, Kanamori S, Hosono M.
  Tumor hypoxia detected by 18F-fluoromisonidazole positron emission tomography (FMISO PET) as a prognostic indicator of radiotherapy (RT). Anticancer Res 38: 1775-1781, 2018
8. Tachibana I, Nishimura Y, Inada M, Fukuda K, Ishikawa K, Nishikawa T, Yokokawa M, Nakamatsu K, Kanamori S, Hida, J.
  Definitive chemoradiotherapy for anal canal cancer: single-center experience. Int J Clin Oncol 23(6):1121-1126
9. Otsuka M, Monzen H, Matsumoto K, Tamura M, Inada M, Kadoya N, Yasumasa N.
  Evaluation of lung toxicity risk with computed tomography ventilation image for thoracic cancer patients. PLoS ONE 13(10): e0204721.
10. Hirata M, Monzen H, Tamura M, Kubo K, Matsumoto K, Hanaoka K, Okumura M, Nishimura Y
  Impact of the Lok-bar for High-precision Radiotherapy with Tomotherapy. Anticancer
  Research, May 2018 38 (5) 2733-2738
11. Kijima K, Monzen H, Matsumoto K, Tamura M, Nishimura Y
  The Shielding Ability of Novel Tungsten Rubber Against the Electron Beam for Clinical Use in Radiation Therapy. Anticancer Research, July 2018 vol. 38 no. 7 3919-3927
12. Kubo K, Monzen H, Tamura M, Hirata M, Ishii K, Okada W, Nakahara R, Kishimoto S, Kawamorita R, Nishimura Y.
  Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer. J Appl Clin Med Phys. 2018 Mar;19(2):121-127.
13. Watanabe S, Hanaoka K, Shibata Y, Kaida H, Ishii K.
  Usefulness of respiratory-gated 18F-FDG PET/CT scan protocol in patients having positive myocardial 18F-FDG uptake. Nuclear Medicine Communications: November 13, 2018
14. Sauerbeck J, Ishii K, Hosokawa C, Kaida H, Scheiwein FT, Hanaoka K, Rominger A, Brendel M, Bartenstein P, Murakami T.
  The correlation between striatal and cortical binding ratio of 11C-PiB-PET in amyloid-uptake-positive patients. Ann Nucl Med. 2018 Jul;32(6):398-403. doi: 10.1007/s12149-018-1258-8. Epub 2018 May 5.
15. Nakayama S, Monzen H, Onishi Y, Kaneshige S, Kanno I.
  Estimation of extremely small field radiation dose for brain stereotactic radiotherapy using the Vero4DRT system. Phys Med. 2018 Jun;50:52-58.
16. Ueda Y, Fukunaga JI, Kamima T, Adachi Y, Nakamatsu K, Monzen H.
  Evaluation of multiple institutions' models for knowledge-based planning of volumetric modulated arc therapy (VMAT) for prostate cancer. Radiat Oncol. 2018 Mar 20;13(1):46.
17. Uemoto K, Doi H, Shiomi H, Yamada K, Tatsumi D, Yasumoto T, Takashina M, Koizumi M, Oh RJ.
  Clinical assessment of micro-residual tumors during stereotactic body radiation therapy for hepatocellular carcinoma. Anticancer research. 38(2);945-954, 2018.
18. Kodaira T, Kagami Y, Shibata T, Shikama N, Nishimura Y, Ishikura S, Nakamura K, Saito Y, Matsumoto Y, Teshima T, Ito Y, Akimoto T, Nakata K, Toshiyasu T, Nakagawa K, Nagata Y, Nishimura T, Uno T, Kataoka M, Yorozu A, Hiraoka M
  Radiation Therapy Study Group of the Japan Clinical Oncology Group. Results of a multi-institutional, randomized, non-inferiority, phase 3 trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group study (JCOG0701). Ann Oncol 29(4): 992-997, 2018
19. Okamoto H, Minemura T, Nakamura M, Mizuno H, Toyama N, Nishio T, Wakita A, Nakamura S, Nishioka S, Iijima K, Fujiyama D, Itami J, Nishimura Y.
  Establishment of postal audit system in intensity-modulated radiotherapy by radiophotoluminescent glass dosimeters and a radiochromic film. Physica medica 48: 119-126, 2018
20. Kumazaki Y, Ozawa S, Nakamura M, Kito S, Minemura T, Tachibana H, Nishio T, Ishikura S, Nishimura Y.
  An end-to-end postal audit test to examine the coincidence between the imaging isocenter and treatment beam isocenter of the IGRT linac system for Japan Clinical Oncology Group (JCOG) clinical trials. Physica Medica 53: 145–152, 2018
21. Sasaki T, Seto T, Yamanaka T, Kunitake N, Shimizu J, Kodaira T, Nishio M, Kozuka T, Takahashi T, Harada H, Yoshimura N, Tsutsumi S, Kitajima H, Kataoka M, Ichinose Y, Nakagawa K, Nishimura Y, Yamamoto N, Nakanishi Y.
  A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L. Br J Cancer 2018;119(6):675-682.
22. Tanaka F, Yokomise H, Soejima T, Uramoto H, Yamanaka T, Nakagawa K, Yamamoto N, Nishimura Y, Niwa H, Okada M, Nakagawa T, Yamashita M.
  Induction Chemoradiotherapy (50 Gy), Followed by Resection, for Stage IIIA-N2 Non-Small Cell Lung Cancer. Ann Thorac Surg. 2018;106(4):1018-1024.

2017年
1. Tomoko Itazawa, Yukihisa Tamaki, Takafumi Komiyama, Yasumasa Nishimura, Yuko Nakayama, Hiroyuki Ito, Yasuhisa Ohde, Masahiko Kusumoto, Shuji Sakai, Kenji Suzuki, Hirokazu Watanabe and Hisao Asamura.
  The Japan Lung Cancer Society-Japanese Society for Radiation Oncology consensus-based computed tomographic atlas for defining regional lymph node stations in radiotherapy for lung cancer. Journal of Radiation Research, Vol. 58, No.1, 2017, pp. 86-105.
2. Masahiro Inada, Masaki Yokokawa, Takafumi Minami, Kiyoshi Nakamatsu and Yasumasa Nishimura.
  Dosimetry advantages of intraoperatively built custom-linked seeds compared with loose seeds in permanent prostate brachytherapy. Journal of Contemporary Brachytherapy. 2017 Oct; 9(5): 410-417.
3. Hirokazu Hasegawa, Ryuichiro Ashikaga, Kaoru Okajima, Tetsuya Wakayama, Mitsuharu Miyoshi, Yasumasa Nishimura and Takamichi Murakami.
  Comparison of lesion enhancement between BB Cube and 3D-SPGR images for brain tumors with 1.5-T magnetic resonance imaging. Jpn J Radiol. (2017) 35: 463-471
4. Takuya Yamazaki, Takeshi Kodaira, Yosuke Ota, Tetsuo Akimoto, Hitoshi Wada, Junichi Hiratsuka, Yasumasa Nishimura, Shunichi Ishihara, Takeshi Nonoshita, Kazushige Hayakawa, Shuhei Sekii and Nobue Uchida.
  Retrospective analysis of definitive radiotherapy for neck node metastasis from unknown primary tumor: Japanese Radiation Oncology Study Group study. Japanese Journal of Clinical Oncology, 2017, 1-7
5. Tomohiro Matsuura, Yasumasa Nishimura, Kiyoshi Nakamatsu, Shuichi Kanamori, Kazuki Ishikawa, Izumi Tachibana, Makoto Hosono, Toru Shibata.
  Clinical outcomes of IMRT planned with or without PET/CT simulation for patients with pharyngeal cancers. Int J Clin Oncol. 2017 Feb; 22(1): 52-58.
6. Jeong Il Yu, Hee Chul Park, Yong Chan Ahn, Xian-Shu Gao, Jun-Jie Wang, Zhao-Chong Zeng, Yoshinori Ito, Tatsuya Ohno and Yasumasa Nishimura.
  Spine Metastasis Practice Patterns among Korean, Chinese, and Japanese Radiation Oncologists: A Multinational Online Survey Study. Journal of Radiation Research, Vo. 58, No.1, 2017, pp. 155.163
7. Kamomae T, Shimizu H, Nakaya T, Okudaira K, Aoyama T, Oguchi H, Komori M, Kawamura M, Ohtakara K, Monzen H, Itoh Y, Naganawa S.
  Three-dimensionalprinter-generated patient-specific phantom for artificial in vivo dosimetry in radiotherapy quality assurance.
  Phys Med. 2017 Dec;44:205-211. doi:10.1016/j.ejmp.2017.10.005. Epub 2017 Oct 26. PubMed PMID: 29102154.
8. Kamomae T, Monzen H, Kawamura M, Okudaira K, Nakaya T, Mukouyama T, Miyake Y, Ishihara Y, Itoh Y, Naganawa S.
  Dosimetric Feasibility of Using Tungsten-Based Functional Paper for Flexible Chest Wall Protectors in Intraoperative Electron Radiotherapy for 　Breast Cancer.
  Phys Med Biol. 2017 Oct 30. doi: 10.1088/1361-6560/aa96cf. [Epub ahead of print] PubMed PMID: 29083315.
9. Kubo K, Monzen H, Ishii K, Tamura M, Kawamorita R, Sumida I, Mizuno H, Nishimura Y.
  Dosimetric comparison of RapidPlan and manually optimized plans in volumetric modulated arc therapy for prostate cancer.
  Phys Med. 2017 Dec;44:199-204. doi: 10.1016/j.ejmp.2017.06.026. Epub 2017 Jul 10. PubMed PMID: 28705507.
10. Monzen H, Kanno I, Fujimoto T, Hiraoka M.
  Estimation of the shielding ability of a tungsten functional paper for diagnostic x-rays and gamma rays.
  J Appl Clin Med Phys. 2017 Sep;18(5):325-329. doi: 10.1002/acm2.12122. Epub 2017 Jun 28. PubMed PMID: 28656739.
11. Shimomura K, Araki F, Kono Y, Asai Y, Murakami T, Hyodo T, Okumura M,Matsumoto K, Monzen H, Nishimura Y.
  Identification of elemental weight fraction and mass density of humanoid tissue-equivalent materials using dual energy computed tomography. Phys Med. 2017 Jul;39:59-66. doi:10.1016/j.ejmp.2017.05.060. Epub 2017 Jun 13. PubMed PMID: 28623025.
12. Monzen H, Tamura M, Shimomura K, Onishi Y, Nakayama S, Fujimoto T, Matsumoto K, Hanaoka K, Kamomae T.
  A novel radiation protection device based on tungsten functional paper for application in interventional radiology.
  J Appl Clin Med Phys. 2017 May;18(3):215-220. doi: 10.1002/acm2.12083. Epub 2017 Apr 19. PubMed PMID: 28422397.
13. Watabe T, Hanaoka K, Naka S, Kanai Y, Ikeda H, Aoki M, Shimosegawa E, Kirihata M, Hatazawa J
  Practical calculation method to estimate the absolute boron concentration in tissues using 18F-FBPA PET.
  Ann Nucl Med. 2017; 31(6): 481–485. Published online 2017 Apr 24. doi: 10.1007/s12149-017-1172-5
14. Kadoya N, Karasawa K, Sumida I, Arimura H, Kakinohana Y, Kabuki S, Monzen H,Nishio T, Shirato H, Yamada S.
  Educational outcomes of a medical physicist program over the past 10 years in Japan.
  J Radiat Res. 2017 Sep 1;58(5):669-674. doi: 10.1093/jrr/rrx016. PubMed PMID: 28402432.
15. Monzen H, Kubo K, Tamura M, Hayakawa M, Nishimura Y.
  Development of a novellow-radiation-absorbent lok-bar to reduce X-ray scattering and absorption in RapidArc(R) treatment planning and dose delivery.
  J Appl Clin Med Phys. 2017 May;18(3):44-51. doi: 10.1002/acm2.12066. Epub 2017 Apr 6. PubMed PMID: 28383157.
16. Hirata M, Monzen H, Hanaoka K, Nishimura Y.
  MEASUREMENT OF ABSORPTION DOSE OUTSIDE IRRADIATION FIELD IN IMRT.
  Radiat Prot Dosimetry. 2017 Nov 1;176(4):425-433. doi: 10.1093/rpd/ncx027. PubMed PMID: 28338869.
17. Tamura M, Monzen H, Kubo K, Hirata M, Nishimura Y.
  Feasibility of tungsten functional paper in electron grid therapy: a Monte Carlo study.
  Phys Med Biol.2017 Feb 7;62(3):878-889. doi: 10.1088/1361-6560/62/3/878. Epub 2017 Jan 10.PubMed PMID: 28072577.
18. Ishii K, Yamanaga T, Ogino R, Hosokawa Y, Kishimoto S, Nakahara R, Shimada C, Kawamorita R, Tada T, Hayashi Y, Nakajima T,
  Bowel and urinary quality of life after whole-pelvic versus prostate-only volumetric-modulated arc therapy for localized prostate cancer
  Practical Radiation Oncology (In Press)
19. Kubo K, Monzen H, Tamura M, Hirata M, Ishii K, Okada W, Nakahara R, Kishimoto S, Kawamorita R, Nishimura Y.
  Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer.
  J Appl Clin Med Phys. (in Press)

2016年
1. Kamomae T, Oita M, Hayashi N, Sasaki M, Aoyama H, Oguchi H, Kawamura M, Monzen H, Itoh Y, Naganawa S.
  Characterization of stochastic noise and post-irradiation density growth for reflective-type radiochromic film in therapeutic photon beam dosimetry.
  Phys Med. 2016 Oct;32(10):1314-1320.
2. Mikoto Tamura, Hajime Monzen, Kazuki Kubo, Makoto Hirata, Yasumasa Nishimura.
  Feasibility of tungsten functional paper in electron grid therapy: a Monte Carlo study.
  Phys. Med. Biol. (in Press)
3. Anetai Y, Sumida I, Takahashi Y, Yagi M, Mizuho H, Ota S, Suzuki O, Seo Y, Tamari K, Ogawa K.
  A concept for classification of optimal breathing pattern for use in radiotherapy tracking, based on respiratory tumor kinematics and minimum jerk analysis.
  Med Phys. In Press.　(2016)
4. Kurosu K, Sumida I, Mizuno H, Yamaguchi H, Okubo H, Tamari K, Suzuki O, Ota S, Inoue S, Ogawa K.
  Robust measurement point for dose verification in delivery quality assurance for robotic radiosurgery system.J Radiat Res. In Press.　(2016)
5. Kim, M. S., Kubo, K., Monzen, H., Yoon, D. K., Shin, H. B., Kim, S., & Suh, T. S. (2016). Development Treatment Planning System Based on Monte-Carlo Simulation for Boron Neutron Capture Therapy.
  Progress in Medical Physics, 27(4), 232-235.

2015年
1. Hanaoka K, Hosono M, Tatsumi Y, Ishii K, Im S-W, Tsuchiya N, Sakaguchi K, Matsumura I. Heterogeneity of intratumoral (111)In-ibritumomab tiuxetan and (18)F-FDG distribution in association with therapeutic response in radioimmunotherapy for B-cell non-Hodgkin's lymphoma. EJNMMI research. 2015;5:10. doi:10.1186/s13550-015-0093-3.
2. Sato S, Miyabe Y, Takahashi K, Yamada M, Nakamura M, Ishihara Y, Yokota K,Kaneko S, Mizowaki T, Monzen H, Hiraoka M. Commissioning and quality assurance of Dynamic WaveArc irradiation. J Appl Clin Med Phys. 2015 Mar 8;16(2):5080.
3. Kodaira T, Nishimura Y, Kagami Y, Ito Y, Shikama N, Ishikura S, and Hiraoka M. Definitive radiotherapy for head and neck squamous cell carcinoma: update and perspectives on the basis of EBM. Jon J Clin Oncol, Mar; 45(3) 235-243, 2015.
4. Kamomae T, Monzen H, Nakayama S, Mizote R, Oonishi Y, Kaneshige S, Sakamoto T. Accuracy of image guidance using free-breathing cone-beam computed tomography for stereotactic lung radiotherapy. PLoS One. 2015 May 8;10(5):e0126152.
5. Ikeda I., Mizowaki T., Tomohiro O., Yamada M., Nakamura M., Monzen H, Hiraoka M. Effect of intrafractional prostate motion on simultaneous boost intensity-modulated radiotherapy to the prostate: A simulation study based on intrafractional motion in the prone position. Med Dosim. 2015 May 19.
6. Nakayama S, Monzen H, Oonishi Y, Mizote R, Iramina H, Kaneshige S, Mizowaki T.A novel method for dose distribution registration using fiducial marks made by a megavoltage beam in film dosimetry for intensity-modulated radiation therapy quality assurance. Phys Med. 2015 Jun;31(4):414-9.
7. Onishi Y., Nakayama S., Watanabe S., Kaneshige S., Monzen H., Matsumoto K., & Kamomae T. (2015). Comparison of dose accuracy between film and two-dimensional detectors in intensity-modulated radiation therapy. Journal of the Korean Physical Society, July; 67(1), 89-95.2015.
8. Monzen H, Mizowaki T, Yano S, Fujimoto T, Kamomae T, Utsunomiya S, Nakamura M, Hiraoka M. Impact of the Vero4DRT (MHI-TM2000) on the Total Treatment Time in Stereotactic Irradiation. J Nucl Med Radiat Ther 6:238. 2015,doi:10.4172/2155-9619.1000238.
9. Kawamorita, R., Monzen, H., Okada, W., Nakahara, R., Kishimoto, S., Ishii, & Nishimura, Y. Novel Anisotropic Margin Calculation Based On the Cumulative Frequency Distribution of Uncertainties in the Clinical Target Volume. OMICS J Radiol. Aug; 4:4, 2015.
10. Anetai Y, Sumida I, Takahashi Y, Yagi M, Ota S, Mizuno H, Ogawa K.Reference respiratory waveforms by minimum jerk model analysis. Med Phys. Aug 42(9): 5066-5074.2015.
11. Ota S, Monzen H, Sumida I, Yoshioka Y, Kado R, Inoue S, Ogawa K, Nishimura Y. Quality Improvement in External Radiation Therapy Using a Departmental Incident-Reporting System and Multidisciplinary Team Efforts. J Nucl Med Radiat Ther Sep; 6:243. 2015,doi: 10.4172/2155-9619.1000243.
12. Hayashi K, Isohashi F, Ogawa K, Oikawa H, Onishi H, Ito Y, Takemoto M, Karasawa K, Imai M, Kosaka Y, Yamazaki H, Yoshioka Y, Nemoto K, Nishimura Y, and the Japanese Radiation Oncology Study Group (JROSG). Postoperative External Irradiation of Patients with Primary Biliary Tract Cancer: A Multicenter Retrospective Study. Anticancer Res. Nov; 35: 6231-6238, 2015.
13. Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, Shimada H, Takiuchi H, Toh Y, Doki Y, Naomoto Y, Matsubara H, Miyazaki T, Muto M, Yanagisawa A. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. Nov;12:1-30, 2015.

2014年
1. Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Uchida N, Maebayashi T, Kanesaka N, Tamamoto T, Asakura H, Kosugi T, Hatano K, Yoshimura M, Yamada K, Tokumaru S, Sekiguchi K, Kobayashi M, Soejima T, Isohashi F, Nemoto K, Nishimura Y, and the Japanese Radiation Oncology Study Group (JROSG). Factors influencing survival outcome for radiotherapy for biliary tract cancer: a multicentre retrospective study. Radiother Oncol 110：546-552, 2014
2. Igaki H, Onishi H, Nakagawa K, Dokiya T, Nemoto K, Shigematsu N, Nishimura Y, Hiraoka M, JASTRO Health Insurance Committee. A newly introduced comprehensive consultation fee in the national health insurance system in Japan: A promotive effect of multidisciplinary medical care in the field of radiation oncology – results from a questionnaire survey. Jpn J Clin Oncol (in press)
3. Hayashi H, Okamoto I, Ueda S, Tanaka K, Okamoto K, Kawakami H, Nishina S, Takeda M, Fujisaka Y, Satoh T, Terao K, Nishimura Y, Doi K, Nakagawa K. Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancer. Anticancer Res (in press)
4. Hayashi H, Okamoto I, Tanizaki J, Tanaka K, Okuda T, Kato A, Nishimura Y, Nakagawa K. Cystic brain metastasis in non-small cell lung cancer with ALK rearrangement. J Clin Oncol (in press)
5. Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Kanesaka N, Tamamoto T, Kosugi T, Hatano K, Kobayashi M, Ito Y, Takayama M, Takemoto M, Karasawa K, Nagakura H, Imai M, Kosaka Y, Yamazaki H, Isohashi F, Nemoto K, Nishimura Y and the Japanese Radiation Oncology Study Group (JROSG). Impact of intraluminal brachytherapy on survival outcome for radiotherapy for unresectable biliary tract cancer: A propensity score-matched pair analysis. Int J Radiat Oncol Biol Phys 2014; (in press)
6. Ono T, Miyabe Y, Yamada M, Shiinoki T, Sawada A, Kaneko S,*Monzen H*, Mizowaki T, Kokubo M, Hiraoka M.Geometric and dosimetric accuracy of dynamic tumor-tracking conformal arc irradiation with a gimbaled x-ray head.Med Phys. 2014 Mar;41(3)
7. Fujimoto T, *Monzen H*, Nakata M, Okada T, Yano S, Takakura T,Kuwahara J, Sasaki M, Higashimura K,Hiraoka M.Dosimetric shield evaluation with tungsten sheet in 4, 6, and 9MeV electron beams. Phys Med. 2014 Jun 18.
8. Tsuruta Y, Nakata M, Nakamura M, Matsuo Y, Higashimura K, Monzen H, Mizowaki T, Hiraoka M.Dosimetric comparison of Acuros XB, AAA, and XVMC in stereotactic body　radiotherapy for lung cancer.Med Phys. 2014 Aug;41(8)

2013年
1. Nishi T, Nishimura Y, Shibata T, Tamura M, Nishigaito N, Okumura M. Volume and dosimetric changes and initial clinical experience of a two-step adaptive intensity modulated radiation therapy (IMRT) scheme for head and neck cancer. Radiother Oncol 106:85-89, 2013
2. Matsumoto K, Okumura M, Asai Y, Shimomura K, Tamura M, Nishimura Y. Dosimetric properties and clinical application of an a-Si EPID for dynamic IMRT quality assurance. Radiol Phys Technol 6:210-218, 2013
3. Okajima K, Ishikawa K, Matsuura T, Tatebe H, Fujiwara K, Hiroi K, Hasegawa H, Nishimura Y. Multiple primary malignancies in patients with prostate cancer: increased risk of secondary malignancies after radiotherapy. Int J Clin Oncol 18(6):1078-1084, 2013
4. Isohashi F, Ogawa K, Oikawa H, Onishi H, Uchida N, Maebayashi T, Kanesaka N, Tamamoto T, Asakura H, Kosugi T, Uno T, Ito Y, Karasawa K, Takayama M, Manabe Y, Yamazaki H, Takemoto M, Yoshioka Y, Nemoto K, Nishimura Y. Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey.　Radiat Oncol. 2013 Apr 1;8:76.
5. Tachibana I, Nishimura Y, Shibata T, Kanamori S, Nakamatsu K, Koike R, Nishikawa T, Ishikawa K, Tamura M, Hosono M. A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy. J Radiat Res 54:1078-1084, 2013
6. Kawakami H, Okamoto I, Terao K, Sakai K, Suzuki M, Ueda S, Tanaka K, Kuwata K, Morita Y, Ono K, Nishio K, Nishimura Y, Doi K, Nakagawa K. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma. Cancer Medicine 2(6):933-941, 2013
7. Utsunomiya S, *Monzen H*, Akimoto M, Mukumoto N, Ishihara Y, Shiinoki T, Nakamura,M, Miyabe Y, Sato S, Matsuo S, Hiraoka M. A feasibility study on reduction of the entrance-surface dose to neonates by use of a new digital mobile X-ray system. Radiol Phys Technol. ;6(1):157-61,2013
8. Watanabe T, *Monzen H, *Hara M, Mizowaki T, Hiraoka M. Pharmacokinetic model of myocardial (99m)Tc-sestamibi washout.Ann Nucl Med. 27(3):279-84. 2013
9. Akimoto M, Nakamura M, Mukumoto N, Tanabe H, Yamada M, Matsuo Y, *Monzen H*,Mizowaki T, Kokubo M, Hiraoka M. Predictive uncertainty in infrared marker-based dynamic tumor tracking with Vero4DRT. Med Phys. 2013 Sep;40(9)
10. Mampuya WA, Nakamura M, Matsuo Y, Ueki N, Iizuka Y, Fujimoto T, Yano S, *MonzenH*, Mizowaki T, Hiraoka M.Interfraction variation in lung tumor position with abdominal compression during stereotactic body radiotherapy.Med Phys. 2013 Sep;40(9)

2012年
1. Nishimura Y, Koike R, Ogawa K, Sasamoto R, Murakami Y, Itoh Y, Negoro Y, Itasaka S, Sakayauchi T, Tamamoto T. Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: The Japanese Radiation Oncology Study Group (JROSG) survey. Int J Clin Oncol 17:48-54, 2012
2. Watanabe M, Baba H, Ishioka C, Nishimura Y, Muto M. Recent advances in diagnosis and treatment for malignancies of the gastrointestinal tract. Digestion 85: 95-98, 2012
3. Tada T, Chiba Y, Tsujino K, Fukuda H, Nishimura Y, Kokubo M, Negoro S, Kudoh S, Fukuoka M, Nakagawa K, Nakanishi Y. A phase I study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for stage III non-small-cell lung cancer: WJTOG 3305. Int J Radiat Oncol Biol Phys 83: 327-331, 2012
4. Ogawa K, Ito Y, Hirokawa N, Shibuya K, Kokubo M, Ogo E, Shibuya H, Saito T, Onishi H, Karasawa K, Nemoto K, Nishimura Y, and the JROSG Working Subgroup of Gastrointestinal Cancers. Concurrent radiotherapy and Gemcitabine for unresectable pancreatic adenocarcinoma: Impact of adjuvant chemotherapy on survival. Int J Radiat Oncol Biol Phys 83: 559-565, 2012
5. Nishimura Y, Hiraoka M, Koike R, Nakamatsu K, Itasaka S, Kawamura M, Negoro Y, Araki N, Ishikawa H, Fujii T, Mitsuhashi N. Long-term follow-up of a randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer (KROSG0101/JROSG021). Jpn J Clin Oncol 42:807-812, 2012
6. Katakami N, Tada H, Mitsudomi T, Kudoh S, Senba H, Matsui K, Saka H, Kurata T, Nishimura Y, Fukuoka M. A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903). Cancer 118:6126-6135, 2012
7. Hasegawa Y, Okamoto I, Takezawa K, Miyasaki M, Tsurutani J, Yonesaka K, Morinaga R, Tsuya A, Terashima M, Kudoh T, Azuma K, Kurata T, Nishikawa T, Fukuoka M, Nishimura Y, Nakagawa K. A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer. Invest New Drugs DOI:10.1007/s10637-012-9833-7, May 24, 2012
8. Hayashi H, Okamoto I, Kimura H, Sakai K, Nishimura Y, Nishio K, Nakagawa K. Clinical outcomes of thoracic radiotherapy for locally advanced NSCLC with EGFR mutations or EML4-ALK rearrangement. Anticancer Res 32:4533-4538, 2012

2011年
1. Nakamatsu K, Nishimura Y, Kanamori S, Koike R, Tachibana I, Nishikawa T, Shibata T. Randomized clinical trial of postoperative Strontium-90 radiation therapy for pterygia treatment using 30 Gy/3 fractions vs. 40 Gy/4 fractions. Strahlenther Onkol 187: 401-405, 2011
2. Soejima T, Yoden E, Nishimura Y, Ono S, Yoshida A, Fukuda H, Fukuhara N, Sasaki R, Tujino K, Norihisa Y. Radiation therapy in patients with implanted cardiac pacemakers and implantable cardioverter defibrillators: a prospective survey in Japan. J Radiat Res 52:516-521, 2011
3. Takeda M, Okamoto I, Nishimura Y, Nakagawa K. Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer. Lung Cancer: Targets and Therapy 2: 59–67, 2011
4. Ichinose Y, Seto T, Sasaki T, Yamanaka T, Okamoto I, Takeda K, Tanaka M, Katakami N, Sawa T, Kudoh S, Saka H, Nishimura Y, Nakagawa K, Fukuoka M. S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706). J Thoracic Oncol 6: 2069–2075, 2011
5. Okamoto I, Takahashi T, Okamoto H, Nakagawa K, Watanabe K, Nakamatsu K, Nishimura Y, Fukuoka M, Yamamoto N. Single-agent gefitinib with concurrent radiotherapy for locally advanced non–small cell lung cancer harboring mutations of the epidermal growth factor receptor. Lung cancer 72:199-204, 2011
6. Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Ogo E, Etoh H, Kazumoto T, Takayama M, Nemoto K, Nishimura Y, and the JROSG Working Subgroup of Gastrointestinal Cancers. Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients. Int J Radiat Oncol Biol Phys 80:111-118, 2011

2010年
1. Okamoto K, Okamoto I, Takezawa K, Tachibana I, Fukuoka M, Nishimura Y, Nakagawa K. Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small cell lung cancer in elderly patients. Jpn J Clin Oncol 40:54-59, 2010
2. Nishimura Y, Shibata T, Nakamatsu K, Kanamori S, Koike R, Okubo M, Nishikawa T, Tachibana I, Tamura M, Okumura M. A two-step intensity modulated radiation therapy method for nasopharyngeal cancer: the kinki University Experience. Jpn J Clin Oncol 40:130-138, 2010
3. Okumura M, Obata Y, Shimomura K, Tamura M, Nishimura Y . The effect of gantry and collimator angles on leaf limited velocity and position in dynamic multileaf collimator intensity-modulated radiation therapy. Phys Med Biol 55: 3101–3113, 2010
4. Okubo M, Nishimura Y, Nakamatsu K, Okumura M, Shibata T, Kanamori S, Hanaoka K, Hosono M. Radiation treatment planning using positron emission and computed tomography (PET/CT) for lung and pharyngeal cancers: A multiple thresholds method for FDG activity. Int J Radiat Oncol Biol Phys 77:350-356, 2010
5. Shigeoka H, Imamoto H, Nishimura Y, Shimono T, Furukawa H, Imamura H, Yasuda T, Shiozaki H. Complete response to preoperative chemoradiotherapy in highly advanced gastric adenocarcinoma. World J Gastrointest Oncol 2: 282-286, 2010
6. Yamamoto N, Nakagawa K, Nishimura Y, Tsujino K, Satouchi M, Kudo S, Hida T, Kawahara M, Takeda K, Katakami N, Sawa T, Yokota S, Seto T, Imamura F, Saka H, Iwamoto Y, Semba H, Chiba Y, Uejima H, Fukuoka M. Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non–small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105. J Clin Oncol 28:3739-3745, 2010
7. Ogawa K, Shibuya H, Uchida N, Onishi H, Okuno S, Myojin M, Kobayashi M, Ogawa Y, Kanesaka N, Shibuya K, Tokumaru N, Sasamoto R, Karasawa K, Nemoto K, Nishimura Y, and the JROSG Working Subgroup of Gastrointestinal Cancer. Postoperative external beam radiotherapy for resected pancreatic adenocarcinoma: impact of chemotherapy on local control and survival. Anticancer Research 30:2959-2968, 2010
8. Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Etoh H, Kazumoto T, Takayama M, Negoro Y, Nemoto K, Nishimura Y; JROSG Working Subgroup of Gastrointestinal Cancers. Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients. Int J Radiat Oncol Biol Phys. 2010; 77:734-742.
9. Ogawa K, Ito Y, Karasawa K, Ogawa Y, Onishi H, Kazumoto T, Shibuya K, Shibuya H, Okuno Y, Nishino S, Ogo E, Uchida N, Karasawa K, Nemoto K, Nishimura Y, and the JROSG Working Subgroup of Gastrointestinal Cancers. Patterns of radiotherapy practice for pancreatic cancer in Japan: results of the Japanese Radiation Oncology Study Group (JROSG) survey. Int J Radiat Oncol Biol Phys 77:743-750, 2010
10. Okubo M, Nishimura Y, Shibata T, Nakamatsu K, Kanamori S,Tachibana I, Koike R, Nishikawa T, Mori K. Definitive radiation therapy for moderately advanced laryngeal cancer: effects of accelerated hyperfractionation. Jpn J Clin Oncol 40:944-948, 2010

2009年以前
1. Nishimura Y, Mitsumori M, Hiraoka M, Koike R, Nakamatsu K, Kawamura M, Negoro Y, Fujiwara K, Sakurai H, Mitsuhashi N, A randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer: short-term infusion versus protracted infusion chemotherapy（KROSG0101/JROSG021） Radiother Oncol. 92: 260-265, 2009
2. Koike R, Nishimura Y, Nakamatsu K, Kanamori S, Shibata T. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula. Int J Radiat Oncol Biol Phys 70: 1418-1422, 2008.
3. Nakamatsu K, Suzuki M, Nishimura Y, Kanamori S, Koike R, Shibata T, Shintani N, Okumura M, Okajima K, Akai F. Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity modulated radiotherapy. Int J Clin Oncol 13:48-53, 2008.
4. Kuwano H, Nishimura Y, Ohtsu A, Kato H, Kitagawa Y, Tamai S, Toh Y, Matsubara H. Guidelines for diagnosis and treatment of carcinoma of the esophagus; April 2007 edition: part I, edited by the Japan Esophageal Society. Esophagus 5: 61-73, 2008
5. Karasawa K, Sunamura M, Okamoto A, Nemoto K, Matsuno S, Nishimura Y, Shibamoto Y. Efficacy of novel hypoxic cell sensitizer doranidazole in the treatment of locally advanced pancreatic cancer: long-term results of a placebo-controlled randomized study. Radiother Oncol. 87: 326-330, 2008.
6. Yoh T, Hosono M, Komeya Y, Im SW, Ashikaga R, Shimono T, Tsuchiya N, Okada M, Hanada K, Yagyu Y, Nishimura Y, Murakami T. Quantitative evaluation of norcholesterol scintigraphy, CT attenuation value, and chemocal-shift MR imaging for characterizing adrenal adenomas. Ann Nucl Med 22: 513-519, 2008.
7. Okubo M, Nishimura Y, Nakamatsu K, Okumura M, Shibata T, Kanamori S, Hanaoka K, Hosono M. Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system. Ann Nucl Med 22: 579-586, 2008
8. Isomura M, Oya N, Tachiiri S, Kaneyasu Y, Nishimura Y, Akimoto T, Hareyama M, Sugita T, Mitsuhashi N, Yamashita T, Aoki M, Sai H, Hirokawa Y, Sakata K, Karasawa K, Tomida A, Tsuruo T, Miki Y, Noda T, Hiraoka M. IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis. Clin Cancer Res 14:6683-6689, 2008
9. Masunaga S, Nishimura Y, Hiraoka M, Abe M, Takahashi M, Ono K. Efficacy of mild temperature hyperthermia in combined treatments for cancer therapy. Thermal Medicine, 23: 103-112, 2007.
10. Nishimura Y, Nakagawa K, Takeda K, Tanaka M, Segawa Y,　Tsujino K, Negoro S, Fuwa N, Hida T, Kawahara M, Katakami N, Hirokawa K, Yamamoto N, Fukuoka M, Ariyoshi Y. Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, Doranidazole (PR-350), in patients with locally advanced non-small cell lung cancer (WJTOG-0002). Int J Radiat Oncol Biol Phys 69：786-792, 2007.
11. Liu J, Harada H, Ogura M, Shibata T, Hiraoka M. Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts. Br J Cancer. 96: 1871-1878., 2007.
12. Yamazaki H, Nishiyama K, Tanaka E, Koiwai K, Shikama N, Ito Y, Arahira S, Tamamoto T, Shibata T, Tamaki Y, Kodaira T, Oguchi M. Dummy run for a phase II multi-institute trial of chemoradiotherapy for unresectable pancreatic cancer: inter-observer variance in contour delineation. Anticancer Res.;27: 2965-2971, 2007.
13. Suzuki M, Nishimura Y, Nakamatsu K, Okumura M, Hashiba H, Koike R, Kanamori S,? Shibata T. Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk volume (PRV)-margins. Radiother Oncol. 78: 283-290, 2006.
14. Nemoto K, Yamada S, Nishio M, Aoki M, Nakamura R, Matsumoto Y, Sasamoto R, Saitoh Y, Takayama M, Mitsuhashi N, Gomi K, Kanesaka N, Kobayashi M, Ohnishi H, Sasaki S, Tamamura H, Mitsumori M, Nishimura Y, Tsujino K, Takemoto M, Uchida N, Yamamoto M, Shioyama Y, Hirakawa K, Ono S. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society for Therapeutic Radiology and Oncology (JASTRO) Study Group. Anticancer Research 26: 1507-1512, 2006.
15. Hanada K, Hosono M, Kudo T, Hitomi Y, Yagyu Y, Kirime E, Komeya Y, Tsujii N, Hitomi K, Nishimura Y. Regional cerebral blood flow in the assessment of major depression and Alzheimer’s disease in the early elderly. Nucl Med Commun 27: 535-541, 2006.
16. Yamamoto N, Nishimura Y, Nakagawa K , Matsui K, Fukuoka M. Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer. Cancer Chemother Pharmacology 58: 285-291, 2006.
17. Yagyu Y, Awai K, Inoue M, Watai R, Sano T, Hasegawa H, Nishimura Y. MDCT of hypervascular hepatocellular carcinomas: a prospective study using contrast materials with different iodine concentrations. Am J Rentogenol 184:1535-1540, 2005.
18. Sai H, Mitsumori M, Araki N, Mizowaki T, Nagata Y, Nishimura Y, Hiraoka M. Long-term results of definitive radiotherapy for stage I esophageal cancer. Int J Radiat Oncol Biol Phys. 62:1339-44, 2005.
19. Nishimura Y, Nakamatsu K, Shibata T, Kanamori S, Koike R, Okumura M, Suzuki M. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT. Jpn J Clin Oncol 35:375-379, 2005.
20. Suzuki M, Nakamatsu K, Kanamori S, Nishimura Y. Are there dose-rate effects on cell killing following irradiation by intensity modulated radiotherapy (IMRT)? Austral-Asian J Cancer 4: 151-154, 2005.
21. Nishimura Y. Profile. Austral-Asian J Cancer 4: 123-124, 2005.
22. Nishida C, Okajima K, Kudo T, Yamamoto T, Hattori R, Nishimura Y. The relationship between coronary artery calcification detected by non-gated multi-detector CT in patients with suspected ischemic heart disease and myocardial ischemia detected by thallium exercise stress testing. Ann Nucl Med 19:647-653, 2005.
23. Suzuki M, Okumura M, Nishimura Y. Glioblastoma multiforme: case study. In Intensity Modulated Radiation Therapy; A clinical perspective, Eds. Mundt AJ, Roeske JC, BC Decker, pp.253-256, 2005.
24. Liu J, Qu R, Ogura M, Shibata T, Harada H, Hiraoka M. Real-time imaging of hypoxia-inducible factor-1 activity in tumor xenografts. J Radiat Res (Tokyo). 46: 93-102, 2005.
25. Ogura M, Shibata T, Yi J, Liu J, Qu R, Harada H, Hiraoka M. A tumor-specific gene therapy strategy targeting dysregulation of the VHL/HIF pathway in renal cell carcinomas. Cancer Sci. ;96: 288-294, 2005.
26. Awai K, Hiraishi K, Hori S. Effect of Contrast Material Injection Duration and Rate on Aortic Peak Time and Peak Enhancement at Dynamic CT Involving Injection Protocol with Dose Tailored to Patient Weight. Radiology 230: 142-150, 2004.
27. Awai K, Murao K, Ozawa A, Komi M, Hayakawa H, Hori S, Nishimura Y. Pulmonary nodules at chest CT: effect of computer-aided diagnosis on radiologists' detection performance. Radiology 230:347-352, 2004.
28. Suzuki M,Masunaga S, Kinashi Y, Nagata K, Sakurai Y, Nakamatsu K, Nishimura Y, Maruhashi A, Ono K. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model. Int J Radiat Oncol Biol Phys 59: 260-266, 2004.
29. Sai H, Mitsumori M, Yamauchi C, Araki N, Okumura S, Nagata Y, Nishimura Y, Hiraoka M. Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil. Int J Clin Oncol 9: 149-153, 2004.
30. Nakamatsu K, Nishimura Y, Suzuki M, Kanamori S, Maenishi O, Yasuda Y. Erythropoietin/erythropoietin-receptor system as an angiogenic factor in chemically-induced murine hepatic tumors. Int J Clin Oncol 9: 184-188, 2004.
31. Nishimura Y. Progress in radiation therapy for esophageal cancer. Recent Advances and Research Updates 5: 261-270, 2004
32. Awai K, Inoue M, Yagyu Y, Watanabe M, Sano T, Nin S, Koike R, Nishimura Y, Yamashita Y. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT. Radiology. 233:682-688, 2004.
33. Sunamura M, Karasawa K, Okamoto A, Ogata Y, Nemoto K, Hosotani R, Nishimura Y, Matsui K, Matsuno S. Phase III trial of radiosensitizer PR-350 combined with intraoperative radiotherapy for the treatment of locally advanced pancreatic cancer. Pancreas 28: 330-334, 2004.
34. Nishimura Y.? Rationale for chemoradiotherapy. Int J Clin Oncol　9: 414-420, 2004.
35. Suzuki M, Nakamatsu K, Kanamori S, Okajima K, Okumura M, Nishimura Y. Comparison of outocomes between overlapping structure-based and non-overlapping structure-based optimizaion for simultaneous integrated boost IMRT for malignant glioma. Int J Clin Oncol　9: 491-497, 2004.
36. Liu J, Shibata T, Qu R, Ogura M, Hiraoka M. Influences of the p53 status on hypoxia-induced gene expression. J Radiat Res (Tokyo); 45: 333-339. 2004.
37. Takemoto M, Kuroda M, Urano M, Nishimura Y, Kawasaki S, Kato H, Okumura Y, Akaki S, Kanazawa S, Asami J, Joja I, Hiraki Y. The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumors. Int. J. Hyperthermia 19: 193-203, 2003.
38. Suzuki M, Nakamatsu K, Kanamori S, Masunaga S, Nishimura Y. Additive effects of radiation and docetaxel on murine SCCVII tumors in vivo; special reference to changes in the cell cycle. Radiat Res. 159:799-804, 2003.
39. Mizowaki T, Okajima K, Nagata Y, Mitsumori M, Nishimura Y, Shoji K, Asato R, Hiraoka M. Concurrent chemotherapy and radiotherapy with low-dose cisplatin for nasopharyngeal carcinoma. Am J Clin Oncol (CCT) 26: 155-158, 2003.
40. Nishimura Y, Nagata K, Katano S, Hirota S, Nakamura K, Higuchi F, Soejima T, Sai H: Severe complications in advanced esophageal cancer treated with radiation therapy after intubation of esophageal stents; a questionnaire survey of the Japanese Society for Esophageal Diseases. Int. J. Radiat. Oncol. Biol. Phys. 56:1327-1332, 2003.
41. Hosono M, Machida K, Honda N, Takahashi T, Kashimada A, Murata O, Osada H, Ohtawa N, Itoyama S. Intense gallium-67 accumulation in primary mediastinal pure seminomas. Clinical Nuclear Medicine 2003;28(1):25-28.
42. Hosono M, Machida K, Honda N, Takahashi T, Ohtawa N. Visualization of fatal hepatic necrosis on bone scan. Clinical Nuclear Medicine 2003;28(5):398-399
43. Hosono M, Machida K, Inoue Y, Honda N, Takahashi T, Kashimada A, Ohtawa N, Ohno H, Yamano T. Gallium-67 demonstration of extensive soft-tissue involvement of multiple myeloma. Ann Nucl Med 2003;17(1):69-72.
44. Machida K, Inoue Y, Honda N, Hosono M, Takahashi T, Kashimada A. Spontaneous regression of chest wall malignant lymphoma presentation on Ga-67 imaging. Clin Nucl Med 2003;28(5):405-407
45. Takahashi T, Machida K, Honda N, Hosono M, Kashimada A, Murata O, Osada H, Nishimura K. Adult embryonal rhabdomyosarcoma in axilla. Radiation Medicine 2003;21(3):135-137
46. Inoue M,Sano T,Watai R,Ashikaga R,Ueda K, Watatani M,NishimuraY. Dynamic Multidetector CT of Breast Tumors : Diagonostic features and Comparison with Conventional Techniques.AJR.181:679-686,2003.
47. Shimono T, Miki Y, Toyoda H, Egawa H, Uemoto S, Tanaka K, Hattori H,Kanagaki M, Itoh K, Konishi J. MR imaging with quantitative diffusion mapping of tacrolimus-induced neurotoxicity in organ transplant patients.European Radiology.13(5)：986-93，2003.
48. Suzuki M, Nakamatsu K, Kanamori S, Okumra M, Uchiyama T, Akai F, Nishimura Y. Feasibility study of the simultaneous integrated boost (SIB) method for malignant gliomas using intensity modulated radiotherapy (IMRT). Jpn. J. Clin. Oncol 33:271-277, 2003.
49. Suzuki M, Nishimura Y, Nakamatsu K, Kanamori S, Koike R, Kawamoto M, Mori K. Phase I study of weekly docetaxel infusion and concurrent radiation therapy for head and neck cancer. Jpn. J. Clin. Oncol 33:297-301, 2003.
50. Nishimura Y, Koike R, Nakamatsu K, Kanamori S, Suzuki M, Shigeoka H, Shiozaki H. Concurrent chemoradiotherapy with protracted infusion of 5-FU and cisplatin for postoperative recurrent or residual? esophageal cancer. Jpn J Clin Oncol 33: 341-345, 2003.
51. Awai K, Hori S. Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT.　Eur Radiol 13(9):2155-2160, 2003.
52. Yakami M, Mitsumori M, Sai H, Nagata Y, Hiraoka M, Nishimura Y. Development of severe complications caused by stent placement and followed by definitive radiation therapy for T4 esophageal cancer; a report of three cases. Int J Clin Oncol . 8: 395-398, 2003
53. Suzuki M , Okumura M, Nakamatsu K, Kanamori S, Nishimura Y. Effects of inhomogeneity correction algorithms on monitor units calculation: analysis of clinical cases of lung cancer. J Jpn Soc Ther Radiol Oncol . 15: 271-275, 2003.
54. Maeda M, Shiroyama T, Tsukahara H, Shimono T, Aoki S, Takeda K. Transient splenial lesion of the corpus callosum associated with antiepileptic drugs: evaluation by diffusion-weighted MR imaging. Eur Radiol. 13:1902-1906,2003.
55. Ieda Y, Yamamoto N, Nakagawa K, Nishimura Y, Fukuoka M. AUC finding study of daily carboplatin administration combined with concurrent thoracic radiotherapy for elderly non-small cell lung cancer patients. Acta Med Kinki Univ. 26: 35-44, 2002.
56. Nishimura Y, Suzuki M, Nakamatsu K, Kanamori S, Yagyu Y, Shigeoka H. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. . Int. J. Radiat. Oncol. Biol. Phys. 53: 134-139, 2002.
57. Yamada M, Kudoh S, Fukuda H, Nakagawa K, Yamamoto N, Nishimura Y, Negoro S, Takeda K, Tanaka M, Fukuoka M. Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer. Br J Cancer 87: 258-263, 2002.
58. Kudo T, Fukuchi K, Annala AJ, Chatziioannou AF, Allada V, Dahlbom M, Tai YC, Inubushi M, Huang SC, Cherry SR, Phelps ME, Schelbert HR. Noninvasive measurement of myocardial activity concentrations and perfusion defect sizes in rats with a new small-animal positron emission tomograph. Circulation. Jul 2;106(1):118-123, 2002.?
59. Awai K, Takada K, Onishi H, Hori S. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT.　Radiology 224(3):757-763, 2002.
60. Iwase K, Higaki J, Yoon HE, Mikata S, Miyazaki M, Torikai K, Shirai Y, Awai K, Imakita M, Kamiike W. Solitary necrotic nodule of the liver. J Hepatobiliary Pancreat Surg. 9(1):120-124, 2002.?
61. Horii N, Nishimura Y, Okuno Y, Kanamori S, Hiraoka M, Shimada Y, Imamura M. Impact of neoadjuvant chemotherapy on Ki-67 and PCNA labeling indices for esophageal squamous cell carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 49: 527-532, 2001.
62. Koishi M, Yokota S, Mae T, Nishimura Y, Kanamori S, Horii N, Shibuya K, Sasai K, Hiraoka M. The effects of KNK437, a novel inhibitor of heat shock protein synthesis, on the acquisition of thermotolerance in a murine transplantable tumor in vivo. Clin Cancer Res 7: 215-219, 2001.
63. Kokubo M, Nagata Y, Nishimura Y, Kimura H, Shoji K, Asato R, Sasai K, Hiraoka M. Concurrent chemoradiotherapy for oropharyngeal carcinoma. Am J Clin Oncol (CCT) 24:71-76, 2001.
64. Masunaga S, Ono K, Suzuki M, Nishimura Y, Kinashi Y, Takagaki M, Hori H, Nagasawa H, Uto Y, Tsuchiya I, Sadahiro S, Murayama C. Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells. Int. J. Radiat. Oncol. Biol. Phys. 50: 1063-1072, 2001.
65. Oya N, Kokubo M, Mizowaki T, Shibamoto Y, Nagata Y, Sasai K, Nishimura Y, Tsuboyama T, Toguchida J, Nakamura T, Hiraoka M. Definitive intraoperative very high-dose radiotherapy for localized osteosarcoma in the extremities. Int. J. Radiat. Oncol. Biol. Phys. 51: 87-93, 2001.
66. Ueno M, Nishizawa S, Toyoda H, Shimono T, Miyamoto S, Hashimoto N,Konishi J. Assessment of cerebral hemodynamics before and after revascularization in patients with occlusive cerebrovascular disease by means of quantitative IMP-SPECT with double-injection protocol .Ann Nucl Med.15(3):209-215,2001.
67. Nishizawa S, Kuwabara H, Ueno M, Shimono T, Toyoda H, Konishi J.Double-injection FDG method to measure cerebral glucose metabolism twice in a single procedure.Ann Nucl Med.15(3):203-207,2001.
68. Nishizawa S, Shiozaki T ,Ueno M, Toyoda H, Shimono T, Kamoto Y,Fujita T, Yonekura Y, Konishi J.A new method to estimate rCBF using IMP and SPECT without any blood sampling .Ann Nucl Med.14(6):433-440,2001.
69. Hernandez-Pampaloni M, Keng FY, Kudo T, Sayre JS, Schelbert HR.Abnormal longitudinal,base-to-apex myocardial perfusion gradient by quantitative blood flow measurements in patients with coronary risk factors. Circulation 104(5)：527-532，2001.
70. Nishimura Y., Nakai A, Yoshimasu T, Yagyu Y, Nakamatsu K, Sindo H, Ishida O. Long-term results of fractionated Strontium-90 radiation therapy for pterygia. Int. J. Radiat. Oncol. Biol. Phys. 46: 137-141, 2000.
71. Zhu JL, Nagata Y, Kanamori S, Mitsumori M, Okuno Y, Horii N, Nishimura Y, Masunaga S, Hiraoka M. Preliminary clinical results of locoregional hyperthermia for primary and secondary bone tumors. Jpn. J. Hyperthermic Oncol. 16: 17-26, 2000.
72. Nemoto K, Matsumoto Y, Yamakawa M, Jo S, Ito Y, Oguchi M, Kokubo N, Nishimura Y, Yamada S, Okawa T. Treatment of superficial esophageal cancer by external radiation therapy alone: results of a multi-institutional experience. Int. J. Radiat. Oncol. Biol. Phys. 46: 921-925, 2000.
73. Nishida C, Ashikaga R, Araki Y, Nakamatsu K, Ono Y, Fujii K, Nishimura Y. Persistent hypoglossal artery associated with arteriovenous malformation: a case report. Eur. J. Radiol. 33: 59-62, 2000.
74. Masunaga S, Ono K, Nishimura Y, Kanamori S, Saga T, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y, Hori H. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors; reference to the effect on intratumor quiescent cells. Int. J. Radiat. Oncol. Biol. Phys. 47: 799-807, 2000.
75. Yamamoto T, Ashikaga R, Araki Y, Nishimura Y. A case of Marchiafava-Bignami disease: MRI findings on spin-echo and fluid attenuated inversion recovery (FLAIR) images. Eur. J. Radiol. 34: 141-143, 2000.
76. Kokubo M, Nishimura Y, Shibamoto Y, Sasai K, Hosotani R, Imamura M, Hiraoka M. Concurrent chemoradiotherapy combined with intraoperative radiotherapy for locally advanced pancreatic cancer: a feasibility study. Oncol. Reports 7: 773-776, 2000.
77. Kokubo M, Nishimura Y, Shibamoto Y, Sasai K, Kanamori S, Hosotani R, Imamura M, Hiraoka M. Analysis of the clinical benefit of intraoperative radiotherapy in patients undergoing macroscopically curative resection for pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 48: 1081-1087, 2000.
78. Ono Y, Yoshimasu T, Ashikaga R, Inoue M, Shindou H, Fujii K, Araki Y, Nishimura Y. Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. Am J Clin Oncol (CCT) 23: 564-568, 2000.
79. Mizowaki T, Nagata Y, Okajima K, Kokubo M, Negoro Y, Araki N, Hiraoka M. Reproducibility of geometric distortion in magnetic resonance imaging based on phantom studies.? Radiother Oncol 57(2):237-42, 2000.
80. Nagata Y, Araki N, Kimura H, Fujiwara K, Okajima K, Aoki T, Mitsumori M, Sasai K, Hiraoka M, Higuchi T, Fujii S. Neoadjuvant chemotherapy by transcatheter arterial infusion method for uterine cervical cancer.? J Vasc Interv Radiol? 11(3):313-9, 2000.
81. Suzuki M, Masunaga SI, Kinashi Y, Takagaki M, Sakurai Y, Kobayashi T, Ono K. The effects of boron neutron capture therapy on liver tumors and normal hepatocytes in mice. Jpn. J. Cancer Res. 91: 1058-1064, 2000.
82. Kudoh T,Tadamura E,Tamaki N,Hattori N,Inubushi M,Kubo S,Magata Y,Nishimura K,Matsuda K,Konishi J. Iodinated free fatty acid 201Ｔ1 uptake in chronically hypoperfused　myocardium histologic correlation study. J Nucl Med,41（2）：293-296，2000.
83. Tadamura E,Yoshibayashi M,Yonemura T,Kudoh T,Kubo S,Motooka M,Nohara R,Matsumori A,Sasayama S,Matsuda T,Tamaki N,Konishi J. Significant regional heterogeneity of coronary flow reserve in paediatric hypertrophic　cardiomyopathy. European Journal of Nuculear Medicine 27（9）：1340-1348，2000.
84. Ashikaga R, Araki Y, Ono Y, Nishimura Y, Ishida O. Appearance of normal brain maturation on fluid-attenuated inversion-recovery (FLAIR) MR images. Am J Neuroradiol 20: 427-431, 1999.
85. Kanamori S, Nishimura Y, Kokubo M, Sasai K, Hiraoka M, Shibamoto Y, Hosotani R, Imamura M, Abe M. Tumor Response and Patterns of Failure Following Intraoperative Radiotherapy for Unresectable Pancreatic Cancer: Evaluation by Computed Tomography. Acta Oncol.38: 215-220, 1999.
86. Okuno Y, Nishimura Y, Kashu I, Ono K, Hiraoka M.? Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for definitive radiotherapy of esophageal squamous cell carcinomas. Br. J. Cancer 80: 387-395, 1999.
87. Kanamori S, Nishimura Y, Okuno Y, Horii N, Saga T, Hiraoka M. Induction of vascular endothelial growth factor (VEGF) by hyperthermia and/or an angiogenesis inhibitor. Int. J. Hyperthermia 15: 267-278, 1999.
88. Nishimura Y, Okuno Y, Ono K, Mitsumori M, Nagata Y, Hiraoka M. External-beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for superficial esophageal cancer. Cancer. 86: 220-228, 1999.
89. Higashi T, Sakahara H, Torizuka T, Nakamoto Y, Kanamori S, Hiraoka M, Imamura M, Nishimura Y, Tamaki N, Konishi J.? Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG-PET. JNM? 40: 1424-1433, 1999.
90. Lee JU, Hosotani R, Wada M, Doi R, Kosiba T, Fujimoto K, Miyamoto Y, Tsuji S, Nakajima S, Nishimura Y, Imamura M. Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells. Eur J Cancer, 35(9): 1374-80, 1999.
91. Araki Y, Ashikaga R, Fujii K, Nishimura Y, Ueda J, Fujita N. MR fluid-attenuated inversion recovery imaging as routine brain T2-weighted imaging. Eur. J. Radiol. 32: 136-143, 1999.
92. Urano M., Kuroda M., Nishimura Y. Invited review: For the clinical application of thermochemotherapy given at mild temperatures. Int. J. Hyperthermia 15: 79-107, 1999.
93. Tsukiyama I, Katano S, Nishimura Y. Interdisciplinary therapy for patients with superficial and shallowly seated tumors. Jpn. J. Hyperthermic Oncol. 15: 105-112, 1999.
94. Shibuya K, Nagata Y, Itoh T, Okajima K, Murata R, Takagi T, Hiraoka M. Transcatheter arterial infusion therapy in the treatment of advanced pancreatic cancer: a feasibility study.? Cardiovasc Intervent Radiol 22(3):196-200, 1999.
95. Yamamoto M, Nagata Y, Okajima K, Ishigaki T, Murata R, Mizowaki T, Kokubo M, Hiraoka M. Differences in target outline delineation from CT scans of brain tumours using different methods and different observers.? Radiother Oncol 50(2):151-6, 1999.
96. Nagata Y, Okajima K, Kokubo M, Kanamori S, Fujiwara K, Mizowaki T, Sasai K, Hiraoka M, Kataoka N, Konishi I. Clinical results of transcatheter arterial infusion for uterine cervical cancer.? Am J Clin Oncol? 22(1):97-102 , 1999.
97. Griffin RJ, Okajima K, Ogawa A, Song CW.? Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing.? Int J Radiat Biol , 75(10):1299-306, 1999.
98. Nagata Y, Mitsumori M, Okajima K, Mizowaki T, Fujiwara K, Sasai K, Nishimura Y, Hiraoka M, Abe M, Shimizu K, Kotoura Y. Transcatheter arterial embolization for malignant osseous and soft tissue sarcomas. II. clinical results. Cardiovasc. Intervent. Radiol. 21: 208-213, 1998.
99. Urano M, Nishimura Y, Kuroda M, Reynolds R. Are hypoxic cells critical for the outcome of fractionated radiotherapy in a slow-growing mouse tumor? Radiotherapy and Oncol. 48: 221-228, 1998.
100. Fujishiro S, Mitsumori M, Nishimura Y, Okuno Y, Nagata Y, Hiraoka M, Sano T, Marume T, Takayama N. Increased heating efficiency of hyperthermia using an ultrasound contrast agent: a phantom study. Int. J. Hyperthermia 14: 495-502, 1998.
101. )Nishimura Y., Yokoe Y., Nagata Y., Okajima K., Nishida M., Hiraoka M. High dose rate brachytherapy using moulds for oral cavity cancer. Int. J. Clin. Oncol. 3: 351-356, 1998.
102. Yokomise H, Nishimura Y, Fukuse T, Hirata T, Ike O, Mizuno H, Wada H, Hitomi S.? Long-term remission after brachytherapy with external irradiation for locally advanced lung cancer. Respiration; 65:489-491, 1998.
103. Nishimura Y, Hiraoka M. Relationship between thermometry results and tumor response in thermo-radiotherapy. Jpn. J. Hyperthermic Oncol. 14: 162-169, 1998.

III. 和文原著、総説、症例報告

2021年
1. 田村命, 門前一, 松本賢治, 大塚正和, 花岡宏平, 浅井義行. 近畿大学大学院医学研究科基礎医学系医学物理学専攻・近畿大学病院がんセンター放射線治療部医学物理室の紹介. 医学物理 2021年 41巻 1号 p. 44-47. DOI: 10.11323/jjmp.41.1_44
2. Okada W, Doi H, Tanooka M, Sano K, Nakamura K, Sakai Y, Shibata M, Tanaka M. A first report of tumour-tracking radiotherapy with helical tomotherapy for lung and liver tumours: A double case report. SAGE Open Medical Case Reports.2021; 9:2050313X211023688. DOI: 10.1177/2050313X211023688

2020年
1. 西村恭昌、門前一、石川一樹、松本賢治
  治療効率に優れた「Halcyon」を生かしVMATによる全脳全脊髄照射を実施 INNERVISION 12 66-67
2. Yasumasa Nishimura.
  A message from the new editor-in-chief. Int J Clin Oncol. 2020; 25(5), 785-786
3. 土井啓至　
  歯界展望　Vol.136　放射線治療とオーラルマネージメント　医歯薬出版株式会社2020年
4. 石川一樹、植原拓也、松浦知弘、西村恭昌
  放射線治療計画の進歩　頭頚部癌　46(3): 243-247, 2020
5. 松本賢治、大塚正和、田村命、門前一、奥村雅彦
  高速回転Oリングリニアックと汎用リニアックにおけるVMAT治療計画の比較　日本放射線技術学会誌 76巻4号2020.
6. 松本賢治、田村命、大塚正和、若林和樹、木嶋健太、門前一
  電子線に対するリアルタイム可変型タングステンゴムの線量特性について　日本放射線技術学会誌　76巻12号2020.

2019年
1. 石川一樹、西村恭昌
  SmartAdaptを使用した適応放射線治療について　INNERVISION (34・5) 2019
2. 藤浩、秋元哲夫、西村恭昌、高橋進一郎、佐野佳二、古瀬純司
  動き始めた大規模臨床試験　JCOG1315C：陽子線治療 vs. 肝切除　The Liver Cancer Journal 2019-3 Vol.11. No.1
3. 林隆一、丹生健一、松浦一登、西村恭昌、中塚貴志　
  チーム医療としての頭頸部がん診療　日本医師会雑誌第148巻第6号2019年9月
4. 西村恭昌　
  放射線科領域　この5年の進歩　内科　Vol.124 No. 3 (2019)
5. 土井啓至
  肝腫瘍への放射線治療の5W1H～when, where, who, what, why, and how～
  放射線治療かたろう会会誌24号164-174. 2019年5月31日発刊．
6. Doi H, Nakamatsu K, Nishimura Y.
  Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: A review.
  International Journal of Clinical Oncology. 2019 Aug;24(8):899-909.

2018年
1. PET/CTを用いた放射線治療計画　
  医学物理 2018;38 (2):85-88　花岡宏平, 奥村雅彦, 門前一
2. 放射線外部照射での患者安全へ向けて.
  医学物理 2018;38 (2):68-73. 太田誠一
3. アイソトープ内用療法の国際動向調査日本放射線技術学会雑誌74 巻12 号
  花岡宏平, 前田貴雅, 宮司典明, 坂口健太, 米山寛人, 尾川松義, 對間博之
4. 低吸収素材を用いた頭頚部用枕固定支持台の開発　
  日本放射線技術学会誌75巻２号　松本賢治
5. Doi H, Kuribayashi K, Kijima T.
  Utility of polaprezinc in reducing toxicities during radiotherapy: A literature review.
  Future Oncology. 2018;14(19):1977-1988.
6. Doi H, Beppu N, Kitajima K, Kuribayashi K.
  Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.
  Anticancer Research. ;38(2):591-599,2018.

2017年
1. 西村恭昌：頭頚部癌放射線治療の変遷と展望　日本臨牀75巻　増刊号2（2017）
2. 花岡宏平：PET/CT放射線治療計画実施における技術的アプローチ　Rad Fan 15(1) 2‐3-3
3. 松本賢治：頭頸部がんの放射線治療における現状（技術報告）インナービジョン　2017年2月号
4. 太田誠一：放射線治療のリスク解析、日本放射線技術学会放射線治療分科会誌31 (2): 53-60, 2017
5. 太田誠一：ベトナム南部を中心とした放射線技術の知識と技術のシェア -次世代へと繋ぐ交流のかけはし-、国立研究開発法人国立国際医療研究センター国際医療協力局テクニカルレポート10、41-46, 2018.

2016年
1. Monzen H, Tamura M, Hanaoka K, Matsumoto K, Hayakawa M.
  Development and application of radiation shielding paper. Ionaizing radiation. 2016;41(3):139-143.

2014年
1. 中松清志、西村恭昌：肺癌、放射線治療（特集；肺癌、診断と治療の進歩）、日本内科学会雑誌、103：1300-1305, 2014

2013年
1. 西村恭昌：放射線治療専門医制度の現状と新専門医制度への移行、新医療、40(11): 141-144, 2013
2. 西村恭昌、松浦知弘：頭頸部腫瘍に対する強度変調放射線治療、耳喉頭腫 85(3):196-200, 2013
3. 西村恭昌：肺がんに対する放射線療法の進歩、日医雑誌 142(1):43-46, 2013
4. 井垣浩、大西洋、中川恵一、茂松直之、根本建二、西村恭昌、平岡眞寛、外来放射線照射診療料の実態、日本放射線腫瘍学会アンケート調査結果の解析、臨床放射線 58: 364-371, 2013

2012年
1. 西村恭昌：臨床医学の展望2012、放射線腫瘍学、日本医事新報 4585:78-83, 2012
2. 西村恭昌、西環：頭頸部腫瘍に対する適応放射線治療としてのtwo-step法IMRT、臨床放射線　57(4): 482-489, 2012
3. 西村恭昌：食道癌に対する放射線治療の現況と展望、臨床外科67(8): 992-996, 2012

2011年
1. 西村恭昌、小池竜太、石川一樹：食道がんの最新放射線治療、強度変調放射線治療（IMRT）、化学放射線療法の治療成績向上と晩期合併症の低減に向けて、INNERVISION 23(3):37-38, 2011
2. 西村恭昌：化学放射線療法、これだけは知っておきたい、放射線療法Q & A、基本知識と最前線、がん治療レクチャー　2(1):3-6, 2011
3. 西村恭昌、小川和彦：消化器腫瘍委員会、特集：JROSG (Japanese Radiation Oncology Study Group)の現状、癌の臨床、56(7): 499-504, 2011
4. 中井英勝、渡部洋、江藤智麿、中松清志、西村恭昌、星合昊、当科におけるconcurrent chemo-radiation therapyの治療成績、日本婦人科腫瘍学会誌、29(2) :227-232, 2011
5. 西村恭昌、柴田徹、中松清志、金森修一、小池竜太、西川龍之、立花和泉、石川一樹：上咽頭癌に対する強度変調放射線治療（IMRT）、近畿大学での経験、臨床放射線 56:943-949, 2011
6. 西村恭昌、小池竜太：強度変調放射線治療（IMRT）による食道癌治療、癌と化学療法 38(9): 1421-1423, 2011
7. 石川一樹、小池竜太、立花和泉、西川龍之、中松清志、金森修一、柴田徹、西村恭昌、切除不能局所進行食道癌に対する術前化学放射線療法の検討、癌の臨床　57(2):71-75, 2011
8. 西村恭昌、放射線治療専門医の養成、腫瘍内科 7(1):39-42, 2011
9. 西村恭昌：予防的全脳照射、インフォームドコンセントのための図説シリーズ、肺がん、抗悪性腫瘍薬、改訂版、西條長宏編、医薬ジャーナル社、pp.70-71、2011
10. 西村恭昌：放射線治療、インフォームドコンセントのための図説シリーズ、肺がん、改訂4版、西條長宏、加藤治文編、医薬ジャーナル社、pp.90-95、2011

2010年
1. 西村恭昌：食道癌に対する放射線療法の進歩、医学のあゆみ、233(8): 595-599, 2010
2. 西村恭昌：強度変調放射線治療、JOHNS (Journal of Otolaryngology, Head and Neck Surgery) 26 (6):927-930, 2010
3. 西村恭昌：食道癌に対する照射技術の進歩、消化器外科、33(8):1319-1324, 2010
4. 西村恭昌、小池竜太、石川一樹：食道癌に対する強度変調放射線治療（IMRT）、Rad Fan 8(12):55-57, 2010
5. 西村恭昌：非小細胞肺癌に対する放射線療法の現状と問題点、コンセンサス癌治療、9(4):194-197, 2010

2009年以前
1. 西村恭昌：肺癌に対する放射線療法の最新動向、内科 103(2): 241-244, 2009
2. 小池竜太、西村恭昌：悪性瘻孔を有する進行食道癌に対する化学放射線療法、臨床腫瘍プラクティス 5(1): 64-66, 2009
3. 西村恭昌：上咽頭癌に対する強度変調放射線治療（IMRT）：治療計画法を中心に、映像情報 Medical 41(6): 626-629, 2009
4. 西村恭昌：放射線療法の考え方と最近の進歩、最新医学、64(6): 1109-1114, 2009
5. 西村恭昌、大久保充、PET-CTシミュレーションによる放射線療法：現状と今後の展開、癌の臨床54(2): 87-90, 2008.
6. 金森修一、大久保充、中松清志、小池竜太、西川龍之、廣井啓二、柴田徹、西村恭昌：Stage III乳癌の温存乳房に対する放射線治療、臨床放射線 53：442-448, 2008.
7. 西村恭昌：強度変調放射線療法（ＩＭＲＴ）、カレントテラピー 26(5):408-411, 2008.
8. 西村恭昌：肺癌放射線療法の適応、肺癌：基礎･臨床研究ののアップデート、日本臨床、増刊号、66(増刊号6)：458-462, 2008.
9. 西村恭昌：日本での食道癌に対する放射線治療研究の現状、日中医学2008-1, 22 (5):46-49, 2008.
10. 西村恭昌：放射線治療オンコロジーチームの養成は、今後の必須作業である、新医療 400: 71-73、2008年4月.
11. 西村恭昌、小池竜太：化学放射線療法の進歩、外科治療　99(4): 336-340, 2008
12. 西村恭昌、柴田徹、中松清志：放射線療法の進歩・IMRT、臨床放射線53(11)：1547-1554, 2008
13. 西村恭昌：粒子線治療と高精度X線放射線治療の比較、臨床放射線　53: 1071-1077, 2008
14. 西村恭昌：肺癌放射線治療の現状と展望、呼吸と循環 56(12): 1213-1219, 2008
15. 西村恭昌：頭頸部腫瘍に対する強度変調放射線治療（IMRT）、これからはじめる人のために、医学のあゆみ 227(9): 704-709, 2008
16. 西村恭昌、放射線治療に伴う晩期有害事象；食道がん、癌の臨床53(5): 297-302, 2007.
17. 西村恭昌、肺癌放射線治療のリスクマネージメント、呼吸26(11):1039-1043, 2007.
18. 余田栄作、副島俊典、辻野佳世子、西村恭昌、福田晴行、佐々木良平、吉田明弘、小野誠治、ペースメーカーおよび埋め込み式除細動器装着患者に対する放射線治療に関する予備アンケート報告、日放腫会誌、19: 165-169, 2007.
19. 西村恭昌：６大学連携オンコロジーチーム養成プラン、Rad Fan 5 (12): 106-107, 2007.
20. 西村恭昌、強度変調放射線療法（ＩＭＲＴ）の現状と展望、臨床放射線 51：565-571, 2006.
21. 西村恭昌、強度変調放射線療法（ＩＭＲＴ）による進歩、日本放射線技術学会近畿部会誌12(2): 39-43, 2006.
22. 中松清志、西村恭昌：頭頸部および中枢神経腫瘍に対する強度変調放射線治療（IMRT）、臨床放射線 51（10）：1171-1178, 2006.
23. 西村恭昌：放射線腫瘍医の人材育成、Digital Medicine 6(3): 37-38, 2006.
24. 西村恭昌、山田章吾：放射線腫瘍学講座に関する全国アンケート結果：広報委員会の役割、日放腫会誌、18: 66-70, 2006.
25. 山田章吾、小川芳弘、有賀久哲、大内憲明、仲田栄子、晴山雅人、白土博樹、阿部由直、根本建二、大西洋、西村恭昌、中村和正、早渕尚文：早期の癌に対する標準的放射線治療法確立のための研究、Innervision 21 (7): 25, 2006.
26. 小倉昌和、柴田徹、原田浩、平岡眞寛：腎細胞癌に対する腫瘍特異的遺伝子治療、日本臨床　64 (Supple 2): 672-675, 2006.
27. 寺内一真、下野太郎、松村文典、西村恭昌、木村雅友、MRIでｆｌｏｗｖｏｉｄを認めなかった馬尾原発傍神経節腫の１例、臨床放射線 50：430-433, 2005.
28. 根本建二、山田章吾、西尾正道、青木昌彦、中村隆二、松本康夫、笹本龍太、斉藤吉弘、高山誠、三橋紀夫、五味光太郎、兼坂直人、小林雅夫、田中史穂、佐々木茂、玉村裕保、光森通英、西村恭昌、辻野佳世子、武本充広、内田伸恵道法、塩山善之、平河浩一、小野誠治、JASTRO研究グループによる標準的放射線治療法を用いた食道表在癌の治療成績、中間報告、日放腫会誌、17:187-193, 2005.
29. 西村恭昌、放射線療法の適応と化学放射線療法、臨床腫瘍プラクティス 1(No 2): 168-171, 2005.
30. 西村恭昌、化学放射線療法:食道癌、Mebio Oncolgy 2(4): 38-44, 2005.
31. 中村和正、晴山雅人、塩山善之、根本建二、小川芳弘、白土博樹、西村恭昌、広川裕、高井良尋、早渕尚文、山田章吾：早期下咽頭癌の放射線治療に関するアンケート調査結果報告、日放腫会誌、17: 41-47, 2005.
32. 広田佐栄子、永田靖、菱川良夫、内山幸男、村上昌雄、副島俊典、村山千恵子、阿部由直、岡崎篤、西村恭昌、大場仁敏、放射線治療に対する意識調査および情報提供の重要性についての検討、患者1529人を対象として(2002年)、日医放会誌65: 248-254, 2005.
33. 西村恭昌、早川和重、斉藤博、有吉寛、肺癌放射線治療のガイドライン、MEDICO 35 (5): 183-185, 2004.
34. 西村恭昌：小細胞肺癌に対する放射線療法、肺癌 44: 71-75, 2004.
35. 西村恭昌：食道癌に対する放射線療法、日獨医報 49: 36-44, 2004.
36. 西村恭昌、中松清志、柴田徹：　強度変調放射線療法（IMRT）での治療計画、新医療 360: 103-106, 2004.
37. 中松清志、西村恭昌、鈴木実：Simultaneous Integrated Boost (SIB)法を用いた悪性神経膠腫に対するIMRT、癌の臨床 50 (13): 1085-1088, 2004.
38. 西村恭昌、鈴木実、中松清志、奥村雅彦：　IMRT(intensity modulated radiation therapy)の理想と現状, Radiology Frontier 6 (01): 9-12, 2003.
39. 早川和重、西村恭昌、斉藤博、有吉寛：　肺癌、放射線治療のガイドライン作成について、癌と化学療法 30(3): 343-347, 2003.
40. 奥村雅彦、西村恭昌、橋場久幸、鈴木実、澄田貢、村野喜彦：　近畿大学におけるIMRT (intensity modulated radiation therapy)の精度保証、日放腫会誌、15:29-36, 2003.
41. 出井進也、町田喜久雄、本田憲業、細野　眞、高橋健夫：肺疾患における99mTc-テクネガス/99mTc-MAA肺SPECTを用いた換気/血流比画像の検討　断層映像研究会雑誌　30(1):30-35, 2003.
42. 町田喜久雄、大島統男、小泉潔、小須田茂、橋本　順、細野　眞、本田憲業、松田博史、松本徹、百瀬敏光、森豊：脳血流SPECTとMRIの痴呆診断能の比較および他施設の読影者間の読影能の変動の検討　核医学　40(1):54-56, 2003.
43. 粟井和夫、柳生行伸、綿井良輔、下野太郎、井上正昭、細野眞、西村恭昌：肝のダイナミックMDCTにおける造影剤の使用法。画像診断、9: 1017-1025,2003.
44. 西村恭昌：放射線腫瘍学の臨床試験；特徴と現状、臨床放射線、48:1513-1518, 2003.
45. 大多和伸幸、町田喜久雄、本田憲業、細野　眞、高橋健夫：全脳放射線治療を行った転移性脳腫瘍患者における脳血流シンチグラフィーを用いた脳血流量の検討、断層映像研究会雑誌、30:86-91, 2003.
46. 任誠雲、下野太郎、粟井和夫、柳生行伸、綿井良輔、西村恭昌、西岡栄恵、伊藤良太：表在型平骨筋肉腫の1例、臨床放射線、48:1706-1710, 2003.
47. 西村恭昌：放射線腫瘍学における探索型臨床研究、新医療29(2): 123-126, 2002.
48. 西村恭昌：IMRTの目指すもの：physicsと radiobiologyの統合、放射線治療分科会誌16(1): 4-5, 2002.
49. 西村恭昌：放射線医学における新しい言葉、映像情報Medical 34(3): 253, 2002.
50. 下野太郎、足利竜一朗：ウイルス性感染症、日独医放　47(3)：270-284，2002.
51. 岡嶋馨、山本敬、西田千嘉子、西村恭昌：フィルムレスのPACSシステムの初期経験、Radiology Frontier 4: 109-115, 2001.
52. 中松清志、鈴木実、金森修一、西村恭昌、原聡：　多分割照射にて長期生存が得られた術後局所再発癌の１例、肺癌の臨床、4 (1): 123-125, 2001.
53. 西村恭昌：肺がんの化学放射線療法、映像情報Medical、33(12): 1187-1191, 2001.
54. 西村恭昌：放射線療法の考え方、放射線科専門医会ニュース、No. 124: 3-5, 2001.
55. 花田雅憲、花田一志、西村恭昌、足利竜一朗：医学的検査、精神治療学16（増）：51-60, 2001.
56. 野本由人、土器屋卓志、斉藤真理、西村哲夫、広川裕、西山謹司、山下孝、西村恭昌、井上武宏：高線量率気管支腔内照射のガイドライン；厚生省がん研究助成金土器屋班の検討、日放腫会誌、13: 217-222, 2001.
57. 西村恭昌：放射線治療における進歩：食道癌、放射線治療分科会誌、14(1): 21-28, 2000.
58. 山田章吾、根本健二、高井良尋、広川裕、晴山雅人、永倉久泰、西村恭昌、早渕尚文、小口正彦、伊藤善之、酒井邦夫、大川智彦：食道表在癌に対する標準的放射線治療法、日放腫会誌、12: 169-176, 2000.
59. 西村恭昌：化学放射線療法：neoadjuvant chemotherapy versus concurrent chemotherapy. 癌の臨床46 (3) :273-277, 2000.
60. 平岡真寛、金森修一、堀井直敏、奥野芳茂、光森通英、永田靖、渋谷景子、笹井啓資、小石元紹、西村恭昌：温熱療法、最近の進歩、癌の臨床46 (3) :306-308, 2000.
61. 小西淳二、竹田寛、西村恭昌：日本医学放射線学会教育委員会；放射線医学教育卒前教育に関する全国医学部アンケート集計結果；委員会報告、日医放会誌60 (8): 469-472, 2000.
62. 山田章吾、根本健二、広川裕、晴山雅人、永倉久泰、西村恭昌、早渕尚文、小口正彦、伊藤善之、酒井邦夫、大川智彦：食道表在癌に対する放射線治療の標準化に関する研究、日放腫会誌、12: 383-384, 2000.
63. 菊地雄三、喜多みどり、浜島信之、晴山雅人、根本健二、酒井邦夫、伊東久夫、幡野和男、菅原正、池田ひろし、唐沢久美子、茂松直之、佐々木武仁、小口正彦、伊藤善之、西嶋博司、西村恭昌、広川裕、寺嶋廣美、吉田弘、玉木義雄：１日多分割照射法の有効性に関する臨床試験（平成７年９月から４年間）日放腫会誌、12: 389-393, 2000.
64. 西村恭昌：高線量率腔内照射と１日１門照射の晩期障害；LQモデル(NTD-2Gy)による検討、日放腫会誌、11:183-190, 1999.
65. 根本健二、山川通隆、松本康男、小口正彦、伊藤善之、西村恭昌、城誠也、小川芳弘、大川智彦、山田章吾：食道表在癌の放射線治療成績、外照射単独治療例の検討、JASTRO研究グループによる多施設データ集計、日放腫会誌、11:207-213, 1999.
66. 西村恭昌、光森通英：肛門癌治療の進歩；放射線化学療法、癌の臨床45:937-941, 1999.
67. 西村恭昌：放射線分割照射中のRepopulation, Reoxygenation, Repair,およびReassortment臨床的意義、癌の臨床 44:147-150, 1998.
68. 西村恭昌、村田るみ、平岡真寛、黒田昌宏、浦野宗保：分割照射repopulationreoxygenationに関する基礎的臨床的考察、癌の臨床 44:223-224, 1998.
69. 堀井直敏、西村恭昌、平岡真寛：癌の温熱療法、耳鼻咽喉科診療Q&A、27: 144-145, 1998.
70. 西村恭昌、奥野芳茂、村田るみ：細胞周期関連遺伝子の発現による腫瘍増殖能の推定と放射線分割照射の選択、Innnervision 13(9):45, 1998.
71. 西田千嘉子、足利竜一郎、荒木裕、小野幸彦、吉増隆之、藤井広一、西村恭昌、中尾雄三：視神経萎縮が片側性であったsepto-optic dysplasiaの一例、臨床放射線　43:969-971, 1998.
72. 西村恭昌、平岡真寛：下咽頭癌に対する放射線化学療法と多分割照射法、癌の臨床、44 (11): 1261-1266, 1998.
73. 西村恭昌、平岡真寛、奥野芳茂、増永慎一郎：血管新生増殖因子の制御による温熱効果増感（平成８年度日本ハイパーサーミア学会研究グループ助成研究報告書）、日本ハイパーサーミア誌14：267-268、1998.
74. 西尾正道、伊藤潤、川島和之、永倉久泰、根本健二、福原昇、萬篤憲、斉藤吉弘、野末政志、西村恭昌、赤木由紀夫、新部英男：食道癌の照射線量；外照射単独ならびに腔内照射併用、日放腫会誌、10 (suppl. 2): 49-54, 1998.
75. 増永慎一郎、小野公二、赤星光彦、西村恭昌、平岡真寛：放射線・化学療法に対する静止期腫瘍細胞の反応；低温度温熱処理併用の意義、日本ハイパーサーミア誌14：7-14、1998.
76. 永田　靖、光森通英、西村恭昌、奥野芳茂、金森修一、堀井直敏、斉藤秀和、藤原一央、平岡真寛：温熱療法とIVR、臨床放射線、43: 697-702, 1998.

IV. 著書、分担執筆

2021年
1. 土井啓至.XIV その他 8.放射線肝炎. 別冊日本臨牀領域別症候群シリーズ No.14 肝・胆道系症候群（第３版）−その他の肝・胆道系疾患を含めて−肝臓編（下）竹原徹郎(編)，日本臨牀社 (東京)，2021, 363-366. ISSN 0047-1852
2. Hiroshi Doi, Kozo Kuribayashi. Definitive radiotherapy for locally advanced non-small cell lung cancer: current status and future perspectives. Lung Cancer - Modern Multidisciplinary Management, Henry Park (ed.), IntechOpen (Rijeka, Croatia). 2021, Chapter 5. ISBN 978-1-78985-576-0. DOI: 10.5772/intechopen.93927
3. Kazuhiro Kitajima, Hiroshi Doi, Kozo Kuribayashi. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Malignant Pleural Mesothelioma: What Is the Role in Mesothelioma Detection and Treatment Response Assessment? Malignant Pleural Mesothelioma Advances in Pathogenesis, Diagnosis, and Treatments. Nakano T, Kijima T (Eds.), Springer 2021, Chapter 18, 207-221. ISBN 978-981-15-9158-7

2020年
1. Hiroshi Doi and Kozo Kuribayashi：Lung Cancer – Modern Multidisciplinary Management IntechOpen　2020年
2. 土井啓至：肺癌診療 WJOG肺がんグループのプラクティス　緩和照射　クリニコ出版2020年
3. 西村恭昌：入門腫瘍内科学　放射線療法　改訂第3版　南江堂　2020年

2019年
1. 西村恭昌：放射線医科学の辞典　朝倉書店　2019年（分担執筆）
2. 松本賢治：三次元半導体検出器の経時的感度変化の検討　日本放射線技術学会雑誌75巻９号
3. 松本賢治：外部放射線治療装置のX線出力特性　日本放射線技術学会雑誌75巻10号
4. 松本賢治：TrueBeamおよびHalcyonの画像誘導放射線治療(IGRT)の機能について　Innervision (34,9)2019

2018年
1. Stereotactic body radiation therapy for hepatocellular carcinoma.
  土井　啓至（分担執筆）Cirrhosis, Xingshun Qi (ed.), InTech (Rijeka, Croatia). 2018
  ISBN 978-953-51-6146-2.
2. Resistance to Ibritumomab in Lymphoma
  花岡　宏平 (分担執筆) Springer International Publishing ISBN:978-3-319-78237-9
3. 放射線治療技術標準テキスト　松本賢治（分担執筆）医学書院

2017年
1. 松本賢治：がん・放射線療法2017　秀潤社　分担執筆
2. 松本賢治：新放射線治療技術の標準　日本放射線技師会出版会　分担執筆
3. 花岡宏平：核医学画像評価　日本放射線技術学会　オーム社　分担執筆
4. 太田誠一：診療放射線技術_第14版　下巻　第12章　南江堂　分担執筆

2016年
1. 松本賢治：がん・放射線療法2017　分担執筆
2. 松本賢治：インナービジョン　2017年2月号　頭頸部癌の放射線治療における現状─ VMAT の特長および品質管理の技術報告
3. 花岡宏平：日本放射線技術学会叢書(37)初学者のための核医学実験入門　分担執筆
4. 花岡宏平：核医学検査技術学　改訂３版　分担執筆

2012年
1. 西村恭昌：放射線療法および化学放射線療法、早期食道癌；そのコンセンサスと最前線、桑野博行編著、128-136, 2012, 中外医学社、東京
2. 西村恭昌：肛門がん、臨床放射線腫瘍学；最新知見に基づいた放射線治療の実践、日本放射線腫瘍学会、日本放射線腫瘍学研究機構編集、359-346、2012、南江堂、東京
3. 西村恭昌：放射線治療計画ガイドライン2012年版、日本放射線腫瘍学会編（ガイドライン委員長）、2012、金原出版、東京

2011年
1. 西村恭昌：肺癌に対する放射線治療の品質管理、治療計画法はどうあるべきか？　2011-2012 EBM呼吸器疾患の治療、永井厚志、大田健、江口研二、橋本修編集、471-475, 2011、中外医学社、東京
2. 西村恭昌：消化器癌、西谷弘、遠藤啓吾、松井修、伊藤久夫編集、標準放射線医学、第7版、763-771, 2011, 医学書院、東京

2010年
1. 西村恭昌：放射線腫瘍医の立場から、食道がん標準化学療法の実際、桑野博行編、pp. 36-39、2010、金原出版、東京
2. 西村恭昌：化学放射線療法の進歩、がん医療の今、第１集、監修：西尾正道、pp37-42, 2010、市民のためのがん治療の会編、国立市
3. 西村恭昌：消化器腫瘍、総論、がん・放射線療法2010、大西洋、唐澤久美子、唐澤克之編集、pp846-849, 2010、篠原出版新社、東京
4. 西村恭昌：加速過分割照射は通常照射より有効か？　2011-2012 EBMがん化学療法・分子標的治療法、西條長宏監修、233-237, 2010、中外医学社、東京

2009年
1. 西村恭昌：肺がんの治療、治療の合併症・副作用、放射線療法、インフォームドコンセントのための図説シリーズ、肺がん、改訂3版、西條長宏、加藤治文編、pp.136-137、2009、医薬ジャーナル社、大阪

2008年
1. 増永慎一郎、光森通英、西村恭昌、平岡眞寛：乳腺腫瘍；ハイパーサーミア、がん温熱療法ガイドブック、日本ハイパーサーミア学会編、pp.92-95, 2008、毎日健康サロン、大阪.

2007年以前
1. 西村恭昌：治療方針に影響を与える因子；放射線治療、工藤翔二監修、呼吸器Common Diseaseの診療；肺癌のすべて、pp.200-203, 2007、文光堂、東京.
2. 西村恭昌：強度変調放射線療法(IMRT)、大西武雄監修、放射線医科学、生体と放射線・電磁波・超音波、pp91-93, 2007, 学会出版センター、東京.
3. 西村恭昌：放射線療法、加藤治文、福岡正博監修、ハンドブックよくわかる肺がん Questions & Answers、pp.89-102, 2007、NPO西日本胸部腫瘍臨床研究機構(WJTOG)、大阪.
4. 西村恭昌：化学放射線療法；エビデンス放射線治療、渋谷均、晴山雅人、平岡真寛編著、pp. 19-24,? 2007中外医学社、東京.
5. 西村恭昌：局所進行肺癌、化学放射線療法；エビデンス放射線治療、渋谷均、晴山雅人、平岡真寛編著、pp. 167-173, 2007中外医学社、東京.
6. 西村恭昌：線量分割と照射期間：改訂第２版、放射線治療マニュアル、平岡真寛、笹井啓資、井上俊彦編著、pp.110-121、2006、中外医学社、東京 .
7. 西村恭昌：膵臓：改訂第２版、放射線治療マニュアル、平岡真寛、笹井啓資、井上俊彦編著、pp.322-332、2006、中外医学社、東京.
8. 西村恭昌：食道癌・表在癌、早期のがん治療法の選択、放射線治療、山田章吾編集、pp.131-141、2006、金原出版、東京.
9. 西村恭昌：小細胞肺癌に対する胸部放射線療法、MOOK 2004-2005肺癌の臨床、加藤治文ほか、監修、pp.167-175, 2005, 篠原出版新社、東京.
10. 西村恭昌：小細胞肺癌に対する予防的全脳照射(PCI)の課題、MOOK 2005-2006肺癌の臨床、加藤治文ほか、監修、pp.255-260, 2006, 篠原出版新社、東京.
11. 西村恭昌：肺癌の放射線治療に伴う放射線肺臓炎の頻度と予防法・治療を教えてください、放射線治療：専門家に聞く最新の臨床、渋谷均、笹井啓資、小久保雅樹編集、pp.147-150、2004、中外医学社、東京.
12. 西村恭昌：総論、放射線治療計画ガイドライン・2004、日本放射線科専門医会・医会、日本放射線腫瘍学会、日本医学放射線学会編、pp.1-3, 2004、メディカル教育研究社、埼玉.
13. 西村恭昌：小細胞肺癌、放射線治療計画ガイドライン・2004、日本放射線科専門医会・医会、日本放射線腫瘍学会、日本医学放射線学会編、pp.72-76, 2004、メディカル教育研究社、埼玉.
14. 西村恭昌：肺癌に対する放射線療法の考え方、肺癌診療二頁の秘訣、藤村重文編集、pp.202-203、2004, 金原出版、東京.
15. 柴田　徹：V. 呼吸器疾患の治療法　４.　放射線治療：呼吸器病学総合講座、和田洋巳、三嶋理晃　監修．pp 176-176, 2004、メディカルビュー社、大阪.
16. 西村恭昌：切らずに治すと言われたけれど、シミュレイション内科、呼吸器疾患を探る、腫瘍編、河野修興編著、pp.196-201, 2003. 永井書店、大阪.
17. 西村恭昌：小細胞肺癌に対する予防的全脳照射、Mook　肺癌の臨床、Annual Review,監修：加藤治文ほか、pp.165-170, 2003、篠原出版新社、東京.
18. 西村恭昌：小細胞肺癌：限局型小細胞肺癌の化学放射線治療、臨床腫瘍学、有吉寛、他編集、日本臨床腫瘍学会編、pp. 528-534, 2003、癌と化学療法、東京.
19. 佐々木真理、下野太郎：脳神経・頭頸部　3.奇形、変性、代謝障害、脱髄、炎症、外傷、放射線科学　Textbook of Radiology　＜診断＞　第6版、pp27-33、 2003、日本放射線科専門医会、東京.
20. 西村一雅、南学、下野太郎：画像診断を考える　-よりよい診断のために-　、編著：西村一雅、南学、下野太郎、2003、秀潤社.
21. 西村恭昌：　放射線治療各論；頸部食道、癌・放射線療法2002、編集：大川智彦、田中良明、佐々木武仁、pp.531-543, 2002. 篠原出版新社、東京.
22. 西村恭昌：　温熱療法および放射線療法に与える血管新生の影響、集学的癌治療の研究と臨床、監修；加納永一、pp.181-189, 2002. 篠原出版新社、東京.
23. 下野太郎：臨床編　中毒・代謝　総論、これでわかる拡散MRI、編著：青木茂樹、阿部修、pp.236-239、2002、秀潤社、東京.
24. 下野太郎、前田正幸：臨床編　中毒・代謝　reversible posterior leukoencephalopathy syndrome (PRLS)、これでわかる拡散MRI、編著：青木茂樹、阿部修、pp.240-241、2002、秀潤社、東京.
25. 下野太郎：臨床編　中毒・代謝　免疫抑制剤[サイクロスポリンCsA,tacrolimus(FK506)]による脳症、これでわかる拡散MRI、編著：青木茂樹、阿部修、pp.242-243、2002、秀潤社、東京.
26. 下野太郎、渡辺嘉之：臨床編　中毒・代謝　子癇脳症 eclamptic encephalopathy、これでわかる拡散MRI、編著：青木茂樹、阿部修、pp.244-245、2002、秀潤社、東京.
27. 下野太郎、青木茂樹：臨床編　中毒・代謝　溶血性尿毒症症候群 hemolytic uremic syndrome (HUS)、これでわかる拡散MRI、編著：青木茂樹、阿部修、pp.246-247、2002、秀潤社、東京.
28. 下野太郎、山本憲：臨床編　中毒・代謝　低酸素性虚血性脳症 hypoxic-ischemic encephalopathy、これでわかる拡散MRI、編著：青木茂樹、阿部修、pp.248-249、2002、秀潤社、東京.
29. 下野太郎：臨床編　中毒・代謝　低血糖脳症 hypoglycemic coma、これでわかる拡散MRI、編著：青木茂樹、阿部修、pp.250-251、2002、秀潤社、東京.
30. 下野太郎、山本憲：臨床編　中毒・代謝　一酸化炭素（C0）中毒、これでわかる拡散MRI、編著：青木茂樹、阿部修、pp.252-253、2002、秀潤社、東京.
31. 下野太郎：臨床編　中毒・代謝　Wilson病 Wilson disease、これでわかる拡散MRI、編著：青木茂樹、阿部修、pp.254-255、2002、秀潤社、東京.
32. 下野太郎、山本憲：臨床編　中毒・代謝　橋中心髄鞘崩壊症 central pontine myelinolysis (CPM)、これでわかる拡散MRI、編著：青木茂樹、阿部修、pp.258-259、2002、秀潤社、東京.
33. 下野太郎、山本憲：臨床編　中毒・代謝　Leigh脳症 subacute necrotizing encephalopathy、これでわかる拡散MRI、編著：青木茂樹、阿部修、pp.262-263、2002、秀潤社、東京.
34. 下野太郎、渡辺嘉之、、前田正幸：臨床編　中毒・代謝　てんかん重積 status epilepticus、これでわかる拡散MRI、編著：青木茂樹、阿部修、pp.274-275、2002、秀潤社、東京.
35. 渡邉　学：画像上診断が困難であった肝FNHの1例、腹部画像診断アトラス、pp.88-89、2002、腹部放射線研究会.
36. 西村恭昌：線量分割と照射期間：放射線治療マニュアル、平岡真寛、笹井啓資井上俊彦編著、pp.109-119、2001、中外医学社、東京.
37. 西村恭昌：膵臓：放射線治療マニュアル、平岡真寛、笹井啓資、井上俊彦編著、pp.314-324、2001、中外医学社、東京.
38. 西村恭昌：乳癌、標準放射線医学、第6版、監修：高島力、佐々木康人、pp.736-740, 2001. 医学書院、東京.
39. 下野太郎：両側視床対称性病変を認める疾患、所見からせまる脳MRI－系統鑑別診断－　土屋一洋、青木茂樹、編著、pp.143-161、2001、秀潤社、東京.
40. Hiraoka M, Mitsumori M, Nagata Y, Horii N, Kanamori S, Kimura H, Okumura S, Okuno Y, Koishi M, Masunaga S, Akuta K, Nishimura Y. Current status of clinical hyperthermic oncology in Japan. In Thermotherapy for neoplasia, inflamation, and pain. Ed. by Kosaka M, Sugahara T, Schmidt KL, Simon E. Springer-Verlag (Tokyo), pp.471-479, 2000.
41. 平岡真寛、西村恭昌、富樫かおり、小西淳二編集：画像からみた癌の病期分類、2000、金芳堂、京都.
42. 西村恭昌：放射線腫瘍学・総論：放射線科学、Textbook of Radiology　第５版（基礎、治療、核医学）編集：放射線科専門医会、pp.放射線治療①1-5, 2000、メディカル教育研究社、埼玉.
43. 井上正昭：6章　泌尿器科腫瘍、Ⅰ腎臓・尿管、画像から見た癌の病期分類、編集：平岡真寛、西村恭昌、pp.211-225、2002、金芳堂京都.
44. 下野太郎:変性疾患・てんかん、脳・頭頚部のMRI、編集：三木幸雄、pp.26-41、2000、Medical　View、東京.
45. 下野太郎：多発性硬化症以外の脱髄、代謝、中毒、炎症性疾患、脳・頭頚部のMRI、編集：三木幸雄、pp.47-65、2000、Medical　View.
46. 下野太郎：先天性代謝疾患、脳・頭頚部のMRI、編集：三木幸雄、pp.66-81、2000、Medical　View、東京.
47. 下野太郎：奇形、発生障害、脳・頭頚部のMRI、編集：三木幸雄、pp.130-160、2000、Medical　View、東京.
48. 下野太郎：感染症、脳・頭頚部のMRI、編集：三木幸雄、pp.202-233、2000、Medical　View、東京.
49. 藤井廣一:消化器腫瘍 : 胃、画像から見た癌の病期分類、編集：平岡真寛、西村恭昌、富樫かおり、小西淳二、pp.79-91、2000、金芳堂、京都.
50. 藤井廣一:消化器腫瘍 : 大腸、画像から見た癌の病気分類、編集：平岡真寛、西村恭昌、富樫かおり、小西淳二、pp.92-104、2000、金芳堂、京都.
51. 小野幸彦：消化器腫瘍：肝臓、画像から見た癌の病期分類、編集：平岡真寛、西村恭昌、富樫かおり、小西淳二、pp.105-118、2000、金芳堂、京都.
52. 山本敬：消化器腫瘍：胆嚢・肝外胆管、画像から見た癌の病期分類、編集：平岡真寛、西村恭昌、富樫かおり、小西淳二、pp.119-133、2000、金芳堂、京都.
53. 西村恭昌：食道癌放射線治療のコツ、臨床放射線科のコツと落とし穴、治療、編集：小塚隆弘、pp. 60-61, 1999、中山書店、東京.
54. 西村恭昌：切除不能膵癌に対する放射線治療のコツ、臨床放射線科のコツと落とし穴、治療、編集：小塚隆弘、pp.106-107, 1999、中山書店、東京.
55. 西村恭昌：臨床における温度計測法、ハイパーサーミアマニュアル；効果的な癌温熱療法を実施するために、日本ハイパーサーミア学会監修、編集：平岡真寛、田中良明、pp.75-86, 1999、医療科学社、東京.
56. 西村恭昌：大腸癌のハイパーサーミア：難治癌への挑戦、ハイパーサーミアの臨床、編集：松田忠義、菅原努、阿部光幸、田中敬正、pp.180-184, 1999、医療科学社、東京.
57. 西村恭昌：温度測定の仕組み、１.温度因子の重要性と温度計測法の実際：難治癌への挑戦、ハイパーサーミアの臨床、編集：松田忠義、菅原努、阿部光幸、田中敬正、pp.409-419, 1999、医療科学社、東京.
58. Abe M, Nishimura Y, Shibamoto Y, Imamura M. The role of intraoperative radiotherapy in the treatment of pancreatic cancer. In Progress in Radio-Oncology VI. ed. by HD Kogelnik & F Sedelmayer, Monduzzi Editore (Bologna, Italy), pp.409-415, 1998.
59. 西村恭昌：線量時間関係の基礎と臨床：癌の放射線治療、編集：田中敬正、平岡真寛、赤木　清、笹井啓資、pp.190-198、 1998、金芳堂、京都
60. 井上正昭、石田修：腎臓・副腎・後腹膜－CTからみた解剖、新画像診断のための解剖図鑑７改討版第３版、編集：永井純、pp.28-43、1998、メジカルビュー社、東京.
61. 熊野町子：画像診断マニュアル　3.頭頸部　13．甲状腺、画像診断マニュアル、編集：梶田明義、前田知穂、楢林勇、中尾宣夫、pp.113-129、1998、金芳堂、京都.
62. 熊野町子：画像診断マニュアル　12.核医学　2.脳、画像診断マニュアル、編集：梶田明義、前田知穂、楢林勇、中尾宣夫、pp.459-472、1998、金芳堂、京都.
63. 熊野町子：画像診断マニュアル　12.核医学　5.内分泌、画像診断マニュアル、編集：梶田明義、前田知穂、楢林勇、中尾宣夫、pp.485-498、1998、金芳堂、京都.
64. 熊野町子：画像診断マニュアル　12.核医学　7.泌尿生殖器　８.骨、画像診断マニュアル、編集：梶田明義、前田知穂、楢林勇、中尾宣夫、pp.502-513、1998、金芳堂、京都.

Ｖ. 国際学会での発表

2021年
1. Takuya Uehara, Hiroshi Doi, Kazuki Ishikawa, Saori Tatsuno, Yutaro Wada, Yasuo Oguma, Masahiro Inada, Kiyoshi Nakamatsu, Makoto Hosono, Yasumasa Nishimura. Serum Lactate Dehydrogenase is a Predictive Biomarker in Oropharyngeal Cancer Patients Undergoing Radiotherapy. 63rd ASTRO Annual Meeting. 2021.10.24-27, Chicago, USA.
2. Hiroshi Doi, Hiroyuki Yokoyama, Masayuki Fujiwara, Shogo Harui, Ayako Kakuno, Hidenori Yanagi, Yoshio Hishikawa, Naoki Yamanaka, Norihiko Kamikonya. Neoadjuvant short-course hyperfractionated accelerated radiotherapy for rectal cancer. European Society for Therapeutic Radiotherapy and Oncology (ESTRO) 2021. 2021.8.27-31, Madrid, Spain.
3. Saori Tatsuno, Hiroshi Doi, Wataru Okada, Eri Inoue, Kenji Nakamura, Keisuke Sano, Yutaro Wada, Takuya Uehara, Masahiro Inada, Kiyoshi Nakamatsu, Hajime Monzen, Makoto Hosono, Kenji Matsumoto, Masao Tanooka, Masahiro Tanaka, Yasumasa Nishimura. Previous pneumectomy is a risk factor of severe radiation pneumonitis after IMRT for lung cancer. European Society for Therapeutic Radiotherapy and Oncology (ESTRO) 2021. 2021.8.27-31, Madrid, Spain.
4. Katsuya Okuhata, Mikoto Tamura, Hajime Monzen, Yasumasa Nishimura. Dosimetric characteristics of a thin bolus with real time variable shape tungsten rubber for photon beam. The 9th Korea-Japan Joint Meeting on Medical Physics.
5. Yasunori Nakamura, Hajime Monzen, Mikoto Tamura, Takeshi Nii, Masayoshi Mizuta. Reduction of γ-ray attenuation with a new rigid couch in SPECT. 21st Asia-Oceania Congress of Medical Physics.
6. Shota Hattori, Hiroyuki Kosaka, Hajime Monzen, Mikoto Tamura. Protection of radiation exposure for physician's brain using a tungsten rubber flap in interventional radiology. 21st Asia-Oceania Congress of Medical Physics.
7. Kazuki Wakabayashi, Hajime Monzen, Mikoto Tamura, Yoshiki Takei, Katsuya Okuhata, Shimpei Anami, Hiroshi Doi, Yasumasa Nishimura. Development of a Novel Real-Time Shapeable Bolus for Electron Radiotherapy. 21st Asia-Oceania Congress of Medical Physics.
8. Kazuki Wakabayashi, Hajime Monzen, Mikoto Tamura, Kenji Matsumoto, Yoshiki Takei, Yasumasa Nishimura. Dosimetric evaluation of a real-time variable shape tungsten rubber as a skin collimator in electron radiotherapy. The 5th International Cancer Research Symposium.
9. Kenji Nakamura, Katsuya Okuhata, Masakazu Otsuka, Mikoto Tamura, Hajime Monzen. The iteratively improved method with KBP to standardize VMAT plan quality in prostate cancer. 21st Asia-Oceania Congress of Medical Physics.
10. Yuya Yanagi, Mikoto Tamura, Hajime Monzen. Radiation Protection of Nail with Real-time Shapeable Tungsten Rubber in the Total Skin Electron Beam (TSEB) Therapy. 21st Asia-Oceania Congress of Medical Physics.
11. Takaaki Ito, Wataru Omasa, Kazutaka Yoshida, Mikoto Tamura, Hajime Monzen. Establish of dose-parameter analysis model to improve VMAT plan quality for prostate cancer. 21st Asia-Oceania Congress of Medical Physics.
12. Yusuke Sakai, Masao Tanooka, Hajime Monzen, Mikoto Tamura, Masahiro Tanaka. Advantages of Thermoplastic Sheet Bolus in Postmastectomy Radiation Therapy. 21st Asia-Oceania Congress of Medical Physics.
13. Mikoto Tamura. Current research topic of radiation treatment planning with AI. The 7th Online Conference of Southeast Asia and Open Asia
14. Wataru Okada, Masao Tanooka, Keisuke Sano, Mayuri Shibata, Yusuke Sakai, Kenji Nakamura, Hiroshi Doi, Masahiro Tanaka. Optimal threshold of model parameters for the respiratory tracking system with helical tomotherapy. European Society for Therapeutic Radiotherapy and Oncology (ESTRO) 2021. 2021.8.27-31, Madrid, Spain.

2019年
1. Hiroshi Doi, Mikoto Tamura, Hajime Monzen, Yasumasa Nishimura.
  An Experimental Animal Model of Re-Irradiation in Terms of Radiation-Induced Damages in Normal Intestine. 61st ASTRO Annual Meeting. 2019.9.15-18, Chicago, USA.
2. Hiroshi Doi, Kiyoshi Nakamatsu, Shimpei Anami, Takuya Uehara, Yutaro Wada, Kohei Fukuda, Masahiro Inada, Kazuki Ishikawa, Shuichi Kanamori, Hajime Monzen, Yasumasa Nishimura.
  Immunogenic prognostic factors in patients with brain metastases from non-small cell lung cancer. European Society for Therapeutic Radiotherapy & Oncology (ESTRO) 38. 2019.4.26-30, Milan, Italy.
3. Shimpei Anami, Hiroshi Doi, Kiyoshi Nakamatsu, Takuya Uehara, Yutaro Wada, Kohei Fukuda, Masahiro Inada, Kazuki Ishikawa, Shuichi Kanamori, Yasumasa Nishimura.
  Lactate dehydrogenase predicts survival in small cell lung cancer patients with brain metastases. European Society for Therapeutic Radiotherapy & Oncology (ESTRO) 38. 2019.4.26-30, Milan, Italy.
4. Kenta Kijima, Anchali Krisanachinda, Mikoto Tamura, Hajime Monzen.
  Feasibility Study of Nevel Tungsten Shielding Material for Electron Radiation Therapy. The 11th Annual Scientific Meeting of Thai Medical Physicist Society. Bangkok, Thailand, January 24-26th,2019
5. Hiroyuki Kosaka, Hajime Monzen.
  Radiation protection with novel Tungsten material in diagnostic radiology field. The 11th Annual Scientific Meeting of Thai Medical Physicist Society. Bangkok, Thailand. Thailand, January 24-26th,2019
6. Kazuki Kubo, Hajime Monzen, Kohei Shimomura, Kenji Matsumoto, Tomoharu Sato, Mikoto Tamura, Kiyoshi Nakamatsu, Kentro Ishii, Ryu Kawamorita.
  Our methodology and experience in pre-treatment patient specific IMRT QA and survey of consistency in IMRT QA result between institutions. The 11th Annual Scientific Meeting of Thai Medical Physicist Society. Bangkok, Thailand. Thailand, January 24-26th,2019
7. Mikoto Tamura, Hajime Monzen, Kenji Matsumoto, Masakazu Otsuka, Masahiko Okumura, Yasumasa Nishimura.
  Comparison of measured and standard beam profiles with a novel rigid board for a Halcyon linear accelerator. The 7th Asia Radiation Therapy Symposium. Bangkok, Thailand. April 24-26th,2019
8. Mikoto Tamura, Hajime Monzen, Kenji Matsumoto, Masakazu Otsuka, Kazuki Kubo, Yasumasa Nishimura.
  A cleaned-up RapidPlan modeling method for volumetric modulated arc therapy in prostate cancer. The 7th Asia Radiation Therapy Symposium. Bangkok, Thailand. April 24-26th,2019
9. Kenta Kijima, Anchali Krisanachinda, Petchaleya Suwanpradit, Mikoto Tamura, Yasumasa Nishimura, Hajime Monzen.
  Radiation shielding efficiency of tungsten rubber in interventional radiology. The 7th Asia Radiation Therapy Symposium. Bangkok, Thailand. April 24-26th,2019
10. Kenji Matsumoto, Makoto Hirata, Kohei Hanaoka, Mikoto Tamura, Hajime Monzen, Masahiko Okumura.
  The impact for the irradiation time by offset distance between PTV and isocenter in Tomotherapy.
  The 7th Asia Radiation Therapy Symposium. Bangkok, Thailand. April 24-26th,2019
11. Mikoto Tamura, Hajime Monzen, Kenji Matsumoto, Masahiko Okumura, Hiroshi Doi, Yasumasa Nishimura.
  Development of a novel couch to reduce potential risk for the skin toxicity in megavoltage radiotherapy. The 7th Japan-Taiwan Radiation Oncology Symposium. Tokyo, Japan. May 11th,2019
12. Mikoto Tamura, Hajime Monzen, Kenji Matsumoto, Masakazu Otsuka.
  Feasibility of a new photochromic diarylethene film for clinical dosimetry in diagnostic area.
  The 7th Annual Congress of Vietnam Association Radiation Technologist. August 24th,2019
13. Hajime Monzen, Kenta Kijima, Mikoto Tamura, Seiichi Ota, Kenji Matsumoto.
  Feasibility study of the shielding ability of novel tungsten rubber against the electron beam in radiation therapy. The 7th Annual Congress of Vietnam Association Radiation Technologist. August 24th,2019
14. Kenji Matsumoto, Kohei Shimomura, Mikoto Tamura, Kohei Hanaoka, Hajime Monzen, Masahiko Okumura.
  Verification of representative beam data for a novel linac halcyon with 3D water phantom and measurement board. The 7th Annual Congress of Vietnam Association Radiation Technologist. August 24th,2019
15. Yasunori Nakamura, Masayoshi Mizuta, Satoru Matsuo, Hajime Monzen.
  Usefulness of the principle of selective excitation technique non-electrocardiogram-gated 3D-TOF method in lower-extremity MRA using a whole-body coil. The 7th Annual Congress of Vietnam Association Radiation Technologist. August 24th,2019
16. Mikoto Tamura, Hajime Monzen, Kenji Matsumoto, Masakazu Otsuka.
  Development of a new photochromic diarylethene film for clinical dosimetry. The 19th Asia-Oceania Congress of Medical Physics. Perth, Australia. October 28-30th, 2019
17. Mikoto Tamura, Hajime Monzen, Kenji Matsumoto, Masakazu Otsuka.
  Traveling performance of dual-layer multi-leaf collimator in HalcyonTM linac: A clinical experience. The 19th Asia-Oceania Congress of Medical Physics. Perth, Australia. October 28-30th, 2019
18. Yoshiki Takei, Takeshi Kamomae, Mikoto Tamura, Hajime Monzen.
  Feasibility of using tungsten functional paper as a thin bolus for electron beam radiotherapy.
  The 19th Asia-Oceania Congress of Medical Physics. Perth, Australia. October 28-30th, 2019
19. Masakazu Otsuka, Hajime Monzen, Mikoto Tamura, Kazuki Kubo, Kenji Matsumoto, Yassumasa Nishimura.
  Comparison of plan quality with KBP for prostate VMAT plan established in three different terms.
  The 19th Asia-Oceania Congress of Medical Physics. Perth, Australia. October 28-30th, 2019
20. Kazuki Kubo, Hajime Monzen, Kentaro Ishii, Mikoto Tamura, Ryu Kawamorita.
  Inter-planner variation in treatment plan quality of hypofractionated prostate only and SIB whole pelvis VMAT plans created with a KBP. The 19th Asia-Oceania Congress of Medical Physics. Perth, Australia. October 28-30th, 2019
21. Kazuki Kubo, Kenta Kijima, Kenji Matsumoto, Mikoto Tamura, Hajime Monzen.
  Dosimetric shield evaluation with a novel radiation shielding material, tungsten containing rubber in electron beams. The 19th Asia-Oceania Congress of Medical Physics. Perth, Australia. October 28-30th, 2019
22. Kazuki Kubo, Masakazu otsuka, Min-Geon Choi, Mikoto Tamura, Kenji Matsumoto, Hajime Monzen.
  Evaluation of shielding ability of a novel radiation shielding material, free-form tungsten containing rubber: actual measurement and Monte Carlo simulation. The 19th Asia-Oceania Congress of Medical Physics. Perth, Australia. October 28-30th, 2019
23. Shota Hattori, Hiroyuki Kosaka, Mikoto Tamura, Hajime Monzen, Koji Yamada.
  Qualitative evaluation of metal artifact reduction in follow-up after coiling of intracranial aneurysms: comparison of digital tomosynthesis images with computed tomography images. The 19th Asia-Oceania Congress of Medical Physics. Perth, Australia. October 28-30th, 2019
24. Makoto Hirata, Kohei Hanaoka, Kenji Matsumoto, Mikoto Tamura, Hajime Monzen.
  The effectiveness of offset on the planning target volume away from the gantry isocenter in TomoTherapy: A phantom study. The 19th Asia-Oceania Congress of Medical Physics. Perth, Australia. October 28-30th, 2019
25. Hiroyuki Kosaka, Shota Hattori, Koji Yamada, Mikoto Tamura, Hajime Monzen.
  To compare the radiation shielding ability of tungsten functional paper and Organ-based tube current modulation for the eye lens in head computed tomography: A phantom study. The 19th Asia-Oceania Congress of Medical Physics. Perth, Australia. October 28-30th, 2019
26. Katsuya Okuhata, Hajime Monzen, Mikoto Tamura, Kenji Matsumoto, Masakazu Otsuka, Kazuki Kubo, Takuya Uehara,Hiroshi Doi, Kazuki Ishikawa, Yasumasa Nishimura.
  Mechanical performance and dosimetric accuracy of a commercial knowledge-based VMAT planning for oropharyngeal cancer. The 19th Asia-Oceania Congress of Medical Physics. Perth, Australia. October 28-30th, 2019
27. Kenta Kijima, Anchali Krisanachinda, Panya Pasawang, Kohei Hanaoka, Hajime Monzen, Yasumasa Nishimura.
  Shielding Efficiency of Novel Tungsten Rubber Against Radionuclides at Nuclear Medicine Division. The 19th Asia-Oceania Congress of Medical Physics. Perth, Australia. October 28-30th, 2019
28. Masakazu Otsuka, Hajime Monzen, Mikoto Tamura, Kazuki Kubo, Kenji Matsumoto, Yasumasa Nishimura.
  Comparison of plan quality with KBP for prostate VMAT plan established in three different terms.
  European Society Radiotherapy & Oncology meets Asia 2019. Singapore. December 6-8th,2019
29. Kenta Kijima, Anchali Krisanachinda, Mikoto Tamura, Yasumasa Nishimura, Hajime Monzen.
  Feasibility of a tungsten rubber grid collimator for electron grid therapy. European Society Radiotherapy & Oncology meets Asia 2019. Singapore. December 6-8th,2019

2018年
1. H. Doi, S. Harui, A. Sugimoto, M. Fujiwara, K. Kamino, T. Nakajima, S. Ikuta, T. Aihara, N. Yamanaka, Y. Hishikawa.
  Clinical implications of a novel iron-containing fiducial marker in radiotherapy for liver tumors. European Society for Therapeutic Radiotherapy & Oncology (ESTRO) 37. 2018.4.20-24, Barcelona, Spain.
2. H. Doi, M. Fujiwara, K. Kitajima, M. Tanooka, T. Terada, K. Noguchi, R. Ishikura, N. Kamikonya, K. Yamakado.
  Comparison between T staging and FDG-PET for predicting outcomes of maxillary sinus carcinoma. European Society for Therapeutic Radiotherapy & Oncology (ESTRO) 37. 2018.4.20-24, Barcelona, Spain.
3. Kenta Kijima, Hajime Monzen, Kenji Matsumoto, Mikoto Tamura and Yasumasa Nishimura.
  Shielding ability of novel tungsten rubber against electron beam. The 10th Annual Scientific Meeting Thai Medical Physicist Society (Bangkok), January 17-19th, 2018
4. Tamura M, Monzen H, Kosaka H, Kawanami R, Hattori S, Morimoto D, Goto Y, Yamada K, Okumura M, Nishimura Y.
  The shielding ability of the tungsten functional paper against scattered x-rays for operator in interventional radiology. The 10th Annual Scientific Meeting Thai Medical Physicist Society (Bangkok), January
  17-19th, 2018
5. Kazuki Kubo, Hajime Monzen, Do-Kun Yoon, Kentaro Ishii, Ryu Kawamorita, Tae Suk Suh, Yasumasa Nishimura.
  Comparison of treatment plan between boron neutron capture therapy and volumetric modulated arc therapy for brain tumor patients. The 10th Annual Scientific Meeting Thai Medical Physicist Society
  (Bangkok), January 17-19th, 2018
6. Seiichi Ota, Takahiro Saiga, Kenji Matsumoto, Kohei Shimomura, Hajime Monzen and Masahiko Okumura. Developing novel low-attenuation-material for immobilization devices on head and neck
  radiotherapy. The 10th Annual Scientific Meeting Thai Medical Physicist Society (Bangkok), January 17-19th, 2018
7. Yoshiki Takei, Ryosuke Sakurai, Kentarou Otsubo, Hidekazu Nambu, Hiroshi Doi, Hajime Monzen. Visibility Evaluation of Gold Fiducial Marker for Dose Reduction in IGRT by using kV imaging. The 10th Annual
  Scientific Meeting Thai Medical Physicist Society (Bangkok), January 17-19th, 2018
8. Hiroyuki Kosaka, Kenji Matsumoto, Hajime Monzen
  Characteristics of novel radiation protection gloves (Tungsten rubber) for operator's hands exposure. The 10th Annual Scientific Meeting Thai Medical Physicist Society (Bangkok), January 17-19th, 2018
9. Kohei Hanaoka, Masahiko Okumura, Yasumasa Nishimura, Hanjime Monzen, Shota Watanabe, Yusuke Shibata, Hayato Kaida, Makoto Hosono, Kazunari Ishii
  Static and moving phantom studies for radiation treatment planning in a 4-dimentional PET/CT. 12th congress of the world federation of nuclear medicine and biology, 20-24 April 2018, Melbourne, Australia
10. Seiichi Ota
  Geometrical margin consideration in Stereotactic body radiotherapy (SBRT) for early-stage non-small-cell lung cancer (NSCLC)
  The 6th annual conference of Vietnam Association of Radiological Technologists (Hanoi), Aug 17-18th, 2018
11. Kazuki Kubo, Hajime Monzen, Kohei Shimomura, Kenji Matsumoto, Tomoharu Sato, Mikoto Tamura, Kiyoshi Nakamatsu, Kentaro Ishii, Ryu Kawamorita.
  Comparison of multiple institutions' patient-specific IMRT QA measurement.
  The 6th annual conference of Vietnam Association of Radiological Technologists (Hanoi), Aug 17-18th, 2018
12. Kazuki Kubo, Hajime Monzen, Katsuya Okuhata, Mikoto Tamura, Masakazu Otsuka, Kentaro Ishii, Ryu Kawamorita, Yasumasa Nishimura.
  Comparison of dosimetric parameters and plan complexity between volumetric modulated arc therapy plans with different collimator angles for prostate with whole pelvis irradiation. 18th Asia-Oceania
  Congress of Medical Physics. 2018.11.11-14. Malaysia, Kuala Lumpur.
13. Morikazu Amano, Yoshihiro Kawai, Yasuhiko Matsuoka, Makoto Sakashita, Noriyuki Kadoya, Takeshi Kamomae, Hajime Monzen.
  In an appropriate and effective way to CT imaging for Deformable Image Registration. The 18th Asia-Oceania Congress of Medical Physics. 2018.11.11-14. Malaysia, Kuala Lumpur.
14. Takeshi Kamomae, Hajime Monzen, Kazuma Sugita, Kuniyasu Okudaira, Morikazu Amano, Yoshihiro Kawai, Hiroshi Oguchi, Motoki Kumagai, Mariko Kawamura, Kazuhiro Ohtakara, Yoshiyuki Itoh, Shinji Naganawa
  Feasibility of novel thin bolus using tungsten functional paper for electron beam radiotherapy.
  The 18th Asia-Oceania Congress of Medical Physics. 2018.11.11-14. Malaysia, Kuala Lumpur.
15. Kenta Kijima, Hajime Monzen, Kenji Matsumoto, Mikoto Tamura, and Yasumasa Nishimura.
  The Shielding Ability of Novel Tungsten Rubber Against the Electron Beam for Clinical Use in Radiation Therapy. The 18th Asia-Oceania Congress of Medical Physics.
  2018.11.11-14. Malaysia, Kuala Lumpur.
16. Mikoto Tamura, Hajime Monzen, Kenji Matsumoto, Masakazu Otsuka, Kazuki Kubo, Takuya Uehara, Masahiro Inada, Hiroshi Doi, Kazuki Ishikawa, Kiyoshi Nakamatsu, Yasumasa Nishimura.
  Effect of cleaned-up RapidPlan model to plan quality for volumetric modulated arc therapy in prostate cancer.
  The 18th Asia-Oceania Congress of Medical Physics. 2018.11.11-14. Malaysia, Kuala Lumpur.
17. Mikoto Tamura, Hajime Monzen, Makoto Hirata, Kazuki Kubo, Kenji Matsumoto, Kohei Hanaoka, Masahiko Okumura, Yasumasa Nishimura.
  Application of a novel lok-bar for high-precision radiotherapy with tomotherapy.
  The 18th Asia-Oceania Congress of Medical Physics. 2018.11.11-14. Malaysia, Kuala Lumpur.
18. Yoshiki Takei, Ryosuke Sakurai, Hidekazu Nambu, Kenji Matsumoto, Mikoto Tamura, Hajime Monzen.
  The bolus effect with the tungsten function paper in build-up region for electron radiotherapy.
  The 18th Asia-Oceania Congress of Medical Physics. 2018.11.11-14. Malaysia, Kuala Lumpur.
19. Hiroyuki Kosaka, Daisuke Murata, Koji Yamada, Hajime Monzen
  Simple reduction method of eye lens exposure in routine head computed tomography.
  The 18th Asia-Oceania Congress of Medical Physics. 2018.11.11-14. Malaysia, Kuala Lumpur.
20. Masakazu Otsuka, Hajime Monzen, Kenji Matsumoto, Mikoto Tamura, Masahiko Okumura, Yasumasa Nishimura.
  Development of a novel lok-bar low-radiation-asorption in dose delivery and dose monitoring.
  The 18th Asia-Oceania Congress of Medical Physics. 2018.11.11-14. Malaysia, Kuala Lumpur.
21. Makoto Hirata, Hajime Monzen, Takatoshi Suzuki, Kazuyoshi Oonishi
  A phantom study: The impact of irradiation time by offset distance with Tomotherapy.
  The 18th Asia-Oceania Congress of Medical Physics. 2018.11.11-14. Malaysia, Kuala Lumpur.
22. Hiroyuki Kosaka, Morikazu Amano, Kenji Matsumoto, Mikoto Tamura, Hajime Monzen
  Exposure and image quality in computed tomography using tungsten functional paper.
  The 34th Japan Conference of Radiological Technologists & 6th Asia Radiotherapy Symposium, Yamaguchi
23. Makoto Hirata, Hajime Monzen, Takatoshi Suzuki, Tsutomu Inoue, Kazuyoshi Oonishi , Hiroyuki Daimon, Kazuki Imanishi2, Yumi Adachi, kazunori Fujii and Noriaki Takeda.
  A phantom study：The impact of offset distance in Tomotherapy.
  The 34th Japan Conference of Radiological Technologists & 6th Asia Radiotherapy Symposium, Yamaguchi
24. Kenji Matsumoto, Hiroki Sugimoto, Hajime Monzen, Masahiko Okumura
  Contouring technique to improve calculated dose accuracy and comparison of calculation algorithm in a commercial treatment planning system.
  The 34th Japan Conference of Radiological Technologists & 6th Asia Radiotherapy Symposium, Yamaguchi

2017年
1. Kazuki Ishikawa, Masahiro Inada, Kouhei Fukuda, Hitoshi Tatebe, Kiyoshi Nakamatsu, Syuichi Kanamori and Yasumasa Nishimura.
  Anatomical and Dosimetric Changes during IMRT for Oropharyngeal Cancer (OPC) detected by weekly Cone-beam CT (CBCT) with deformable image registration (DIR). ASTRO 2017, San Diego
2. Masahiro Inada, Kiyoshi Nakamatsu, Kazuki Ishikawa and Yasumasa Nishimura.
  Dosimetry Comparison Between Intraoperatively Built Custom Linked Seeds and Loose Seeds in Permanent Prostate Brachytherapy: Do Intraoperative Built Custom Linked Seeds Improve Dosimetry of Prostate Margin? ASTRO 2017, San Diego
3. Kazuki Ishikawa, Masahiro Inada, Kouhei Fukuda, Hitoshi Tatebe, Kiyoshi Nakamatsu, Syuichi Kanamori and Yasumasa Nishimura.
  Anatomical and Dosimetric Changes during IMRT for Oropharyngeal Cancer (OPC) detected by weekly Cone-beam CT (CBCT) with deformable image registration (DIR). The 8th Japan-Korea joint Meeting on Medical Physics 2017, Osaka
4. Hiroyuki Kosaka, Hajime Monzen
  Characteristics of novel radiation protection device (Tungsten functional paper) and establish recycle model for environment
  The 5th Vietnam Association of Radiological Technologists 2017, Dalat
5. Kenji Matsumoto, Hajime Monzen, Kohei Hanaoka, Mikoto Tamura, Masahiko Okumura
  Skin reaction in radiation therapy and low absorption materials for couch top
  The 5th Vietnam Association of Radiological Technologists 2017, Dalat
6. Mikoto Tamura, Hajime Monzen, Kenji Matsumoto, Masahiko Okumura, and Yasumasa Nishimura.
  Reduction of the skin surface dose for megavoltage photon beams passing carbon couch.
  The 59th American Association of Physicists in Medicine, Annual Meeting & ExhibitionAmerican, United States of America.
7. Masakazu Otsuka, Hajime Monzen, Noriyuki Kadoya, Masahiro Inada, Kenji Matsumoto, Yasumasa Nishimura
  Evaluation of lung toxicity risk with computed tomography ventilation functional image for lung stereotactic body radiation therapy and three-dimensional conformal radiation therapy
  The 59th American Association of Physicists in Medicine, Annual Meeting & ExhibitionAmerican, United States of America.
8. Hiroyuki Kosaka, Kohei Shimomura, Hajime Monzen: Feasibility study of bone removal image generation using single shot x-ray imaging with a four-layer stack of image plates
  The 8th Japan-Korea joint Meeting on Medical Physics 2017, Osaka
9. Shielding ability of tungsten rubber against electron beam
  Kenta Kijima, Hajime Monzen, Kenji Matsumoto, Yasumasa Nishimura
  The 8th Japan-Korea joint Meeting on Medical Physics 2017, Osaka
10. Kenji Matsumoto, Hajime Monzen, Masakazu otsuka, Mikoto Tamura, Masahiko Okumura
  The basic feasibility for radiation protection y using metal functional paper in 125I seeds brachytherapy
  The 8th Japan-Korea joint Meeting on Medical Physics 2017, Osaka
11. Kubo K, Yoon D, Tanaka H, Monzen H, Sakurai Y, Ishii K, Kawamorita R, Suh TS, Nishimura Y.
  Treatment planning comparison between boron neutron capture therapy and volumetric modulated arc therapy for patients with brain cancer.
  The 8th Japan-Korea joint Meeting on Medical Physics 2017, Osaka
12. Mikoto Tamura, Hajime Monzen, Kenji Matsumoto, Masahiko Okumura, and Yasumasa Nishimura.
  Reduction of the skin surface dose for megavoltage photon beams.
  The 8th Japan-Korea joint Meeting on Medical Physics 2017, Osaka
13. Kohei Hanaoka, Masahiko Okumura, Kenji Matsumoto, Kohei Shimomura, Hajime Monzen
  Potential impact of metal artifact caused by loc-bar on PET/CT image
  The 8th Japan-Korea joint Meeting on Medical Physics 2017, Osaka
14. Yoshiki Takei, Kenji Matsumoto, Mikoto Tamura, Ryosuke Sakurai, Kentaro Otsubo, Hidekazu Nambu, Hajime Monzen.
  Evaluation and optimization of patient dose from kilovoltage cone beam computed tomography imaging in radiation therapy.
  The 8th Japan-Korea joint Meeting on Medical Physics 2017, Osaka
15. Makoto Hirata, Hajime Monzen, Kohei Hanaoka, Yasumasa Nishimura
  Measurement of absorbed dose at off-axis point in IMRT
  The 8th Japan-Korea joint Meeting on Medical Physics 2017, Osaka
16. Seiichi Ota, Keita Kurosu, Iori Sumida, Hiroya Shiomi, Hirokazu Mizuno, Yuichi Akino, Shinichi Inoue, Keisuke Tamari and Osamu Suzuki
  How does variable collimator accuracy influence dose distribution on prostate cases of robotic stereotactic radiotherapy　
  The 8th Japan-Korea joint Meeting on Medical Physics 2017, Osaka
17. Ryu Kawamorita, Shun Kishimoto, Kazuki Kubo, Ryuta Nakahara, Wataru Okada, Yuta Nakasaka, Masayuki Kusawake, Shogo Matsuda, Ryo Ogino, Kentaro Ishii, Toshifumi Nakajima
  Effectivity of using novel margin recipe and anterior rectal wall registration to treatment planning for intermediate risk prostate cancer patients
  The 8th Japan-Korea joint Meeting on Medical Physics 2017, Osaka
18. Masakazu Otsuka, Hajime Monzen, Kazuki Ishikawa, Kenji Matsumoto, Mikoto Tamura, Tamaki Nishi, Yasumasa Nishimura
  Influence of variation in dose distribution: Comparison between CT-and CBCT- based plans for oropharyngeal cancer
  The 8th Japan-Korea joint Meeting on Medical Physics 2017, Osaka
19. Masakazu Otsuka, Hajime Monzen, Kazuki Ishikawa, Kenji Matsumoto
  Set-up accuracy in dose distribution: Comparison between CT-and CBCT-based plans for oropharyngeal cancer
  17th Asia Oceania Congress of Medical Physics and 38th Annual Conference of Association of Medical Physicists of India, India, Jaipur.
20. Kohei Hanaoka
  FDG PET/CT simulation for radiotherapy planning
  17th Asia Oceania Congress of Medical Physics and 38th Annual Conference of Association of Medical Physicists of India, India, Jaipur.

2016年
1. Hajime Monzen, Mikoto Tamura, Kenji Matsumoto, Kohei Hanaoka, Ikuo Kanno and Yasumasa Nishimura
  Tungsten functional paper: Shielding characteristics of a novel paper-based material for clinical use with x-rays and gamma rays　ISSRT2016, Seoul
2. Hajime Monzen, Mikoto Tamura, Kazuki Kubo, Makoto Hirata, and Yasumasa Nishimura
  A study of the electron GRID therapy with a novel tungsten functional paper
  22th International Conference on Medical Physics 2016, Bangkok
3. Hajime Monzen, Kazuki Kubo,Mikoto Tamura,Masaru Hayakawa, and Yasumasa Nishimura
  Development of a novel carbon lok-bar:Challenge regarding reduction of ray scattering and absorption in radiation therapy
  22th International Conference on Medical Physics 2016, Bangkok
4. Kohei Hanaoka, Makoto Hosono, Hitoshi Tatebe, Kazuki Ishikawa, Hajime Monzen, Kazunari Ishii, Yasumasa Nishimura.
  Pretherapeutic FDG heterogeneity in tumors can predict local control in oropharyngeal cancer patients undergoing intensity-modulated radiation therapy. SNMMI 2016 Annual Meeting, San Diego.
5. Kohei Hanaoka, Hajime Monzen
  Current Development and Strengths of Nuclear Medicine (NM) in Japan
  The 4th annual conference of Vietnam Association of Radiological Technologists, Da Nang
6. Mikoto Tamura, Hajime Monzen, Kenji Matsumoto, Kohei Hanaoka, Yasumasa Nishimura.
  Study of reduction of the injured skin reaction in radiotherapy with carbon fiber couch.
  ISRRT 2016, Seoul
7. Mikoto Tamura, Hajime Monzen, Kenji Matsumoto, Kohei Hanaoka, Yasumasa Nishimura.
  Application of the tungsten functional paper as reduction of exposed dose to operators in interventional
  and therapeutic angiography using Monte Carlo calculation.
  ISRRT 2016@Seoul
8. Kazuki Kubo, Hajime Monzen, Mikoto Tamura, Kentaro Ishii, Ryo Ogino, Ryu Kawamorita, Wataru Okada, Ryuta Nakahara,
  Shun Kishimoto, Kotoko Imai, Toshifumi Nakajima, Yasumasa Nishimura
  Dosimetric comparison of RapidPlan and manually optimized plan in volumetric modulated arc therapy for prostate cancer
  22th International Conference on Medical Physics 2016, Bangkok, Thailand
9. Seiichi Ota
  The basic radiotherapy in beginning a new era　-Patient positioning, the principle of radiotherapy-
  The 4th annual conference of Vietnam Association of Radiological Technologists, Da Nang

2014年
1. Matsumoto K, "Monzen H", Asai Y, Shimomura K, Okumura M. The basic feasibility study for radiation protection by using metal functional paper in 125I seeds brachytherapy.（Presented at the 14th meeting of the Asia Oseania Congress of Medical Physic, Ho Chin Min city, Vietnam, Oct 23-25 2014）
2. Amano M, "Monzen H", Kamiya M, Kuroda T, Takagi M: Radiation dose reduction in computed tomography: a new material method with TFP. （Presented at the 14th meeting of the Asia Oseania Congress of Medical Physic, Ho Chin Min city, Vietnam, Oct 23-25 2014）
3. Kamomae T, Itoh Y, "Monzen H", Okudaira K, Nakaya T, Miyake Y, Oguchi H, Kawamura M, Okada T, Naganawa S. Evaluation of dosimetric attenuation with new tungsten-based functional paper for intraoperative radiotherapy (IORT) for breast cancer.（Presented at the 14th meeting of the Asia Oseania Congress of Medical Physic, Ho Chin Min city, Vietnam, Oct 23-25 2014）
4. Nakayama S, "Monzen H", Oonishi Y, Mizote R, Kaneshige S, Mizowaki T. A novel method for dose distribution registration using fiducial marks made by a megavoltage beam in film dosimetry for intensity-modulated radiation therapy quality assurance. (Presented at the 14th meeting of the Asia Oseania Congress of Medical Physic, Ho Chin Min city, Vietnam, Oct 23-25 2014)
5. "Monzen H", Tamura M, Shimomura K, Kamomae T, Oonishi Y, Nakayama S, Fujimoto T, Matsumoto K, Okumura M Novel evaluation of a radiation protection for operator in interventional radiology with a tungsten-based functional paper.(Presented at the 14th meeting of the Asia Oseania Congress of Medical Physic, Ho Chin Min city, Vietnam, Oct 23-25 2014)
6. "Monzen H". A Revolution in High Precision with Vero System. (Key note speaker, Presented at the 14th meeting of the Asia Oseania Congress of Medical Physic, Ho Chin Min city, Vietnam, Oct 24 2014)
7. K. Shimomura, Y. Kono, Y. Asai, M. Okumura, M. Uemura, K. Matsumoto, T. Hyodo, T. Murakami, Y. Nishimura, "H. Monzen", F. Araki. Analysis of physical density and weight fraction for human tissue materials using dual energy computed tomography. (Presented at the 7th Korea-Japan Joint Meeting on Medical Physics in conjunction with the 48th Meeting of Korean Society of Medical Physics and the 108th Meeting of Japan Society of Medical Physics, Busan, Korea on September 25-27, 2014.

2013年
1. Nishimura Y. A two-step method of IMRT for head and neck cancer. Presented as an invited speaker at the Third International Conference on Real-time Tumor-tracking Radiation Therapy with 4D Molecular Imaging Technique, Sapporo, Japan, Feb. 7-8, 2013.
2. Nakamatsu K, Nishimura Y, Tachibana I. High-dose intensity modulated radiation therapy (IMRT) using a simultaneous integrated boost (SIB) method combined with temozolomide (TMZ) for malignant gliomas. Int J Radiat Oncol Biol Phys, 87 (25), supple.: S249, 2013. (Presented at the 55th Annual Meeting of the American Society for Radiation Oncology, Atlanta, USA, Sept 22-25, 2013)
3. Nakamatsu K, Nishimura Y, Yokokawa M, Nishikawa T, Ishikawa K, Tamura M, Shibata T. Intensity modulated radiation therapy (IMRT) for high-risk prostate cancer: effects of total dose on PSA failure. Int J Radiat Oncol Biol Phys, 87 (25), supple.: S359-360, 2013. (Presented at the 55th Annual Meeting of the American Society for Radiation Oncology, Atlanta, USA, Sept 22-25, 2013)
4. Matsuura T, Ishikawa K, Tachibana I, Yokokawa M, Nishimura Y. Clinical outcomes of IMRT planned with or without PET/CT simulation for patients with pharyngeal cancer. Int J Radiat Oncol Biol Phys, 87 (25), supple.: S447-448, 2013. (Presented at the 55th Annual Meeting of the American Society for Radiation Oncology, Atlanta, USA, Sept 22-25, 2013)
5. Tachibana I, Nishimura Y , Kanamori S, Nakamatsu K, Yokokawa M, Koike R, Nishikawa T, Ishikawa K, Matsuura T. Clinical results of definitive radiation therapy for postoperative locoregional recurrence of non-small cell lung cancer (NSCL). Int J Radiat Oncol Biol Phys, 87 (25), supple.: S521-522, 2013. (Presented at the 55th Annual Meeting of the American Society for Radiation Oncology, Atlanta, USA, Sept 22-25, 2013)
6. Nishimura Y. IMRT for head and neck cancer in Japan. Presented as an invited speaker at the MD Anderson Radiation Oncology Gilbert H Fletcher Society 37th Annual Scientific Meeting, Kyoto, Japan, April 18-19, 2013.
7. Nishimura Y. Chemoradiation therapy for locally advanced esophageal cancer; Japanese perspective. Presented as an invited speaker at the ESTRO-JASTRO Joint Symposium, 2nd ESTRO forum, Geneva, Switzerland, April 19-23, 2013
8. Nishimura Y. Esophageal squamous cell carcinoma. Panelist, the 5th CSTRO-JASTRO-KOSRO Trilateral Symposium, Chengdu, China, 21st Nov. 2013

2012年
1. Nishimura Y, Harada H, Soejima T, Tsujino K, Hayakawa K, Kozuka T, Tanaka M, Sasaki T, Yamamoto N, Nakagawa K. Phase II study of nimotuzumab in combination with concurrent chemoradiotherapy (CRT) in patients with locally advanced non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys, 84 (35), supple.: S68, 2012. Presented at the 54th Annual Meeting of the American Society for Radiation Oncology, Boston, USA, Oct 28- 31, 2012
2. Koike R, Nishimura Y, Ishikawa K, Nakamatsu K, Kanamori S, Nishikawa T, Tachibana I, Matsuura T. Definitive chemoradiation therapy (CRT)using intensity modulated radiation therapy (IMRT) boost for cervical esophageal cancer. Int J Radiat Oncol Biol Phys, 84 (35), supple.: S306, 2012. Presented at the 54th Annual Meeting of the American Society for Radiation Oncology, Boston, USA, Oct 28- 31, 2012
3. Yamazaki T, Kodaira T, Ota Y, Akimoto T, Wada H, Hiratsuka J, Nishimura Y, Ishihara S, Nonoshita T, Hayakawa K. Retrospective analysis of definitive radiotherapy for neck node metastasis from unknown primary tumor: Japanese Radiation Oncology Study Group Study. Int J Radiat Oncol Biol Phys, 84 (35), supple.: S515, 2012. Presented at the 54th Annual Meeting of the American Society for Radiation Oncology, Boston, USA, Oct 28- 31, 2012
4. Nishimura Y. A two-step adaptive Intensity modulated radiation therapy (IMRT) scheme for head and neck cancer. Presented as an invited speaker at the JASTRO-ESTRO Workshop in the 25th annual meeting of JASTRO. Tokyo, Japan, November 23, 2012.

2011年
1. Matsumoto K, Okumura M, Asai Y, Shimomura K, Tamura M, Nishimura Y. Clinical experience of an amorphous silicon EPID device for pretreatment dosimetry of dynamic IMRT. Radiother Oncol. 99 supple. 1: S508-S509, 2011. Presented at the 11th Biennial Conference on Physics and Radiation Technology for Clinical Radiotherapy, London, UK, 8-12 May, 2011
2. Nishimura Y, Tachibana I, Shibata T, Kanamori S, Nakamatsu K, Koike R, Nishikawa T, Ishikawa K, Tamura M, Hosono M. Tumor hypoxia and reoxygenation of human tumors imaged by 18F-misonidazole (F-MISO) positron emission tomography (PET). Presented at the 14th International Congress of Radiation Research, Warsaw, Poland, Aug 28 – Sept 1, 2011. (Abstract Book, pp124)
3. Ogawa K, Ito Y, Hirokawa N, Shibuya K, Kokubo M, Ogo E, Shibuya H, Karasawa K, Nemoto K, Nishimura Y. Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival. Int J Radiat Oncol Biol Phys, 81 (2), supple.: S341, 2011. Presented at the 53rd Annual Meeting of the American Society for Radiation Oncology, Miami Beach, FL, USA, Oct 2- 6, 2011
4. Nishimura Y, Shibata T, Nakamatsu K, Kanamori S, Koike R, Nishikawa T, Tachibana I, Ishikawa K. Adaptive radiation therapy scheme of a two-step intensity modulated radiation therapy (IMRT) method for nasopharyngeal cancer (NPC). Int J Radiat Oncol Biol Phys, 81 (2), supple.: S512-513, 2011. Presented at the 53rd Annual Meeting of the American Society for Radiation Oncology, Miami Beach, FL, USA, Oct 2- 6, 2011
5. Tachibana I, Nishimura Y, Shibata T, Kanamori S, Nakamatsu K, Tamura M, Koike R, Nishikawa T, Ishikawa K. Hosono M. A prospective clinical trial on tumor hypoxia imaging with 18F-misonidazole (F-MISO) positron emission tomography (PET). Int J Radiat Oncol Biol Phys, 81 (2), supple.: S731-732, 2011. Presented at the 53rd Annual Meeting of the American Society for Radiation Oncology, Miami Beach, FL, USA, Oct 2-6, 2011
6. Nishi T, Nishimura Y, Shibata T, Tamura M, Asai Y, Okumura M. Dosimetric evaluation of two-step method as adaptive replanning strategies for head and neck IMRT. Int J Radiat Oncol Biol Phys, 81 (2), supple.: S826, 2011. Presented at the 53rd Annual Meeting of the American Society for Radiation Oncology, Miami Beach, FL, USA, Oct 2-6, 2011
7. Nishimura Y, Tachibana I, Okubo M, Hosono M. FDG and F-MISO PET-CT in the treatment planning for radiation therapy. Presented as an invited speaker at the First International Conference on Real-time Tumor-tracking Radiation Therapy with 4D Molecular Imaging Technique, Kyoto, Japan, Feb. 3-4, 2011.

2010年
1. Nishimura Y, Koike R, Ogawa K, Sasamoto R, Murakami Y, Itoh Y, Negoro Y, Itasaka S, Sakayauchi T, Tamamoto T. Practice of Radiotherapy for Esophageal Cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey. Disease of the Esophagus, 23 supple. 17A-18A, 2010 Presented at the 12th world Congress of the International Society for the Diseases of the Esophagus, Kagoshima, Japan, Sept 2-5, 2010
2. Nishimura Y, Mitsumori M, Hiraoka M, Koike R, Nakamatsu K, Kawamura M, Araki N, Fuji T, Takahashi T, Mitsuhashi N. Final analysis on long-term survival and late toxicities for a randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer（KROSG-0101, JROSG-021）. Int J Radiat Oncol Biol Phys, 78 (3), supple.: S297-298, 2010. Presented at the 52nd Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego, CA, USA, Oct 31- Nov 4, 2010
3. Tada T, Tsujino K, Fukuda H, Nishimura Y, Kokubo M, Negoro S, Kudoh S, Nakamura S, Nakagawa K, Nakanishi Y. A phase I study of chemoradiotherapy with use of three-dimensional conformal radiotherapy (3D-CRT) and accelerated hyperfractionation (AHF) for unresectable non-small-cell lung cancer (NSCLC): WJOG3305. Int J Radiat Oncol Biol Phys, 78 (3), supple.: S110, 2010. Presented at the 52nd Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego, CA, USA, Oct 31- Nov 4, 2010
4. Ito Y, Ogawa K, Shibuya K, Nishino S, Shibuya H, Karasawa K, Kazumoto T, Karasawa K, Nemoto K, Nishimura Y. Concurrent chemoradiotherapy for unresectable locally advanced pancreatic adenocarcinoma: impact of adjuvant chemotherapy on local control and survival. Int J Radiat Oncol Biol Phys, 78 (3), supple.: S195, 2010. Presented at the 52nd Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Diego, CA, USA, Oct 31- Nov 4, 2010
5. Tsujino K, Tada T, Fukuda H, Nishimura Y, Kokubo M, Soejima T, Takada Y, Nishikawa T, Nakagawa K. Results of a phase I dose escalation trial (WJOG3305) using accelerated hyperfractionated 3D-conformal radiation therapy (AHF-3DCRT) and concurrent chemotherapy for unresectable stage III Non-Small Cell Lung Cancer (NSCLC). Presented at the 4th APLCC (Asia Pacific Lung Cancer Conference) at Seoul, Korea, Dec. 3, 2010.
6. Ishikawa K, Okajima K, Hiroi K, Matsuura T, Nishikawa T, Nishimura Y. Tumor viability of lymph node metastases from esophageal cancer treated by preoperative chemoradiotherapy: histopathological evaluation correlated with node diameter before and after neoadjuvant therapy. Presented at the RSNA 2010, Chicago IL, USA, Nov 29, 2010.

2009年以前
1. Satouchi M, Yamamoto N, Chiba Y, Kudoh S, Hida T, Kubo A, Seto T, Nishimura Y, Nakagawa K, Fukuoka M, West Japan Oncology Group (WJOG). Randomized, phase III study of mitomycin/vindesine/cisplatin (MVP) versus weekly irinotecan/carboplatin (IC) or weekly pacritaxel/carboplatin (PC) with concurrent thoracic radiotherapy (TRT) for unresectable stage III non-small cell lung cancer (NCSLC): WJTOG0105. J Clin Oncol, 27 (15S), Part I of II:383s, 2009. Presented at the 45th Annual Meeting of the American Society of Clinical Oncology, Orlando, FL, USA, May 29 – June 2, 2009
2. Tada H, Tanaka M, Katakami N, Kurata T, Mitsudomi T, Negoro S, Kudoh S, Nishiyama H, Nishimura Y, Nakagawa K, Phase III study of induction chemotherapy (docetaxel and carboplatin) with or without radiotherapy followed by surgery in patients with stage IIIA (pN2) non-small cell lung cancer (NSCLC): WJTOG9903. J Clin Oncol, 27 (15S), Part I of II:396s, 2009. Presented at the 45th Annual Meeting of the American Society of Clinical Oncology, Orlando, FL, USA, May 29 – June 2, 2009
3. Nishimura Y, Tujino K, Satouchi M, Tanaka M, Kodaira T, Kokubo M, Fukuda H, Yamamoto N, Nakagawa K, Fukuoka M. Phase III study of mitomycin/vindesine/cisplatin (MVP) vs. weekly irinotecan/carboplatin (IC) or weekly pacritaxel/carboplatin (PC) with concurrent thoracic radiotherapy (TRT) for unresectable stage III non-small cell lung cancer (WJTOG0105): special reference on delivery of TRT. Int J Radiat Oncol Biol Phys, 75 (3), supple.: S37-38, 2009. Presented at the 51st Annual Meeting of the American Society for Radiation Oncology, Chicago, Illinois, USA, Nov. 1 – 5, 2009
4. Tachibana I, Shibata T, Nishikawa T, Koike R, Nakamatsu K, Kanamori S, Nishimura Y. Radiation therapy for postoperative recurrence of non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys, 75 (3), supple.: S460-461, 2009. Presented at the 51st Annual Meeting of the American Society for Radiation Oncology, Chicago, Illinois, USA, Nov. 1 – 5, 2009
5. Soejima T, Yoden E, Nishimura Y, Ono S, Yoshida A, Fukuda H, Fukuhara N, Sasaki R, Tujino K, Norihisa Y. Radiation therapy in patients with implanted cardiac pacemakers and implantable cardiodefibrillators: a prospective survay in Japan. Int J Radiat Oncol Biol Phys, 75 (3), supple.: S500, 2009. Presented at the 51st Annual Meeting of the American Society for Radiation Oncology, Chicago, Illinois, USA, Nov. 1 – 5, 2009
6. Nishimura Y, Mitsumori M, Hiraoka M, Koike R, Nakamatsu K, Kawamura M, Negoro Y, Fujiwara K, Sakurai H, Mitsuhashi N. A randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer: short-term infusion versus protracted infusion chemotherapy （KROSG-0101, JROSG-021）. Int J Radiat Oncol Biol Phys, 72 (1), supple.: S129-130, 2008. Presented at the 50th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston, MA, USA, Sept. 21-25, 2008
7. Koike R, Nishimura Y, Nakamatsu K, Kanamori S, Ohkubo M, Hiroi K, Shibata T, Nishikawa T, Shiozaki H. Definitive chemo-radiotherapy for esophageal cancer; failure pattern and salvage treatments. Int J Radiat Oncol Biol Phys, 72 (1), supple.: S242-243, 2008. Presented at the 50th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston, MA, USA, Sept. 21-25, 2008
8. Matsumoto K, Okumura M, Asai K, Sakaguchi K, Shintani N, Nishi T, Shimomura K, Nishimura Y. Dosimetric properties of an amorphous silicon electric portal device for verification of dynamic IMRT. Int J Radiat Oncol Biol Phys, 72 (1), supple.: S557, 2008. Presented at the 50th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston, MA, USA, Sept. 21-25, 2008
9. Nishimura Y, Shibata T, Nakamatsu K, Kanamori S, Koike R, Okubo M. Intensity modulated radiation therapy (IMRT) for head and neck cancers and esophageal cancers. Abstract Book of the 5th Japan-US Cancer Therapy Symposium & the 5th S. Takahashi Memorial International Joint Symposium. pp.24, 2007, Presented as an invited speaker at the 5th Japan-US Cancer Therapy Symposium & the 5th S. Takahashi Memorial International Joint Symposium. Sendai, Japan, September 7-9, 2007.
10. Okubo M, Nishimura Y, Nakamatsu K, Okumura M, Shibata T, Kanamori S, Hanaoka K, Hosono M,. Clinical and phantom studies for treatment planning of lung cancer in an integrated positron emission and computed tomography (PET/CT) system. Abstract Book of the 5th Japan-US Cancer Therapy Symposium & the 5th S. Takahashi Memorial International Joint Symposium. pp.59, 2007, Presented as an invited speaker at the 5th Japan-US Cancer Therapy Symposium & the 5th S. Takahashi Memorial International Joint Symposium. Sendai, Japan, September 7-9, 2007.
11. Shibata T, Koike R, Nakamatsu K, Kanamori S,Okubo M, Hiroi K, Nishimura Y, Nakagawa K, Fukuoka M. A long-term result by hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small cell lung cancer (LD-SCLC): a retrospective analysis in a single institution. J Thoracic Oncol 2 (8) supple 4: S832, 2007, Presented at the 12th World Conference on Lung Cancer, Seoul, Korea, Sept 2-6, 2007.
12. Shibata T, Nakamatsu K, Koike R, Okubo M, Hiroi K, Nishikawa T, Kanamori S, Mori K, Nishimura Y, Intensity modulated radiotherapy for oropharyngeal and hypopharyngeal cancers: a short-term result. Euro J Cancer supple. 5(No 4), 344, 2007, Presented at the European Cancer Conference; ECCO 14, Barcelona, Spain, Sept. 23-27, 2007.
13. Koike R, Nishimura Y, Nakamatsu K, Kanamori S, Ohkubo M, Hiroi K, Shibata T. Protracted infusion chemotherapy combined with radiotherapy for esophageal cancer with malignant fistula. Int J Radiat Oncol Biol Phys, 69 (3), supple.: S295, 2007, Presented at the 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Los Angels, CA, USA, Oct. 28-Nov. 1, 2007.
14. Nishimura Y, Okubo M, Nakamatsu K, Okumura M, Shibata T, Kanamori S, Koike R, Hiroi K, Nishikawa T, Hosono M. Static and moving phantom studies for treatment planning in an integrated PET/CT system. Int J Radiat Oncol Biol Phys, 69 (3), supple.: S694-695, 2007, Presented at the 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Los Angels, CA, USA, Oct. 28-Nov. 1, 2007.
15. Nishimura Y. Nakamatsu K, Shibata T, Kanamori S, Koike R, Hiroi K, Okubo M, Okumura M. Preliminary results of intensity modulated radiation therapy (IMRT) for nasopharyngeal cancer (NPC) at Kinki University. Abstract Book of the 1st Hokkaido International Crosscutting Symposium: Molecular Bio-imaging and 4D Image-guided Radiotherapy, pp.42, 2006, Presented at the 1st Hokkaido International Crosscutting Symposium: Molecular Bio-imaging and 4D Image-guided Radiotherapy, Sapporo, Hokkaido, July 14-16, 2006.
16. Okubo M, Okumura M, Hanaoka K, Nakamatsu K, Shibata T, Kanamori S, Koike R, Usami K, Hosono M, Nishimura Y. A phantom study for delineating target volume in an integrated FRD-PET/CT simulation system. Abstract Book of the 1st Hokkaido International Crosscutting Symposium: Molecular Bio-imaging and 4D Image-guided Radiotherapy, pp.28, 2006, Presented at the 1st Hokkaido International Crosscutting Symposium: Molecular Bio-imaging and 4D Image-guided Radiotherapy, Sapporo, Hokkaido, July 14-16, 2006.
17. Nakamatsu K, Nishimura Y, Shibata T, Koike R, Kanamori S, Yagyu Y. Final results of a randomized trial of 30Gy/3 fractions versus 40Gy/4 fractions in postoperative Strontium-90 radiation therapy (RT) for pterygia. Radioth Oncol 81(supple. 1): S243, 2006, Presented at the 25th European Society for Therapeutic Radiology and Oncology, Leipzig, Germany, October 8-12, 2006.
18. Nishimura Y, Nakamatsu K, Shibata T, Kanamori S, Koike R, Hiroi K, Okubo M, Okumura M. Clinical results of parotid-sparing intensity moduolated radiation therapy (IMRT) for nasopharyngeal cancer (NPC). Radioth Oncol 81(supple. 1): S367, 2006, Presented at the 25th European Society for Therapeutic Radiology and Oncology, Leipzig, Germany, October 8-12, 2006.
19. Nishimura Y, Nakagawa K, Takeda K, Tanaka M, Kataoka M, Segawa Y, Tsujino K, Negoro S, Fukuoka M, Ariyoshi Y. Phase I/II Trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients (pts) with locally advanced non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys, 66 (3), supple.: S29, 2006, Presented at the 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA, USA, Nov. 5-9, 2006.
20. Koike R, Nishimura Y, Nakamatsu K, Kanamori S, Ohkubo M, Hiroi K, Shibata T. Chemo-radiotherapy using intensity-modulated radiation therapy (IMRT) boost for locally advanced cervical esophageal cancer. Int J Radiat Oncol Biol Phys, 66 (3), supple.: S310-311, 2006, Presented at the 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA, USA, Nov. 5-9, 2006.
21. Nishimura Y. Progress in radiation therapy for esophageal cancer; Japanese experience. Proceeding of the 1st International Conference on Esophageal Cancer, 15-19, 2005, Presented as an invited speaker at the 1st International Conference on Esophageal Cancer, Zhengzhou, China, Sept. 16-19, 2005.
22. Suzuki M, Nishimura Y, Nakamatsu K, Okumura M, Hashiba H, Koike R, Kanamori S, Shibata T. Analysis of intrafractional set-up errors and intrafractional organ motions during IMRT for head and neck cancers to define an appropriate PTV-margin. Int. J. Radiat. Oncol. Biol. Phys., 63 (2), supple.1: S357, 2005.
23. Nemoto K, Yamada S, Mitsuhashi N, Gomi K, Nishio M, Yamamoto M, Shioyama Y, Tsujino K, Mitsumori M, Nishimura Y, Nakamura R, Matsumoto Y. Results of radiation therapy for superficial esophageal cancer using standard radiotherapy method recommended by JASTRO Study Group. Int. J. Radiat. Oncol. Biol. Phys., 63 (2), supple.1: S276, 2005.
24. Soejima T, Yoden E, Tsujino K, Fujii O, Ichimiya Y, Nishimura Y, Fukuda H, Sasaki R, Yoshida A. Radiation therapy in patients with cardiac pacemakers and implantable cardio-defibrillators: a survey of patterns of practice among radiation oncology in Japan. Euro J Cancer supple. 3(No 2), 408, 2005.　 Presented at the European Cancer Conference 13, Paris, France, Oct. 30 ? Nov. 3, 2005.
25. Nishimura Y, Nakamatsu K, Shibata T, Kanamori S, Koike R, Suzuki M, Mori K. Patterns of local-regional recurrence in patients with head and neck cancer treated by parotid-sparing IMRT. Euro J Cancer supple. 3(No 2), 295, 2005.　 Presented at the European Cancer Conference 13, Paris, France, Oct. 30 ? Nov. 3, 2005.
26. Nakamatsu K, Nishimura Y, Suzuki M, Okajima K, Akai F. A clinical study of intensity modulated radiotherapy (IMRT) using the simultaneous integrated boost method for malignant gliomas. Euro J Cancer supple. 3(No 2), 137, 2005.　 Presented at the European Cancer Conference 13, Paris, France, Oct. 30 Nov. 3, 2005.
27. Nishimura Y. Progress in chemo-radiotherapy for esophageal cancer. Presented as a guest faculty in Japan/U.S. Cancer Therapy Symposium; New Horizons of Targeted Treatment in Radiation Oncology, Maui, Hawaii, May 18-21, 2005.
28. Hosono M, Kudoh T, Komeya Y, Koike R, Yagyu Y, Nakamatsu K, Hanada K, Im S, Nishimura Y. Wall motion quantification on Tl-201 gated SPECT for detecting ischemia. JNM abstract book supple. 45: 222p, 2004. Presented at 51st Annual Meeting of the Society of Nuclear Medicine at Philadelphia, June 19-23, 2004.
29. Hosono M, Machida K, Matsui T, Honda N, Takahashi T, Osada H, Ohtawa N, Asano T, Nishimura Y. Regional CBF changes and detection of vasospasm in subarchnoid hemorrhage. JNM abstract book supple. 45: 268p-269p, 2004. Presented at 51st Annual Meeting of the Society of Nuclear Medicine at Philadelphia, June 19-23, 2004.
30. Hanada K, Hosono M, Kirime Y, Yagyu Y, Hitomi Y, Nakamatsu K, Komeya Y, Shiba I, Koike R, Hitomi K, Nishimura Y. Regional cerebral blood flow in assessment of major depression and Alzheimer’s disease in early elderly. JNM abstract book supple. 45: 278p-279p, 2004. Presented at 51st Annual Meeting of the Society of Nuclear Medicine at Philadelphia, June 19-23, 2004.
31. Hanada K, Hosono M, Yagyu Y, Hitomi Y, Nakamatsu K, Koike R, Tujii N, Tamura Y, Komeya Y, Hitomi K, Nishimura Y. Different regional cerebral blood flow patterns in chronic schizophrenia with and without delusion. JNM abstract book supple. 45: 284p-285p, 2004. Presented at 51st Annual Meeting of the Society of Nuclear Medicine at Philadelphia, June 19-23, 2004.
32. Nambu H, Shimono T, Watanabe M, Koganeya Y, Okajima K, Nishimura Y. Energy and field size characteristics of displacement the effective point in thimble ionization chamber by parallel setting to the X-ray beam axis. Presented at the RSNA 2004.
33. Nishimura Y. Nakamatsu K, Kanamori S, Okumura M. Importance of mean dose and initial volume of parotid glands in xerostomia of patients with head and neck cancers receiving IMRT. Int. J. Radiat. Oncol. Biol. Phys., 60 (1), supple.: S522, 2004. Presented at the 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Atlanta, GA, USA, Oct. 3-7, 2004.
34. Nakamatsu K, Nishimura Y. Tagyu Y, Koike R, Kanamori S. A randomized trial of 30 Gy/3 fractions versus 40 Gy/4 fractions in postoperative Strontium-90 radiation therapy (RT) for pterygia. Int. J. Radiat. Oncol. Biol. Phys., 60 (1), supple.: S551-S552, 2004. Presented at the 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Atlanta, GA, USA, Oct. 3-7, 2004.
35. Nishimura Y. Nakamatsu K, Kanamori S, Shibata T, Suzuki M. Patterns of local-regional recurrence following parotid-sparing IMRT for head and neck cancers at Kinki University.? Presented at the 4th S. Takahashi Memorial International Workshop on 3 Dimensional Conformal Radiotherapy, Nagoya, Japan, Dec. 10-12, 2004.
36. Nishimura Y. Chemoradiotherapy for esophageal cancer; Japanese experience. Japan-Korea-China Tri-lateral Symposium on Radiation Oncology. Chiba, Japan, Nov. 17-18, 2004.
37. Suzuki M, Nishimura Y, Nakamatsu K, Kanamori S, Terao K, Mori K, Murata K. Phase I study of weekly docetaxel infusion and concurrent radiation therapy for head and neck cancer. Presented at the 39th Annual Meeting of American Society of Clinical Oncology, Chicago, IL, USA, May 31 ? June 3, 2003.( Proceedings of ASCO, vol. 22: 514, 2003).
38. Nishimura Y, Suzuki M, Nakamatsu K, Kanamori S, Uchiyama T, Akai F. A pilot study of the simultaneous integrated boost method for malignant gliomas using IMRT. Abstract Book of the 12th International Congress of Radiation Research, pp 216, Brisbane, Australia, Aug.17-22, 2003.
39. Honda N, Machida K, Matsumoto T, Matsuda H, Imabayashi E, Hosono M. Diagnostic performance of brain perfusion SPECT for Alzheimer's disease: comparison between visual interpretation and three-dimensional sterotactic surface display. 50th annual meeting of Society of Nuclear Medicine, New Orleans, USA. June 21-25, 2003. J Nucl Med 2003;44:12P.
40. Hosono M, Machida K, Matsui T, Honda N, Takahashi T, Kashimda A, Murata O, Osada H, Ohtawa N,Asano. Evaluation of regional CBF in subarachnoid hemorrhage using 99mTc-ECD. 50th annual meeting of Society of Nuclear Medicine, New Orleans, USA. June 21-25, 2003. J Nucl Med 2003;44:232P.
41. Mishra AK, Hosono M, Chuttani K, Mishra P, Sharma RK, Chatal JF. Isothiocyanato-dioxo-carboxymethyl-tetraazacyclotridecane as a new chelate to label antibody with technetium-99m. 50th annual meeting of Society of Nuclear Medicine, New Orleans, USA. June 21-25, 2003. J Nucl Med 2003;44:301P.
42. Honda N, Machida K,? Hosono M, Kashimada A, Takahashi T, Osada H,? Watanabe W, Murata O, Okada T. 201Tl SPECT and CT fusion in thoracic malignancy. 50th annual meeting of Society of Nuclear Medicine, New Orleans, USA. June 21-25, 2003. J Nucl Med 2003;44:376P.
43. Inoue M, Watanabe M, Watai R, Yagyu Y, Ashikaga R, Nishimura Y.Dynamic multidetecto-row CT of breast tumors ; Diagnostic criteria and comparison of other modalities.15th European Congress of Radiology, Vienna, Austria, March 7-11,2003.European Radiology 2003;13;Supple:400-401.
44. Yagyu Y, Inoue M, Awai K, Watai R, Sano T, Watanabe M, Nishimura Y.Detection of hypervascular hepatocellular carcinomas at multidetector row CT: Prospective study of the effect or different concentrations of contrast materials15th European Congress of Radiology,? Vienna, Austria, March 7-11, 2003. (Supplement 1 to volume 13 / European Radiology / February 2003, p 440).
45. Honda N, Machida K, Hosono M, Matsumoto T, Matsuda H, Momose T, Oshima M, Koizumi K, Hashimoto J, Mori Y. Three-dimensional stereotacitc surface projection of brain perfusion SPET enhances diagnosis of Alzheimer’s disease. August 23-27, 2003. Congress 2003 of European Association of Nuclear Medicine, Amsterdam, the Netherlands. Eur J Nucl Med 2003;30:Supple 2:S300.
46. Ohtawa N, Machida K, Honda N, Takahashi T, Hosono M, Kashimada A, Osada H, Watanabe W, Murata O, Okada T, Nishimura K, Ohno H, Yamano T. Global cerebral blood flow changes measured by brain perfusion SPECT immediately after whole brain irradiation. August 23-27, 2003. Congress 2003 of European Association of Nuclear Medicine, Amsterdam, the Netherlands. Eur J Nucl Med 2003;30:Supple 2:S301.
47. Nishino M, 　　Shimono T et al. Tuberculosis of Brain , Head, and Neck . 89th Scientific Assembly of Radiological Society of North America(RSNA).Chicago，USA,Nov30-Dec5,2003.
48. Nishida C, Okajima K, Yamamoto T, Kudo T, Hasegawa H, Nishimura Y. Coronary artery calcification in symptomatic patients on non-gated multi-detector CT: correlation with thallium exercise stress test. Presented at the 89th Scientific Assembly of Radiological Society of North America(RSNA).Chicago，USA,Nov30-Dec5,2003.
49. Nishimura Y, Nakamatsu K, Kanamori S: Tumor angiogenesis and hyperthermia. Presented as a congress lecture at the 3rd Asian Congress on Hyperthermic Oncology, Zhengzhou, China, April 10-12, 2002.
50. Nishimura Y: Recent advance in radiation therapy for esophageal cancer. Presented as an invited speaker at the International Symposium of Radiation Oncology, China, Japan, Korea, Shijiazhuang, China, September 18, 2002.
51. Nishimura Y. Radiation biology for IMRT. Presented as an invited speaker at the FNCA Seminar on Radiation Oncology 2002, Tokyo, Japan, December 20, 2002.
52. Inoue M, Watanabe M, Watai R, Yagyu Y, Ashikaga R, Nishimura Y. Dynamic multidetector-row CT for breast tumors. Presented at the 88th Scientific Assembly and Annual Meeting of Radiological Society of North America, Chicago, IL, USA, Dec 1-6, 2002.(Radiology 225 (p): 121-122, 2002).
53. Sai H, Mitsumori M, Araki N, Okumura S, Nishimura Y, Hiraoka M. Concurrent chemoradiotherapy in esophageal cancer; comparison between intermittent high dose cisplatin with 5-fluorouracil and daily lowdose cisplatin with continuous low dose infusion of 5-fluorouracil. Presented at the 88th Scientific Assembly and Annual Meeting of Radiological Society of North America, Chicago, IL, USA, Dec 1-6, 2002.(Radiology 225 (p): 415, 2002).
54. Nakamatsu K, Nishimura Y, Suzuki M, Kanamori S, Okajima K, Okumura M. Intra-fraction organ motion during IMRT for head and neck cancer. Presented at the 88th Scientific Assembly and Annual Meeting of Radiological Society of North America, Chicago, IL, USA, Dec 1-6, 2002.( Radiology 225 (p): 506, 2002).
55. Suzuki M, Nakamatsu K, Kanamori S, Nishimura Y. Inverse planning of simultaneous integrated boost (SIB) method for high-grade gliomas: usefulness for defining GTV and CTV-annulus as two separate target volumes. Presented at the 88th Scientific Assembly and Annual Meeting of Radiological Society of North America, Chicago, IL, USA, Dec 1-6, 2002.( Radiology 225 (p): 711, 2002).
56. Awai K, Murao K, Ozawa A, Yamanaka T, Komi M, Hayakawa H, Hori S.Computer-aided diagnosis in detection of lung nodules on chest CT: Effects on radiologists' performance. 88th scientific assembly and annual meeting, the Radiological Society of North America, Chicago, IL, USA, Dec 1-6, 2002.
57. Nishimura Y, Suzuki M, Nakamatsu K, Kanamori S, Yagyu Y, Shigeoka H. Concurrent chemoradiotherapy with protracted infusion of 5-FU and cisplatin for advanced esophageal cancer. Presented at the 6th International Congress of Radiation Oncology, Melbourne, Australia, Jan 30 ? Feb 2, 2001.( Radiother. Oncol. 58 (suppl. 1): s120-s121, 2001).
58. Suzuki M, Nakamatsu K, Nishimura Y. Docetaxel inhibits recruitment from G0 phase to cycling phase of SCC7 murine tumor. Presented at the 6th International Congress of Radiation Oncology, Melbourne, Australia, Jan 30 ? Feb 2, 2001.( Radiother. Oncol. 58 (suppl. 1): s76, 2001).
59. Nakamatsu K, Suzuki M, Yoshimasu T, Kumano M, Nishimura Y. Radiation pnemonitis associated with chemoradiation for non-small cell lung cancer. Presented at the 6th International Congress of Radiation Oncology, Melbourne, Australia, Jan 30 ? Feb 2, 2001.( Radiother. Oncol. 58 (suppl. 1): s102, 2001).
60. Nakamatsu K, Suzuki M, Kanamori S, Nishimura Y, Yasuda Y. Erythropoietin as an angiogenic factor in murine hepatic tumors. Presented at the 11th European Cancer Conference, Oct 21-25th, 2001, Lisbon, Portugal.(Eur J. Cancer 37 (supple. 6): S112, 2001).
61. Nambu H, Okajima K, Nishimura Y. Image quality of the digitally reconstructed radiographs (DRRs): Improvement by isotropic voxel obtained by a multi-detector row CT and the clinical application. Presented at the 43rd Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Francisc, California, USA, Nov 4-8th, 2001.( Int. J. Radiat. Oncol. Biol. Phys., 51 (3), supple.: 377, 2001).
62. Shimono T, Miki Y, Toyoda H, Egawa H, Uemoto S, Tanaka K.MR imaging with quantitative diffusion mapping of tacrolimus-induced neurotoxicity in organ tranplant patients.87th Scientific Assembly of Radiological Society of North America (RSNA).Chicago,USA,Nov 25-30,2001.
63. Suzuki M,Nakamatsu K,Kanamori S,Nishimura Y.Intensity-modulated radiotherapy for head and neck cancer and brain tumors : DVH analysis.The 3rd Presented at the 3rd S. Takahashi Memorial International Workshop, Nagoya, Japan, Dec. 8-10th, 2001. 001.( Radiother. Oncol. 58 (suppl. 1): s76, 2001).
64. Nishimura Y, Horii N, Okuno Y, Kanamori S, Hiraoka M, Shimada Y. Imamura M. Impact of neoadjuvant chemotherapy on Ki-67 and PCNA labeling indices for esophageal cancer. Presented at the first International Conference on Translational Research and Pre-Clinical Strategies in Clinical Radio-Oncology (ICTR 2000), Lugano, Switzerland, March 5-8, 2000, (Int. J. Radiat. Oncol. Biol. Phys., 46 (3): 768-769, 2000).
65. Masunaga S, Ono K, Nishimura Y, Kanamori S, Saga T, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Hori H. Combined effects of tirapazamine and mild hyperthermia on TNP-470 treated solid tumors; reference to the effect on intratumor quiescent cells. Presented at the first International Conference on Translational Research and Pre-Clinical Strategies in Clinical Radio-Oncology (ICTR 2000), Lugano, Switzerland, March 5-8, 2000.( Int. J. Radiat. Oncol. Biol. Phys., 46 (3): 720-721, 2000).
66. Nishimura Y. Microvasculature as a target in hyperthermia. Presented as a symposist at the 8th International Congress of Hyperthermic Oncology, Kyong-ju, Korea, April 26-29th, 2000.
67. Nishimura Y. Kanamori S , Hiraoka M.: Angiogenesis as a target in hyperthermia. Presented at the 8th International Congress of Hyperthermic Oncology, Kyong-ju, Korea, April 26-29th, 2000.
68. Nagata Y, Zhu JL, Kanamori S, Mitsumori M, Okuno Y, Horii N, Nishimura Y, Masunaga S. Clinical results of locoregional hyperthermia for primary and secondary bone tumors. Presented at the 8th International Congress of Hyperthermic Oncology, Kyong-ju, Korea, April 26-29th, 2000.
69. Horii N, Kimura H, Mitsumori M, Kanamori S, Okuno Y, Hiraoka M, Nishimura Y.: Simultaneously intraluminal thermoradiotherapy for advanced esophageal cancer. Presented at the 8th International Congress of Hyperthermic Oncology, Kyong-ju, Korea, April 26-29th, 2000.
70. Nagata Y, Hiraoka M, Akuta K, Kanamori S, Mitsumori M, Okuno Y, Horii N, Nishimura Y, Masunaga S. Clinical results of radiofrequency hyperthermia for primary and secondary malignant liver tumors. Presented at the 8th International Congress of Hyperthermic Oncology, Kyong-ju, Korea, April 26-29th, 2000.
71. Takemoto M, Kuroda M, Urano M, Nishimura Y, Ono E, Shibuya K, Kawasaki S, Katoh H, Hiraki Y. In vivo thermoenhancing effect for chemotherapeutic agents with mild hyperthermia. Presented at the 8th International Congress of Hyperthermic Oncology, Kyong-ju, Korea, April 26-29th, 2000.
72. Oya N, Kokubo M, Mizowaki T, Sai H, Sasai K, Nishimura Y, Shibamoto Y, Toguchida J, Tsuboyama T, Nakamura T, Hiraoka M. Very high-dose intraoperative radiation therapy for osteosarcomas. Presented at the 42nd Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Boston, Massachusetts, USA, Oct 22-26th, 2000.( Int. J. Radiat. Oncol. Biol. Phys., 48 (3), supple.: 215-216, 2000).
73. Okajima K, Nishiwaki K, Kawakami A, Okamoto K, Nishimura Y.CT evaluation of tumor response after concurrent chemoradiotherapy for squamous cell lung cancer:Correlation of CT findings with histopathologic tumor viability.86th Annual Metting of Radiological Society of North America,Nov 2000, Chicago, IL, USA.
74. Suzuki M, Masunaga S , Kinashi T , Takagaki M , Sakurai Y , Kobashi T ,Ono K.The effects of boron neutron capture therapy on liver tumors and normal hepatocytes in mice.　Presented at the Ninth International Symposium on Neutron Capture Therapy for Cancer, Osaka, Japan, Oct. 2-6th, 2000.
75. Hernandez-Pampaloni M, Kudo T, Keng FY , Soyre JＳ, Schelbert HR. Noninvasive assessment of abnormal coronary perfusion gradient by position emission tomography in subjects with coronary risk factors. The 47th Annual meeting of the society of nucler medicine ,St.Louis, Missouri, USA, June, 2000.
76. Peschl S, Wu HM, Kudo T, Schelbert HR, Huang SC.Movement correction with factor analysis in dynamic FDG-PET studies for extracting the blood-time-activity function.　The 47th Annual meeting of the society of nucler medicine，St.Louis, Missouri，USA, June,2000.
77. Kanamori S, Nishimura Y, Horii N, Saga T, Suzuki H, Hiraoka M. Anti-vascular endothelial growth factor neutralizing antibody and an angiogenesis inhibitor enhance effects of hyperthermia. In Proceedings of the American Association for Cancer Research. 40: 552, 1999. (Philadelphia, PA, USA).
78. Ieda Y, Yamamoto N, Yoshida M, Nogami T, Komiya T, Nakagawa K, Yamada M, Kudoh S, Nishimura Y, Fukuoka M. Phase I and pharmacokinetic study of daily carboplatin (CBDCA) adjusted by AUC combined with concurrent thoracic radiotherapy (TRT) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC). Presented at the 35th Annual Meeting of American Society of Clinical Oncology, Atlanta, Gorgia, USA, May 15-18, 1999 (Proceedings of ASCO, vol. 18: 187a, 1999).
79. Nishimura Y, Nakai Y, Nakamatsu K, Yagyu Y, Yoshimatsu T. Long-term results of high-dose fractionated 90-Strontium radiation therapy for pterygia. Presented at the 41th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Antonio, Texas, USA, Oct 31-Nov 4, 1999.（Int. J. Radiat. Oncol. Biol. Phys., 45 (3), supple.: 393, 1999）.
80. Yamada S, Nemoto K, Hirokawa Y, Hareyama M, Nishimura Y, Hayabuchi N, Oguchi M, Sakai K, Takai Y, Okawa T. Proposal of an optimal radiation treatment method for superficial esophageal cancer from a research group of JASTRO. Presented at the 41th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Antonio, Texas, USA, Oct 31-Nov 4, 1999.（Int. J. Radiat. Oncol. Biol. Phys., 45 (3), supple.: 332, 1999）.
81. Horii N, Nishimura Y, Okuno Y, Kanamori S, Hiraoka M, Shimada Y. The changes in Ki-67 and PCNA labeling index between biopsy and surgical specimen for esophageal cancer. 85th Scientific Assembly and Annual Meeting of Radiological Society of North America, Chicago, IL, USA, Nov 28- Dec 3, 1999.( Radiology 213 (p): 241-242, 1999.).
82. Nishimura Y., Hiraoka M.: Importance of thermal parameters in thermoradiotherapy. Presented as a symposist at the Osaka International Forum on Hyperthermic Oncology, Osaka, Japan, September 9, 1999.
83. Horii N, Kanamori S, Nishimura Y,Nagata Y, Hiraoka M : Thermoradiotherapy for cervical lymph nodes metastases from head and neck cancer.In Abstracts of the 46th Annual Meeting of the Radiation Research Society and the 17th Annual Meeting of the North American Hyperthermia Society. pp. 92, 1998 .(Louisville, KY, USA).
84. Kanamori S, Nishimura Y, Okuno Y, Horii N, Saga T, Hiraoka M.? Induction of vascular endothelial growth factor (VEGF) by hyperthermia and/or an angiogenesis inhibitor. In Abstracts of the 46th Annual Meeting of the Radiation Research Society and the 17th Annual Meeting of the North American Hyperthermia Society. pp. 94, 1998. (Louisville, KY, USA).
85. Okuno Y, Nishimura Y, Kashu I, Ono K, Hiraoka M. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of esophageal cancer. Presented at the 40th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Phoenix, Arizona, Oct 25-29, 1998. (Int. J. Radiat. Oncol. Biol. Phys., 42 (1), supple.: 275, 1998).
86. Nishimura Y, Hiraoka M. Relationship between thermometry results and tumor response for superficial & deep-seated tumors. Presented as a symposist at the Symposium on Hyperthermia and Radiomodifiers, Puri, India, Feb. 7-9, 1998.
87. Y. Nishimura, M. Kokubo, R. Hosotani , M. Kogire, M. Hiraoka, M. Imamura. Preliminary Results of Concurrent Chemoradiotherapy Combined with IORT for Locally Advanced Pancreatic Cancer. Presented at the first Congress of International Society of Intraoperative Radiation Therapy, Pamplona, Spain, Sept 6-9, 1998.
88. Nishimura Y, Okuno Y, Horii N, Hiraoka M. Radiation therapy for superficial esophageal cancer: role of intraluminal brachytherapy. Presented at the 84th Scientific Assembly and Annual Meeting of Radiological Society of North America, Chicago, IL, USA, Nov. 29 Dec. 4, 1998. ( Radiology 209 (p): 436-437, 1998).
89. Inoue M, Ono Y, Fujii K, Araki Y, Nishimura Y, Ishida O. Usefulness of intravenous 3D-CT portography for portal hypertension: comparison with splanchnic angiography and enhanced 3D-MR angiography. Presented at the 84th Scientific Assembly and Annual Meeting of Radiological Society of North America, Chicago, IL, USA, Nov. 29 ? Dec. 4, 1998.( Radiology 209 (p): 561, 1998).

VI. 研究助成金

2021年
1. 西村恭昌（研究代表者）石川一樹、稲田　正浩（研究分担者）
  頭頸部癌に対する強度変調放射線治療における臓器特異的耐容線量の解明：日本学術振興会　基盤研究(C)
2. 細野眞（研究代表者）　門前　一、田村　命（研究分担者）
  新規RI内用療法の導入に向けた線量評価に基づく標準的な実施指針の開発：日本学術振興会　基盤研究(C)
3. 細野眞（研究分担者）　甲斐田勇人（研究代表者）
  食道癌術前化学療法の治療効果予測―低酸素イメージングと癌シグナル伝達因子との相関：日本学術振興会　基盤研究(C)
4. 門前　一（研究代表者）　松本　賢治、土井　啓至、田村　命、花岡　宏平（研究分担者）
  鉛を含まない放射線遮蔽材を用いた新規放射線治療法の開発：日本学術振興会　基盤研究(C)
5. 門前　一（研究代表者）　田村　命（研究分担者）
  世界中の空気を綺麗にするプロジェクト：近畿大学 "オール近大" 新型コロナウイルス感染症対策支援プロジェクト
6. 門前　一（研究代表者）
  医学を物理学から覗いてみよう − 自然科学で切り拓く医学の世界 −：日本学術振興会ひらめき☆ときめきサイエンス〜ようこそ大学の研究室へ〜 KAKENHI
7. 門前　一（研究分担者）　秋山　広徳（研究代表者）
  個別化された舌癌小線源治療への道-多様な口腔内環境を乗り越えて：日本学術振興会　基盤研究(C)
8. 中松　清志（研究代表者）土井　啓至（研究分担者）
  臨床的グリオーマ実験モデルを使用した放射線脳壊死への免疫応答の解明：日本学術振興会　基盤研究(C)
9. 土井　啓至（研究代表者）　門前　一（研究分担者）　　
  深層学習の手法を用いた肺癌に対する新規強度変調放射線治療計画システムの開発：日本学術振興会　基盤研究(C)
10. 田村　命（研究代表者）
  フォトクロミックフィルム放射線線量計の開発と医療応用への実践：日本学術振興会　若手研究

2020年
1. 西村恭昌(研究代表者)　　石川一樹、稲田正浩（研究分担者）
  頭頸部癌に対する強度変調放射線治療における臓器特異的耐容線量の解明：日本学術振興会　基盤研究(C)
2. 細野眞（研究代表者）
  新規核種のRI内用療法における線量評価と個別化治療の開発：日本学術振興会　基盤研究(C)
3. 中松清志（研究代表者）　土井啓至（研究分担者）
  臨床的グリオーマ実験モデルを使用した放射線脳壊死への免疫応答の解明：日本学術振興会　基盤研究(C)
4. 門前一（研究代表者）　　松本賢治、土井啓至、田村命、花岡宏平（研究分担者）
  鉛を含まない放射線遮蔽材を用いた新規放射線治療法の開発：日本学術振興会基盤研究(C)
5. 門前一（研究代表者）　松本賢治、土井啓至、田村命（研究分担者）
  国産原材料にこだわった不織布感染対策製品・超軽量簡易ベッドの開発：近畿大学 "オール近大"新型コロナウイルス感染症対策支援プロジェクト
6. 門前一（研究代表者）　　田村命（研究分担者）
  Artificial Intelligence技術を用いたVMAT治療計画の臨床応用に向けた多施設研究：公益社団法人日本放射線技術学会学術研究班
7. 門前一（研究分担者）　秋山広徳（研究代表者）
  個別化された舌癌小線源治療への道-多様な口腔内環境を乗り越えて：日本学術振興会基盤研究(C)
8. 土井啓至（研究代表者）　門前一（研究分担者）
  深層学習の手法を用いた肺癌に対する新規強度変調放射線治療計画システムの開発：日本学術振興会　基盤研究(C)
9. 田村命（研究代表者）
  フォトクロミックフィルム放射線線量計の開発と医療応用への実践：日本学術振興会若手研究
10. 田村命（研究代表者）
  リアルタイム可変型タングステン含有ゴムを用いた新規舌癌小線源治療法の確立：近畿大学学内奨励研究助成金

2019年
1. 西村恭昌（研究代表者）門前　一、石川一樹、稲田　正浩（研究分担者）：
  治療室内CT画像に基づく適応放射線治療の確立：日本学術振興会基盤研究(C)
2. 細野眞（研究代表者）：新規核種のRI内用療法における線量評価と個別化治療の開発：日本学術振興会基盤研究(C)
3. 細野眞（研究代表者）：医療分野の放射線業務における被ばくの実態と被ばく低減に関する調査研究：厚生労働科学研究費補助金　地域医療基盤開発推進研究事業
4. 細野眞（研究代表者）：医療分野の放射線業務における被ばくの実態と被ばく低減に関する調査研究：厚生労働科学研究費補助金　労災疾病臨床研究事業
5. 門前　一（研究代表者）松本　賢治、土井　啓至、田村　命、花岡　宏平（研究分担者）：鉛を含まない放射線遮蔽材を用いた新規放射線治療法の開発：日本学術振興会基盤研究(C)
6. 門前　一（研究代表者）田村　命（研究分担者）：Artificial Intelligence技術を用いたVMAT治療計画の臨床応用に向けた多施設研究：公益社団法人日本放射線技術学会学術研究班
7. 中松　清志（研究代表者）土井　啓至（研究分担者）：臨床的グリオーマ実験モデルを使用した放射線脳壊死への免疫応答の解明：日本学術振興会基盤研究(C)
8. 土井　啓至（研究代表者）：放射線治療後再発に対する再照射実験モデルの確立－放射線感受性と生体応答の検証－：日本学術振興会若手研究(B)
9. 土井　啓至（研究代表者）：放射線治療後再発に対する再照射の実験モデルの確立と生体応答の解明：近畿大学学内研究助成金奨励研究助成金
10. 田村　命（研究代表者）：フォトクロミックフィルム放射線線量計の開発と医療応用への実践：日本学術振興会若手研究
11. 西村　恭昌（研究分担者）：成人固形がんに対する標準治療確立のための基盤研究（JCOG）：国立がん研究センター研究開発費（29-A-3）（研究代表者：大江　裕一郎）
12. 中松　清志、土井　啓至（研究分担者）：早期非小細胞肺癌に対する体幹部定位放射線治療線量増加ランダム化比較試験：日本医療研究開発機構委託研究開発費（研究代表者：永田　靖）
13. 門前　一、松本　賢治、花岡　宏平、田村　命（研究分担者）：放射線治療における新低吸収素材器具の開発：日本学術振興会基盤研究(C) （研究代表者：奥村　雅彦）
14. 門前　一（研究分担者）：口腔癌３次元画像誘導小線源治療におけるリアルタイム線量評価システムの構築：日本学術振興会基盤研究(C) （研究代表者：秋山　広徳）
15. 門前　一（研究分担者）：正確な小線源治療を担保するリアルタイムIn vivo dosimetryの開発：日本学術振興会基盤研究(C)（研究代表者：吉田　謙）
16. 土井啓至（研究分担者）：悪性胸膜中皮腫の癌幹細胞を標的としたStat3阻害治療(START)に関する研究：日本学術振興会基盤研究(C) （研究代表者：松本　成司）

2018年
1. 西村　恭昌（研究代表者）、門前　一、石川　一樹、稲田　正浩（研究分担者）：治療室内CT画像に基づく適応放射線治療の確立：日本学術振興会：基盤研究(C)
2. 門前　一（研究代表者）：金属含有放射線遮蔽紙を用いた新しい放射線防護体系の確立：日本学術振興会：基盤研究(C)
3. 土井　啓至（研究代表者）：放射線治療後再発に対する最照射実験モデルの確立－放射線感受性と生体応答の検証－：日本学術振興会：若手研究(B)
4. 西村　恭昌（研究分担者）：成人固形がんに対する標準治療確立のための基盤研究（JCOG）：国立がん研究センター研究開発費（29-A-3）（研究代表者：大江　裕一郎）
5. 西村　恭昌（研究分担者）：難治性食道がんの治療方針決定に資する技術開発に関する研究：日本医療研究開発機構委託研究開発費（研究代表者：武藤　学）
6. 門前　一（研究分担者）：口腔癌３次元画像誘導小線源治療におけるリアルタイム線量評価システムの構築：日本学術振興会：基盤研究(C)（研究代表者：秋山広徳）
7. 門前　一（研究分担者）：正確な小線源治療を担保するリアルタイムIn vivo dosimetryの開発：日本学術振興会：基盤研究(C)（研究代表者：吉田　謙）
8. 門前　一、松本　賢治、花岡　宏平、田村　命（研究分担者）：放射線治療における新低吸収素材器具の開発：日本学術振興会：基盤研究(C)（研究代表者：奥村　雅彦）
9. 中松　清志（研究分担者）：早期非小細胞肺癌に対する体幹部定位放射線治療線量増加ランダム化比較試験：日本医療研究開発機構委託研究開発費（研究代表者：永田　靖）
10. 土井　啓至（研究分担者）：悪性胸膜中皮腫の癌幹細胞を標的としたStat3阻害治療(START)に関する研究：日本学術振興会：基盤研究(C)（研究代表者：松本成司）
11. 土井　啓至（研究分担者）：ポリマーゲル線量計を用いた放射線治療における金属の影響解析：日本学術振興会：基盤研究(C)（研究代表者：冨士原将之）
12. 土井　啓至（研究分担者）：放射線増感剤・防護剤併用による放射線直腸粘膜障害の予防－酸素と亜鉛の功罪解明－：日本学術振興会：基盤研究(C)（研究代表者：上紺屋憲彦）
13. 土井　啓至（研究分担者）：細胞周期を標的としたCDK阻害剤による分子標的治療法の開発：日本学術振興会：基盤研究(C)（研究代表者：橋本昌樹）

2017年
1. 西村　恭昌（研究代表者）、門前　一、石川　一樹、建部　仁志（研究分担者）：治療室内CT画像に基づく適応放射線治療の確立：日本学術振興会：基盤研究(C)
2. 門前　一（研究代表者）：金属含有放射線遮蔽紙を用いた新しい放射線防護体系の確立：日本学術振興会：基盤研究(C)
3. 土井　啓至（研究代表者）：放射線治療後再発に対する最照射実験モデルの確立－放射線感受性と生体応答の検証－：日本学術振興会：若手研究(B)
4. 西村　恭昌（研究分担者）：成人固形がんに対する標準治療確立のための基盤研究（JCOG）：国立がん研究センター研究開発費（29-A-3）（研究代表者：大江　裕一郎）
5. 西村　恭昌（研究分担者）：難治性食道がんの治療方針決定に資する技術開発に関する研究：日本医療研究開発機構委託研究開発費（研究代表者：武藤　学）
6. 門前　一（研究分担者）：口腔癌３次元画像誘導小線源治療におけるリアルタイム線量評価システムの構築：日本学術振興会：基盤研究(C)（研究代表者：秋山広徳）
7. 門前　一（研究分担者）：正確な小線源治療を担保するリアルタイムIn vivo dosimetryの開発：日本学術振興会：基盤研究(C)（研究代表者：吉田　謙）
8. 門前　一、松本　賢治、花岡　宏平（研究分担者）：放射線治療における新低吸収素材器具の開発：日本学術振興会：基盤研究(C)（研究代表者：奥村　雅彦）
9. 門前　一（研究分担者）：生物画像情報と四次元放射線治療を統合した個別化放射線治療法の開発：日本学術振興会：基盤研究(A)（研究代表者：平岡　真寛）
10. 中松　清志（研究分担者）：早期非小細胞肺癌に対する体幹部定位放射線治療線量増加ランダム化比較試験：日本医療研究開発機構委託研究開発費（研究代表者：永田　靖）
11. 土井　啓至（研究分担者）：悪性胸膜中皮腫の癌幹細胞を標的としたStat3阻害治療(START)に関する研究：日本学術振興会：基盤研究(C)（研究代表者：松本成司）
12. 土井　啓至（研究分担者）：ポリマーゲル線量計を用いた放射線治療における金属の影響解析：日本学術振興会：基盤研究(C)（研究代表者：冨士原将之）
13. 土井　啓至（研究分担者）：放射線増感剤・防護剤併用による放射線直腸粘膜障害の予防－酸素と亜鉛の功罪解明－：日本学術振興会：基盤研究(C)（研究代表者：上紺屋憲彦）
14. 土井　啓至（研究分担者）：細胞周期を標的としたCDK阻害剤による分子標的治療法の開発：日本学術振興会：基盤研究(C)（研究代表者：橋本昌樹）

2016年
1. 西村　恭昌（研究代表者）：頭頸部腫瘍に対する強度変調放射線治療の確立と標準化のための臨床研究：日本医療研究開発機構委託研究開発費
2. 西村　恭昌（研究代表者）、門前　一、石川　一樹、建部　仁志（研究分担者）：治療室内CT画像に基づく適応放射線治療の確立：文部省科学研究費：基盤研究(C)
3. 門前　一（研究代表者）：金属含有放射線遮蔽紙を用いた新しい放射線防護体系の確立：文部省科学研究費：基盤研究(C)
4. 田村　命（研究代表者）：放射線遮蔽金属含有紙の医学への応用：7大学連携先端がん教育基盤創造プラン：がんプロ研究助成
5. 西村　恭昌（研究分担者）成人固形がんに対する標準治療確立のための基盤研究：国立がん研究センター研究開発費（26-A-4）（研究代表者：飛内　賢正）
6. 西村　恭昌（研究分担者）：難治性食道がんの治療方針決定に資する技術開発に関する研究：日本医療研究開発機構委託研究開発費（研究代表者：武藤　学）
7. 門前　一（研究分担者）：口腔癌３次元画像誘導小線源治療におけるリアルタイム線量評価システムの構築：文部省科学研究費：基盤研究(C)（研究代表者：秋山広徳）
8. 門前　一（研究分担者）：生物画像情報と四次元放射線治療を統合した個別化放射線治療法の開発：文部省科学研究費：基盤研究(A)（研究代表者：平岡　真寛）

2015年
1. 西村　恭昌（研究代表者）：頭頸部腫瘍に対する強度変調放射線治療の確立と標準化のための臨床研究：日本医療研究開発機構委託研究開発費
2. 西村　恭昌（研究代表者）、立花　和泉、石川　一樹（研究分担者）：腫瘍内低酸素イメージングに基づく高精度放射線治療の開発：文部省科学研究費：基盤研究(C)
3. 門前　一（研究代表者）：金属粉含有機能紙による新しい放射線防護材の研究・開発：文部省科学研究費：基盤研究(C)
4. 西村　恭昌（研究分担者）：成人固形がんに対する標準治療確立のための基盤研究：国立がん研究センター研究開発費（26-A-4）（研究代表者：飛内　賢正）
5. 西村　恭昌（研究分担者）：難治性食道がんの治療方針決定に資する技術開発に関する研究：日本医療研究開発機構委託研究開発費（研究代表者：武藤　学）
6. 門前　一（研究分担者）：生物画像情報と四次元放射線治療を統合した個別化放射線治療法の開発：文部省科学研究費：基盤研究(A)（研究代表者：平岡　真寛）

2014年
1. 西村恭昌（主任研究者）：頭頸部腫瘍に対する強度変調放射線治療の確立と標準化のための臨床研究（西村班）：厚生労働省革新的がん医療実用化研究事業（H26-革新がん-一般-090）
2. 西村恭昌（研究代表者）、立花　和泉、石川　一樹（研究分担者）：腫瘍内低酸素イメージングに基づく高精度放射線治療の開発：文部省科学研究費：基盤研究(C)
3. 門前　一（研究代表者）：金属粉含有機能紙による新しい放射線防護材の研究・開発：文部省科学研究費：基盤研究(C)
4. 西村恭昌（分担研究者）：成人固形がんに対する標準治療確立のための基盤研究：国立がん研究センター研究開発費（26-A-4）（研究代表者：飛内　賢正）
5. 西村恭昌（分担研究者）：難治性食道がんの治療方針決定に資する技術開発に関する研究（武藤班）：厚生労働省革新的がん医療実用化研究事業

2013年
1. 西村恭昌（研究代表者）：頭頸部腫瘍に対する強度変調放射線治療の確立と標準化のための臨床研究（課題番号:H23-がん臨床-一般-009）：厚生労働省がん臨床研究事業
2. 西村恭昌（研究代表者）、立花　和泉、石川　一樹（研究分担者）：腫瘍内低酸素イメージングに基づく高精度放射線治療の開発：文部省科学研究費：基盤研究(C)
3. 門前　一（研究代表者）：金属粉含有機能紙による新しい放射線防護材の研究・開発：文部省科学研究費：基盤研究(C)
4. 門前　一（分担研究者）：難治がんの治療成績向上を目指した革新的放射線治療技術の開発：文部省科学研究費：基盤研究(S)（研究代表者　平岡眞寛）
5. 門前　一（分担研究者）：三次元半導体検出器を用いたＶＭＡT 照射中におけるエラー解析法の確立：日本放射線腫瘍学会課題研究（研究代表者　井上裕之）

2012年
1. 西村恭昌（研究代表者）：頭頸部腫瘍に対する強度変調放射線治療の確立と標準化のための臨床研究（課題番号:H23-がん臨床-一般-009）：厚生労働省がん臨床研究事業
2. 西村恭昌（研究代表者）：分子イメージングに基づく次世代放射線療法の開発：文部省科学研究費：基盤研究(C)
3. 西村恭昌（研究分担者）：早期の癌に対する標準的放射線治療方法確立と適応決定に関する研究（研究代表者：山田章吾）：文部省科学研究費：基盤研究(A)
4. 西村恭昌（研究分担者）：放射線治療を含む標準治療確立のための多施設共同研究（研究代表者：伊藤芳紀）：厚生労働省がん研究開発費
5. 金森修一（研究分担者）：放射線治療期間の短縮に関する多施設共同臨床試験の確立に関する研究（研究代表者：加賀美芳和）：厚生労働省がん研究助成金

2011年
1. 西村恭昌（研究代表者）：頭頸部腫瘍に対する強度変調放射線治療の確立と標準化のための臨床研究（課題番号:H23-がん臨床-一般-009）：厚生労働省がん臨床研究事業
2. 西村恭昌（研究代表者）：分子イメージングに基づく次世代放射線療法の開発：文部省科学研究費：基盤研究(C)
3. 西村恭昌（研究分担者）：早期の癌に対する標準的放射線治療方法確立と適応決定に関する研究（研究代表者：山田章吾）：文部省科学研究費：基盤研究(A)
4. 西村恭昌（研究分担者）：放射線治療を含む標準治療確立のための多施設共同研究（研究代表者：伊藤芳紀）：厚生労働省がん研究開発費
5. 柴田　徹（研究分担者）：放射線治療期間の短縮に関する多施設共同臨床試験の確立に関する研究（研究代表者：加賀美芳和）：厚生労働省がん研究助成金

2010年
1. 西村恭昌（研究代表者）：分子イメージングに基づく次世代放射線療法の開発：文部省科学研究費：基盤研究(C)
2. 西村恭昌（研究分担者）：早期の癌に対する標準的放射線治療方法確立と適応決定に関する研究（研究代表者：山田章吾）：文部省科学研究費：基盤研究(A)
3. 西村恭昌（研究分担者）：放射線治療を含む標準治療確立のための多施設共同研究（研究代表者：平岡眞寛）：厚生労働省がん研究助成金
4. 西村恭昌（研究分担者）：高精度治療技術による低リスク高線量放射線治療に関する臨床研究 (研究代表者：白土博樹）：厚生労働省がん研究助成金
5. 柴田　徹（研究分担者）：放射線治療期間の短縮に関する多施設共同臨床試験の確立に関する研究（研究代表者：加賀美芳和）：厚生労働省がん研究助成金

2009年以前
1. 西村恭昌（研究分担者）：早期の癌に対する標準的放射線治療方法確立と適応決定に関する研究（研究代表者：山田章吾）：文部省科学研究費：基盤研究(A)
2. 西村恭昌（研究分担者）：放射線治療を含む標準治療確立のための多施設共同研究（研究代表者：平岡眞寛）：厚生労働省がん研究助成金
3. 西村恭昌（研究分担者）：高精度治療技術による低リスク高線量放射線治療に関する臨床研究 (研究代表者：白土博樹）：厚生労働省がん研究助成金
4. 柴田　徹（研究分担者）：放射線治療期間の短縮に関する多施設共同臨床試験の確立に関する研究（研究代表者：加賀美芳和）：厚生労働省がん研究助成金
5. 西村恭昌（研究分担者）：早期の癌に対する標準的放射線治療方法確立のための臨床試験（研究代表者：山田章吾）：文部省科学研究費：基盤研究(A).
6. 西村恭昌（班員）：放射線治療期間の短縮に関する多施設共同臨床試験の確立に関する研究（研究代表者：加賀美芳和）：厚生労働省がん研究助成金.
7. 西村恭昌（班員）：放射線治療を含む標準治療確立のための多施設共同研究（研究代表者：平岡眞寛）：厚生労働省がん研究助成金.
8. 西村恭昌（班員）：高精度治療技術による低リスク高線量放射線治療に関する臨床研究 (研究代表者：白土博樹）：厚生労働省がん研究助成金.
9. 中松清志：日米放射線医交流協会、コニカミノルタ米国留学奨学金.
10. 西村恭昌（研究代表者）：強度変調放射線療法による標的体積内同時ブースト法の確立：文部省科学研究費：基盤研究(C).
11. 西村恭昌（研究分担者）：早期の癌に対する標準的放射線治療方法確立のための臨床試験（研究代表者：山田章吾）：文部省科学研究費：基盤研究(A).
12. 西村恭昌（班員）：その他、がんに対する標準的治療法の確立に関する研究（研究代表者：福岡正博）：厚生労働省がん臨床研究事業.
13. 西村恭昌（班員）：放射線治療期間の短縮に関する多施設共同臨床試験の確立に関する研究（研究代表者：加賀美芳和）：厚生労働省がん研究助成金.
14. 中松清志（研究代表者）：PET-CTシミュレーションによる高精度放射線治療計画の研究：医用原子力技術研究振興財団.
15. 西村恭昌（研究代表者）：強度変調放射線療法による標的体積内同時ブースト法の確立：文部省科学研究費：基盤研究(C).
16. 西村恭昌（研究分担者）：早期の癌に対する標準的放射線治療方法確立のための臨床試験（研究代表者：山田章吾）：文部省科学研究費：基盤研究(A).
17. 西村恭昌（班員）：その他、がんに対する標準的治療法の確立に関する研究（研究代表者：福岡正博）：厚生労働省がん臨床研究事業.
18. 西村恭昌（班員）：放射線治療期間の短縮に関する多施設共同臨床試験の確立に関する研究（研究代表者：加賀美芳和）：厚生労働省がん研究助成金.
19. 西村恭昌（研究代表者）：強度変調放射線療法による標的体積内同時ブースト法の確立：文部省科学研究費：基盤研究(C).
20. 西村恭昌（研究分担者）：早期の癌に対する標準的放射線治療方法確立のための研究（研究代表者：山田章吾）：文部省科学研究費：基盤研究(A).
21. 西村恭昌（班員）：その他、がんに対する標準的治療法の確立に関する研究（研究代表者：福岡正博）：厚生労働省がん臨床研究事業.
22. 西村恭昌（班員）：放射線治療期間の短縮に関する多施設共同臨床試験の確立に関する研究（研究代表者：加賀美芳和）：厚生労働省がん研究助成金.
23. 西村恭昌（研究代表者）：放射線生物学に基づく強度変調放射線治療(IMRT)の開発：文部省科学研究費：基盤研究(C).
24. 西村恭昌（研究分担者）：早期の癌に対する標準的放射線治療方法確立のための研究（研究代表者：山田章吾）：文部省科学研究費：基盤研究(A).
25. 西村恭昌（班員）：その他、がんに対する標準的治療法の確立に関する研究（研究代表者：福岡正博）：厚生労働省研がん臨床研究事業.
26. 西村恭昌（研究代表者）：放射線生物学に基づく強度変調放射線治療(IMRT)の開発：文部省科学研究費：基盤研究(C).
27. 西村恭昌（研究分担者）：早期の癌に対する標準的放射線治療方法確立のための研究（研究代表者：山田章吾）：文部省科学研究費：基盤研究(A).
28. 細野　眞（研究代表者）：放射能標識抗HER2抗体を用いた放射免疫療法の最適化に関する研究：文部科学省科学研究費：基盤研究(C)(2).
29. 細野　眞（研究分担者）：　医療行為に伴い排出される放射性廃棄物の適正管理に関する研究：厚生労働科学研究費補助金医薬安全総合研究事業.
30. 細野　眞（研究分担者）：医療放射線の防護の最適化及び被ばく線量の低減化方策に関する研究：厚生労働科学研究費補助金医薬安全総合研究事業.
31. 西村恭昌（研究代表者）：放射線生物学に基づく強度変調放射線治療(IMRT)の開発：文部省科学研究費：基盤研究(C).
32. 西村恭昌（研究協力者）：EBMの手法による肺癌の診療ガイドライン策定に関する研究（藤村班）：厚生労働科学研究費.
33. 工藤　崇：核医学を用いた非虚血性心疾患に伴う心筋細胞障害判定および治療反応性の予測：文部科学省研究費：若手研究(B).
34. 西村恭昌（研究代表者）、安田佳子：腫瘍血管新生におけるエリスロポイエチンの役割の解明：文部省科学研究費：特定領域研究(C).
35. 西村恭昌（研究協力者）：EBMの手法による肺癌の診療ガイドライン策定に関する研究（藤村班）：厚生労働科学研究費.
36. 鈴木　実：肝悪性腫瘍に対する化学放射線療法に関する基礎的研究：文部省科学研究費：奨励研究(Ａ).
37. 鈴木　実：肝腫瘍に対する硼素化合物の経動脈投与の有用性の検討：医用原子力技術に関する研究助成（医用原子力技術研究振興財団助成金）.
38. 工藤　崇：核医学を用いた非虚血性心疾患に伴う心筋細胞障害判定および治療反応性の予測：文部科学省研究費：若手研究(B).
39. 西村恭昌（研究代表者）：腫瘍の分子病理学的特性と放射線生物学的パラメータの関連性の解明：文部省科学研究費：基盤研究(C).
40. 西村恭昌（研究分担者）：がん関連遺伝子が及ぼす放射線効果への影響（研究代表者：加納永一）：文部省科学研究費：基盤研究(A).
41. 西村恭昌（研究代表者）、安田佳子：腫瘍血管新生におけるエリスロポイエチンの役割の解明：文部省科学研究費：特定領域研究(C).
42. 岡嶋　馨（研究代表者）：多列検出器型CTによる三次元画像を用いた高精度放射線治療計画の基礎的臨床的研究：第5回医用原子力技術に関する研究助成.
43. 西村恭昌（研究代表者）：腫瘍の分子病理学的特性と放射線生物学的パラメータの関連性の解明：文部省科学研究費：基盤研究(C).
44. 西村恭昌（研究分担者）：がん関連遺伝子が及ぼす放射線効果への影響（研究代表者：加納永一）：文部省科学研究費：基盤研究(A).
45. 西村恭昌（研究代表者）：腫瘍の生物学的特性に対応した放射線療法開発のための基礎的臨床的研究：小林孫兵衛記念医学振興財団研究助成金.
46. 西村恭昌（研究代表者）：癌関連遺伝子の増幅、発現と腫瘍内環境因子の関連性の解明：文部省科学研究費：重点領域研究(2)　.
47. 西村恭昌（研究分担者）：がん関連遺伝子が及ぼす放射線効果への影響（研究代表者：加納永一）：文部省科学研究費：基盤研究(A).

VII. 受賞

2021年
1. 奥畑勝也 The 9th Korea-Japan Joint Meeting on Medical Physics. Oral Presentation Award-Bronze.
2. 若林和樹 The 5th International Cancer Research Symposium, Young Investigator Award.

2020年
1. 土井啓至　近畿大学医学会　近畿大学医学会賞　2020
2. 土井啓至　The 3rd International Cancer Research Symposium Best Performance Award　2020

2019年
1. Mikoto Tamura, Hajime Monzen, Kenji Matsumoto, Masakazu Otsuka: ：Development of a new photochromic diarylethene film for clinical dosimetry.：The 19th Asia-Oceania Congress of Medical Physics. Perth, Australia (October 28-30th, 2019) Best Oral Presentation Award

2018年
1. 英語プレゼンテーション賞 (第115回日本医学物理学会学術大会)
  Mikoto Tamura, Hajime Monzen, Kenji Matsumoto, Masakazu Otsuka, Kazuki Kubo, Masahiko Okumura, and Yasumasa Nishimura.
  Application of knowledge-based VMAT treatment planning for prostate cancer to clinical delivery.

2017年
1. 田村命, 松本賢治, 奥村雅彦, 宇都辰郎, 門前一.
  画像誘導放射線治療におけるCone-Beam CT撮影時の体表面線量の評価と撮影条件の検討.
  第60回日本放射線技術学会近畿支部学術大会 (2017) (*新人奨励賞受賞)

2011年
1. 大久保充：日本放射線腫瘍学会・梅垣賞、2011年11月17日

2008年
1. 大久保充：　第67回日本医学放射線学会総会　銅賞、2008年4月6日.

2006年
1. 大久保充：　日本放射線腫瘍学会第19回学術大会　優秀発表賞、2006年11月23日.
2. 西村恭昌：　WJTOG(西日本胸部腫瘍臨床研究機構)賞　2006年5月20日.

2004年
1. Yasumasa Nishimura: ?World Scientists Forum International Awards: Eminent Scientist of the Year 2004, awarded by International Research Promotion Council.　 2004年10月11日 .

2003年以前
1. 工藤　崇：　第3回日本心臓核医学会若手研究者奨励賞　最優秀賞、2003年3月27日.
2. 鈴木　実：　RSNA 2002 Education Exhibit Award: Certificate of Merit, and Excellence in Design Award: Inverse planning of simultaneous integrated boost (SIB) method for high-grade gliomas: usefulness for defining GTV and CTV-annulus as two separate target volumes. At the 88th Scientific Assembly and Annual Meeting of Radiological Society of North America, Chicago, IL, USA, Dec 1-6, 2002.

教室業績集

近畿大学医学部放射線医学講座、研究業績目録

I. 博士学位

II. 英文原著論文

III. 和文原著、総説、症例報告

IV. 著書、分担執筆

Ｖ. 国際学会での発表

VI. 研究助成金

VII. 受賞